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Barrett’s metaplasia (BM) is the condition whereby the stratified squamous 
epithelium at the lower end of oesophagus is replaced by intestinal-like columnar 
epithelium. BM is associated with chronic cell injury caused by acid and bile salts 
refluxing from the stomach (so-called Gastro-oesophageal reflux disease (GORD). 
BM is important clinically as it is the only known precursor to oesophageal 
adenocarcinoma. Metaplasia is associated with the aberrant expression of key (master 
switch) transcription factor(s). It is therefore possible that intestinal transcription 
factors such as those involved in regulation of intestinal gene expression may be 
involved in the development of BM. In addition, the development of BM may be 
linked to exogenous factors such as acid, bile salts and inflammatory mediators, 
which leads to an inflammatory response and the premalignant condition. Therefore, 
the aims of the current project are three-fold to investigate (i) the role of HNF4α in 
the development of BM, (ii) the role of HNF1α, CDX2, FOXA2 and PDX1 in the 
development of BM and (iii) the effects of exogenous factors involved in the 
inflammatory response and the Wnt and Notch pathways on HNF4a and CDX2 
expression in the development of BM. The data showed that ectopic HNF4α, CDX2 
or HNF1α expression induces intestinal gene expression in the human normal 
oesophageal epithelial HET1A cells, but FOXA2 or PDX1 ectopic expression did not 
provoke intestinal gene expression. Furthermore, ectopic HNF4α expression in mouse 
oesophageal epithelial explants induced the squamous-to-columnar cell type 
conversion as well as VILLIN protein expression. These results suggest that ectopic 
expression of HNF4α, CDX2 and HNF1α might be involved in the initiation of BM. 
Finally, exogenous factors involved in the inflammatory and the Wnt and Notch 
pathways treatment failed to induce intestinal gene expression in the HET1A cells, 
but further studies such as extending the treatment time and the use of the 3D 
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1.1 Anatomy and development of the mouse oesophagus 
1.1.1 Oesophagus anatomy 
The oesophagus is a tube-like organ which connects the pharynx and stomach. Food 
from the oral cavity is delivered through the pharynx and the oesophagus to the 
stomach for digestion. The gastrointestinal contents can also be pushed out from 
stomach and intestine under vomiting and reflux conditions (Kuo & Urma, 2006). The 
adult mouse oesophagus is a multi-layered structure, composed of stratified squamous 
epithelium surrounded by connective tissue layers: lamina propria, muscularis mucosa, 
submucosa, muscularis externa and adventitia, from the innermost to the outermost 
layer (Gartner & Hiatt, 2000).  
 
There are differences between human oesophageal epithelium and mouse oesophageal 
epithelium. For example, there are more cell layers in human oesophageal epithelium 
than in the mouse oesophageal epithelium. In addition, unlike mouse, human 
oesophageal epithelium lack a cornified layer (Seery & Watt, 2000). Furthermore, 
human (but not mouse) oesophageal epithelium displays a papillae structure (the 
folding by submucosal projections) and also contains mucosal and submucosal glands,  
(Croagh et al., 2008; Squier & Kremer, 2001; Seery & Watt, 2000). 
 
1.1.2. Oesophageal epithelium development in mouse 
In the mouse, the oesophagus is derived from the foregut endoderm at around 
embryonic day 9.5 (E9.5) (Wells & Melton, 1999). At this stage, the oesophageal 
epithelium is a single layer of columnar epithelium expressing the columnar cell 
marker, cytokeratin 18 (K18). The epithelial cells gradually differentiate and then 
become stratified (multiple layers) squamous epithelium. At about E15.5, the 
oesophageal epithelium is lined by the stratified squamous epithelial cells which 
express markers such as K5 and K14 at the basal region, and K1 and K10 at the 
suprabasal epithelium. This replacement of columnar cells by squamous cells is 
considered as a direct cell type conversion (transdetermination). At birth, a cornified 
layer develops in mice at the outermost layer of epithelium and the epithelium 
consists of cells with the expression of the different intermediate filaments 
(cytoskeletal components) depending on the differentiated stage (Fig 1.1) (Moll et al., 






Figure 1.1. Intermediate filament and p63 expression in the mouse oesophageal 
epithelium                                                         
The Figure illustrates the different intermediate filament expressed in the mouse 
stratified squamous oesophageal epithelium. Oesophageal epithelial cells differentiate 
from the cells at the basal region and migrate toward the surface of the epithelium. 
Cells at basal region express the squamous transcription factor p63. During the 
terminal differentiation, cells express the different types of intermediate filaments. 




1.2. Anatomy and development of the mouse small intestine 
Following gastrulation in the mouse, the pseudostratified endoderm forms and then 
develops into the intestinal epithelium at about E14.5. Cytodifferentiation starts 
between E14.5 and E17.5. During cytodifferentiation, the pseudostratified endoderm 
develops into a single layer of columnar cells. In addition, the villi are also formed at 
this stage (Fig. 1.2). The region between villus (intervillus region) then invaginates 
and becomes a crypt-like structure. At the adult stage, the small intestine epithelium is 
shown in villus-crypt architecture with single layer of columnar cells (Sancho et al., 
2004; de Santa Barbara et al., 2003; Totafurno et al., 1987). 
 
The main function of the small intestine is to aid in the digestion and absorption of 
food. The small intestinal epithelium can be divided into two regions: the villi 
(finger-like protrusions) and crypts (found at the base of the villi). Intestinal stem cells 
are thought to be located in the crypt region and can differentiate into 4 main types of 
intestinal epithelial cells including enterocytes, enteroendocrine cells, Goblet cells and 
Paneth cells. Enterocytes comprise about 80% of intestinal epithelial cells and 
contribute to nutrient absorption. Enteroendocrine cells secrete hormones e.g. 
serotonin, substance P to regulate intestinal functions such as intestinal movement, 
homeostasis and secretion. Goblet cells produce mucus to prevent microbial invasion 
and to protect the intestinal epithelium from the proteolytic activity of digestive 
enzymes. Paneth cells secrete antimicrobial protein and peptides including α-defensin, 
lysozyme and cryptidins to against microbial invasion. Therefore Paneth cells play a 
critical role in the gut innate immune response (Schonhoff et al., 2004; Stappenbeck, 
2009). 
 
In addition to the 4 main cell types, M cells and Tuft cells are also found in the 
intestinal epithelium. M cells are found on the luminal surface of the mucosal 
lymphoid follicles. M cells sample antigen from the gut lumen and transport antigen 
to the immune cells (Jang et al., 2004). Tuft cells account for only 0.4% of intestinal 
epithelial cells and Tuft cell function remains to be discovered although they are 




In the adult, the small intestinal epithelial cells renew every 5 to 7 days. Stem cells 
located at the crypts are considered as the origin of epithelial cells of small intestine 
(Marshman et al., 2002). As the intestinal epithelial cells differentiate, cells including 
enterocytes, enteroendocrine cells and goblet cells migrate from the crypt to villus 
region while Paneth cells inhabit the crypt region (Gartner & Hiatt, 2000). The Notch 
and Wnt pathways have been suggested to determine intestinal cell fate. Notch 
signalling contributes to the differentiation towards the absorptive lineage 
(enterocytes), while Wnt signalling leads to the secretory cell types (Paneth cells, 
enteroendocrine cells and goblet cells) (van der Flier & Clevers, 2009). 
 
1.3. Metaplasia and Transdifferentiation     
Metaplasia is defined as “the transformation of one tissue type into another” whereas 
transdifferentiation is more restricted to the phenomenon of “the transformation of 
one differentiated cell type into another”. The transformation process in metaplasia 
might include the conversion of tissue-specific stem cells, progenitor cells or 
differentiated cell lineages, while transdifferentiation is a subtype of metaplasia which 
refers to the direct conversion between differentiated cell types (Slack, 2007; 
Eberhard & Tosh, 2008). 
 
One of the current models explaining the underlying molecular mechanisms of 
metaplasia suggests that the activation (or inactivation) of certain key transcription 
factors is critical to the switch in phenotype. At the embryonic stage, the expression of 
the key transcription factor(s) affect the transcription of downstream genes, so gives 
the tissue identity with its unique gene expression profile (Fig. 1.3). However, in the 
adult tissue, the expression profile of the key (master switch gene) transcription 
factors might be altered due to a genetic mutation or changes in environmental factors 
(which then alters gene expression). Thus, either the induction of the new 
transcription factor or the loss of the original transcription factor might change gene 
expression pattern and induce a new cell type. For example, CEBP/β (CCAAT 
enhancer binding protein β) is a transcription factor expressed in liver, but is not 
expressed in the pancreas. When CEBP/β is introduced into the pancreatic exocrine 







Figure 1.2. The development of intestinal epithelium                
The embryonic small intestinal epithelium initially forms stratified epithelial 
epithelium which then develops into single layer epithelium with finger-like villi 
structure at late fetus stage. Subsequently, villi elongate and crypts are formed by 
invagination and the villus-crypt units are finished as adult small intestine feature. 
(Figure is modified from de Santa Barbara et al. 2003)   
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Figure 1.3. Concept of metaplasia 
(a). The expression and of transcription factor X determines the tissue type between 
neighbouring regions during embryogenesis. (b). In postnatal life, loss of transcription 




Metaplasia in postnatal life is usually associated with pathological conditions. For 
example, Barrett’s metaplasia is the conversion of the stratified squamous cells at the 
lower end of the oesophagus to columnar intestinal cells and is linked to 
gastro-oesophageal reflux disease. Barrett’s metaplasia has been recognised as the 
only known precursor of oesophageal adenocarcinoma (Badreddine & Wang, 2010) 
(see section 1.4 for further details). Another example in which metaplasia appears is 
Crohn’s disease. Crohn’s disease is a chronic inflammatory bowel disease and gastric 
metaplasia can be found in the sites of ulceration associated with the disease 
(Kushima et al., 1997; Kaneko et al., 2008). Given that metaplasia may be related to 
stimuli from the cellular environment, studying the mechanisms underlying the 
initiation and progression to metaplasia could benefit disease diagnosis and aid in 
treatment. For example, identifying markers which are involved in the formation of 
metaplasia could be applied to disease diagnosis (Shen et al., 2004). Understanding 
the factor(s) that initiate metaplasia might also help to manage disease progression by 
avoiding risk factors. In addition, understanding the mechanisms underlying the 
development of metaplasia is also crucial for developing cell therapy treatments in 
regenerative medicine. As the shortage of organs and tissues for transplantation has 
been an issue, converting one cell type to another cell type to produce the desired cells 
could be a strategy for tissue regeneration and cellular therapy (Shen et al., 2004).  
 
1.4. Barrett’s metaplasia (BM) 
1.4.1. What is Barrett's metaplasia?                         
Barrett’s metaplasia (BM) is the pathological condition in which the normal stratified 
squamous epithelium is replaced by columnar type epithelium at the distal end of the 
adult oesophagus. The columnar cells display characteristics of small intestinal 
epithelium (Shaheen & Richter, 2009). BM has clinical importance as it is the only 
known precursor to oesophageal adenocarcinoma (Thrift et al., 2012). The disease 
progression is from normal oesophagus, oesophagitis, BM, dysplasia to oesophageal 
adenocarcinoma (Jankowski et al., 2000; Conio et al., 2002). The prevalence of BM is 
approximately 1.6%. Around 0.33 % of BM patients go on to develop oesophageal 
adenocarcinoma annually (Desai et al., 2012). Indeed patients with BM have 30 – 125 
times higher risk of developing oesophageal adenocarcinoma than the normal 
population (Paulson & Reid, 2004; Pohl & Welch, 2005; Hahn et al., 2010). As the 
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incidence of oesophageal adenocarcinoma has been increasing over the last 30 years 
(Pohl & Welch, 2005), and BM is the only known precursor, it is therefore important 
to understand the molecular mechanisms underlying the development of BM. 
 
1.4.2 Current treatments for BM 
Because the risk of oesophageal adenocarcinoma in non-dysplastic BM is relatively 
low (~0.33% per year), repeat endoscopic surveillance is suggested for the patient 
with non-dysplastic BM (Desai et al., 2012; Fitzgerald et al., 2014). For the dysplastic 
BM, various treatments are available. The treatments aim to prevent the progression 
to cancer. Some treatments also aim to remove the BM tissue (Spechler, 2014; 
Fitzgerald et al., 2014). Current treatments for dysplastic BM include medical 
treatment, anti-reflux surgery, endoscopic treatment and surgical resection methods. 
 
In conventional medical treatment, proton pump inhibitors (PPIs) are currently the 
most effective available medicines for inhibiting gastric acid secretion through 




-ATPase) function (Sachs et al., 2006). The inhibition 
of gastric acid secretion may help to prevent the acid-induced chronic inflammation at 
the lower end of the oesophagus as well as the secretion of cancer-promoting 
cytokines (such as interleukin 6 (IL-6) and IL-8) by the oesophageal epithelial cells 
(Rafiee et al., 2009; Spechler, 2014). Acid suppression may also prevent acid-induced 
genetic mutation and abnormal cell proliferation (Clemons et al., 2007; Spechler, 
2014). Therefore, PPI treatment might prevent the neoplastic progression in BM. 
 
Anti-reflux surgery aims to improve the closing function of the lower oesophageal 
sphincter function in order to prevent the reflux of the gastric acid to the lower 
oesophagus. The anti-reflux operation is called Fundoplication in which the gastric 
fundus is wrapped around the lower end of the oesophagus and sewn in place 
(Jamieson et al., 1994). Surgical treatment might be more effective than the PPI 
treatment in preventing carcinogenesis in BM (DeMeester & DeMeester, 2000). PPIs 
only prevent gastric acid secretion, but surgical treatment could prevent the gastric 
juice reflex including both gastric acid and bile salts, to the lower end of the 
oesophagus. Bile salts could also potentially promote carcinogenesis in the BM 
(Jenkins et al., 2007; Spechler, 2014). However, the surgical risk, and the cost and 
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effects of anti-reflux surgery need be taken into consideration for BM treatment 
(Spechler, 2014). Therefore, it is proposed that surgical treatment was suggested for 
patients who have poor response to acid suppression treatment (Fitzgerald et al., 
2014).   
 
BM tissue might be eliminated by endoscopic ablative techniques such as 
radiofrequency ablation (RFA), endoscopic mucosal resection (EMR), photodynamic 
therapy (PDT) and cryotherapy. RFA is performed through an endoscope-mounted or 
a balloon-mounted catheter which was attached to the end of the endoscope. When the 
electrodes (covered in the catheter) targets BM tissue, the balloon inflates and the 
electrodes generate radiofrequency energy to ablate the BM tissue (Konda et al., 
2014). PDT is used for treatment of dysplastic BM. During the PDT treatment, a 
photosensitizer (a light sensitive drug) is given to the patient and the photosensitizer is 
selectively absorbed by the malignant cells. The laser light is then introduced to the 
BM region which will induce the photosensitizer to produce an oxidative reaction in 
turn destroying the BM dysplastic tissue (Sánchez et al., 2010). The principle of EMR 
is based on using the endoscopic resection technique to perform a cut or snare 
resection procedure to remove BM mucosa (Seewald et al., 2007). In cryotherapy 
treatment, liquid nitrogen is sprayed onto BM region. Therefore, BM tissue is frozen 
and destroyed (Gosain et al., 2013). Overall, endoscopic treatments are recently used 
primarily for dysplastic BM treatment and the endoscopic treatments seem to be 
cost-effective. However, long-term effects still need to be studied to evaluate the 
benefits of using endoscopic treatment for preventing oesophageal adenocarcinoma 
(Spechler et al., 2011; Fitzgerald et al., 2014). Finally, surgical resection, which is 
known as oesophagectomy, may be recommend for the young patients with extensive 
and multifocal high-grade dysplasia (Shaheen & Richter, 2009). 
 
1.4.3 The cellular origins of BM  
There are four potential mechanisms to explain the appearance of columnar type cells 
in the oesophagus (Fig. 1.4). The first is that the BM might arise as the transformation 
from an oesophageal stem cell to an intestinal stem cell with subsequent 
differentiation to intestinal cell types (goblet cells, enterocytes, Paneth cells and 
enteroendocrine cells) (Barbera & Fitzgerald, 2010). The second is that the BM arises 
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from the stem cells in the submucosal glands (Leedham et al., 2008; Nicholson et al., 
2012). The third may involve the reverse of the cell type conversion observed in 
embryonic development (i.e. conversion from a stratified squamous to columnar-type 
epithelium) (Yu et al., 2005; Barbera & Fitzgerald, 2010). The fourth is that the BM 
cells originate from the gastro-oesophageal junction or gastric cardia (Wang et al., 
2011; Quante et al., 2012). 
 
In terms of the first possibility, the columnar-like intestinal cells in BM might 
differentiate from the oesophageal epithelial stem cells. However, the location and 
identity of the oesophageal epithelial stem cells is still controversial. A study showed 
that CD34
+
 cells at the basal layer have stem cell capacity for self-renewal and 




 basal cells as stem cells and these cells are able to reconstitute oesophageal 
epithelium in vitro (Croagh et al., 2007). Interestingly, a recent study demonstrated 
that the oesophageal epithelium is maintained and repaired by proliferating progenitor 
cells in the basal layer of the stratified squamous epithelium rather than the quiescent 
and self-renewing stem cells (Doupé et al., 2012). Further studies still need to address 
the identity of the epithelial stem cells. 
 
In the second explanation, the theory proposed is that BM cells arise from stem cells 
in the glandular neck region of sub-mucosal glands (Barbera & Fitzgerald, 2010). 
Evidence from serial sections of BM tissue revealed that in some BM samples, 
oesophageal gland ducts open onto the overlying Barrett's epithelium suggesting the 
relationship between gland ducts and BM (Glickman et al., 2001b). In addition, 
characterization of pig oesophageal sub-mucosal gland cultures showed a similar K7 
and K20 expression profile to that in BM (Abdulnour-Nakhoul et al., 2007). Finally, 
clonal analysis of BM sections demonstrated that BM cells display genetic 
heterogeneity suggesting that BM cells originate from different clones (Leedham et al., 
2008; Nicholson et al., 2012). It was also observed that BM cells have the same 
mutation as the adjacent gland ducts suggesting gland ducts are the source of BM.   
 
The third explanation for the appearance of BM is transdifferentiation. The 
oesophageal epithelium during embryonic development initially forms a simple 
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columnar epithelial layer which expresses the columnar epithelial marker K8. From 
around E11.5, the epithelial layer progressively turned into stratified squamous 
epithelium. Cells at basal region begin to express the squamous epithelial marker K14. 
K8/K14 co-staining and in vitro lineage tracing experiments demonstrated that the 
columnar-to-squamous cell type change is a direct cell type conversion referred to as 
transdetermination because it occurs in the embryonic stage of development (Yu et al., 
2005).  
 
In the fourth theory, the BM cells may originate from cells migrating from the 
gastro-oesophageal junction or gastric cardia (Wang et al., 2011; Quante et al., 2012). 
Recently two reports using mouse models support the idea that BM cells may arise 
from the gastro-oesophageal junction or the gastric cardia. In the first report, it was 
observed that p63-null mouse embryos develop a BM-like phenotype (Wang et al., 
2011). Tracking the cell source revealed that these BM-like cells may be the residual 
embryonic cells. These embryonic residual cells are usually located at 
squamous-columnar junction in postnatal life. When squamous epithelium is damaged, 
these residual embryonic cells proliferate and migrate into the oesophagus to replace 
the original squamous epithelium. However, there is a lack of robust lineage tracing 
experiments in this study. In the second report, IL-1β was overexpressed in the mouse 
oesophageal epithelium, and this leads to BM and oesophageal adenocarcinoma 
(Quante et al., 2012). Lineage tracing experiments revealed that BM cells might arise 
from gastric cardiac leucine-rich-repeat-containing G-protein-coupled receptor 5 
(LGR5)-expressing stem cells at the squamous-columnar junction. Indeed, LGR5 is a 
marker for stomach and intestinal stem cells and LGR5 expression is found in the BM 
tissue (Barker et al., 2007, 2010; Becker et al., 2010).These LGR5-positive gastric 
cardiac stem cells presumably migrate into the oesophagus due to an inflammatory 








Figure 1.4. Potential cellular origins of BM                              
BM cells may originate from (a). oesophageal epithelial stem cells, (b). stem cells in 
the submucosal gland, (c). cells transdeterminated from oesophageal epithelial cells or 
(d). stem cells located at gastric or oesophageal-gastric junction. (Figure is amended 
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1.4.4 Molecular mechanisms underlying the development of BM 
The main risk factor for the development of Barrett’s is GORD (gastro-oesophageal 
reflux disease). Around 10% of GORD patients develop Barrett’s metaplasia 
(Westhoff et al., 2005). The key components of the gastric refluxate are bile acids.  
Bile acids are derived from cholesterol in the liver, and are stored and concentrated in 
the gallbladder. After food intake, the duodenum secretes cholecystokinin which 
stimulates the gallbladder to release bile. Bile is then delivered into the duodenum to 
emulsify fats for absorption. In the intestinal lumen, more than 95% of bile acids will 
be reabsorbed from the intestine back to the liver through the portal vein (the 
so-called enterohepatic circulation) (Dawson et al., 2009; Li & Chiang, 2013).  
 
The bile acid family can be divided into primary and secondary bile acids according 
to where they are produced. Primary bile acids including cholic acid and 
chenodeoxycholic acid are produced in the liver. Secondary bile acids such as 
deoxycholic acid (DCA) and lithocholic acid are modified from primary acids by 
bacteria in the intestine (Lefebvre et al., 2009). 
 
Bile acid exposure in the oesophagus is associated with the induction of intestinal 
transcription factor gene expression. Treatment of rat oesophageal keratinocytes with 
cholic acid or DCA have been shown to induce the expression of intestinal 
transcription factor CDX2 (see 1.5.1 section for further details of CDX2)(Kazumori et 
al., 2006). In addition, it has been shown that DCA is able to activate NF-κB 
signalling pathway in OE33 cells (Jenkins et al., 2004, 2008). Because the CDX2 gene 
is a target of NF-κB (Kim et al., 2002; Kazumori et al., 2006), it is therefore possible 
that CDX2 induction by DCA is mediated through an NF-κB-dependent mechanism. 
Furthermore, treatment of OE33 cells, Het-1A (human normal oesophageal cells) cells 
and rat oesophageal keratinocytes with a mixture of cholic acid, glycocholic acid and 
taurocholic acid induces the expression of the intestinal transcription factors CDX1 
and gut-enriched Krüppel-like factor (KLF4) (Kazumori et al., 2009, 2011). Taken 
together these studies suggest that bile acids are highly associated with the 





1.5 Candidate transcription factors in BM development 
The exposure of gastric refluxate might result in the conversion of oesophageal 
squamous cells to intestinal-like columnar cells. The theory about how metaplasia 
arises suggests that metaplasia formation is linked to the mis-expression of few key 
transcription factors (Slack, 2007). It is therefore possible that ectopic expression of 
intestinal transcription factors is associated with the development of BM.  
 
1.5.1 Role of CDX2 in the intestine and BM   
The homeodomain transcription factor caudal-type homeobox (CDX) family proteins 
CDX1 and CDX2 are specifically expressed in the differentiated intestinal epithelium. 
In the mouse, Cdx2 protein is first expressed at E3.5 in the trophectoderm and Cdx1 is 
detected at E7.5 along the embryonic axis. By E8.5, Cdx2 is found in the hindgut 
endoderm, while Cdx1 begins to be expressed in the hindgut endoderm from E12.5 
(Beck et al., 1995; Subramanian et al., 1995; Silberg et al., 2000). Cdx1 and Cdx2 
participate in axial patterning and Cdx2 also regulates anterior-posterior patterning of 
the intestine epithelium (Guo et al., 2004; Kaestner, 2010). In addition, Cdx2 plays a 
central role in initiating intestinal epithelial differentiation. Forced expression of Cdx2 
in the undifferentiated rat intestinal epithelial cell line, IEC-6, initiates differentiation 
(Suh & Traber, 1996). It was also shown that Cdx2 regulates intestinal gene 
expression such as sucrase-isomaltase (Si) and lactase (Suh & Traber, 1996; Lorentz 
et al., 1997). 
 
CDX2 is absent in the normal oesophageal epithelium, but CDX2 is expressed in BM. 
Therefore CDX2 has been considered to be a marker of BM (Eda et al., 2003; Moons 
et al., 2004; Burnat et al., 2007). Research utilizing transgenic mice models showed 
that Cdx2 homozygous knockout mice died between E3.5-E5.5 due to implantation 
failure (Chawengsaksophak et al., 1997; Strumpf et al., 2005). Cdx2 heterozygous 
knockout mice are viable, but intercalary regeneration (or order filling-in of the tissue) 
in the form of stratified squamous epithelium was discovered in the proximal colon 
(Tamai et al., 1999; Beck et al., 1999). In addition, studies from conditional Cdx2 
knockout mice (Cdx2
loxP/loxP
; Foxa3-Cre) in which Cdx2 expression is ablated around 
E9.5, lead to the absence of colon and the loss of intestinal characteristics. The 
posterior intestinal cells displayed characteristics of oesophageal epithelium such as 
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expression of p63 and K13 (Gao et al., 2009). More importantly, in Foxa3-Cdx2 
transgenic mice, ectopic expression of Cdx2 in gastric mucosa promotes the 
intestinalization of gastric epithelium, suggesting the critical role of Cdx2 in the 
development of intestinal metaplasia (Silberg et al., 2002).  
 
In vitro studies have demonstrated that ectopically expressing Cdx2 in primary rat 
oesophageal epithelial cells induces mucin 2 (Muc2) expression (an intestinal goblet 
cell marker) suggesting that the transcription factor may play a role in the 
development of BM
 
(Kazumori et al., 2006). However, K14-Cdx2 transgenic mice in 
which the K14 promoter drives Cdx2 expression in the basal layer of oesophageal 
epithelium, did not induce the expression of BM associated genes, but treating 
K14-Cdx2 mice with 5’-Azacytidine (5’Aza), which is a DNA methyltransferase 
inhibitor initiated the expression of BM associated markers including K18 and Cdx1. 
This suggests chromatin modification might also be required in the development of 
BM (Kong et al., 2011b).Furthermore, it was suggested that the exposure of bile and 
acid is associated with the induction of Cdx2 expression in oesophageal epithelium 
(Marchetti et al., 2003; Debruyne et al., 2006). For example, it was observed Cdx2 
protein production was induced by the bile salt or acid treatment in the primary rat or 
mouse oesophageal epithelial cell cultures (Marchetti et al., 2003; Kazumori et al., 
2009). 
 
In addition to CDX2, CDX1 may also be involved in the development of BM (Wong 
et al., 2005). Cdx1 null mice are viable and show the anterior homeotic 
transformations of the vertebrae (Subramanian et al., 1995). Like CDX2, CDX1 is 





-ATPase-Cdx1) in which Cdx1 is expressed in the gastric mucosa develops 
gastric intestinal metaplasia (Mutoh et al., 2004). In addition, Cdx1 protein can be 
induced by a cocktail of bile acids (cholic acid, glycocholic acid and taurocholic acid) 
in primary cultured rat oesophageal epithelial cells. A positive inter-regulation was 
observed between CDX1 and CDX2 expression in the OE33 cells. The transfection of 
CDX1 expression vector increased CDX2 promoter activity. Similarly, CDX1 
promoter activity was increased following the transfection of CDX2 expression vector. 
This suggests that CDX1 and CDX2 together contribute to the initiation of BM 
33 
 
(Kazumori et al., 2009). Although CDX transcription factors may be key regulators in 
the initiation of intestinal metaplasia, it is not clear whether the expression of CDX 
transcription factors alone or in combination with other intestinal transcription factors 
initiate BM.   
  
1.5.2 Role of HNF4α in the intestine and BM                            
Hepatocyte nuclear factor 4α (HNF4α) is an orphan nuclear receptor that functions as 
a transcription factor. HNF4α is mainly expressed in the liver, pancreas, intestine and 
kidney. HNF4α is essential for embryonic development. In mouse, as early as E4.5, 
Hnf4α is specifically expressed in visceral endoderm and regulates protein secretion 
for gastrulation. Hnf4α knockout mice die before E10.5 due to the disruption of 
gastrulation (Chen et al., 1994; Duncan et al., 1997). 
 
HNF4α is expressed in the differentiated intestinal epithelium and regulates 
differentiation, cell proliferation and homeostasis. Lack of Hnf4α in conditional 
Hnf4α knockout mice (Villin-Cre-ERT; Hnf4αloxP/loxP) showed abnormal homeostasis, 
cell structure and barrier function in intestinal epithelium. Hnf4α deletion alters 
intestinal cytodifferentiation resulting in increased numbers of Goblet cells and the 
inhibition of enterocyte and enteroendocrine maturation (Babeu et al., 2009; Cattin et 
al., 2009). Observations from in vitro models also showed that Hnf4α is involved in 
the differentiation of intestinal epithelium. For example, forced Hnf4α expression in 
IEC-6 cells (an undifferentiated intestinal epithelial cell line) was able to induce cell 
differentiation in a co-culture model (Lussier et al., 2008).  
 
Interestingly, overexpression of HNF4α in non-intestinal cells (including NIH-3T3 
cells (mouse embryonic fibroblast) and Mia PaCa-2 (Human pancreatic carcinoma)) 
promotes the transcription of intestinal genes such as apolipoprotein A-IV (APOA-IV), 
Trefoil factor 3 (TFF3) and VILLIN. In addition, the formation of apical microvilli 
and dense ultrastructures reminiscent of intestinal epithelial cell characteristics was 
also observed in NIH-3T3 cells in which HNF4α was overexpressed (Babeu et al., 
2009). More importantly, HNF4α is not expressed in oesophageal epithelium, but it is 
present in the glands and epithelium of oesophageal tissue in BM (Piessen et al., 2007; 
Colleypriest, 2010). Indeed, forced expression of Hnf4α in primary mouse 
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oesophageal epithelial cells provoked intestinal Villin gene and protein expression 
(Colleypriest and Tosh personal communication). Therefore, HNF4α is a potential 
key transcription factor for intestinal epithelium identity and may play a critical role 
in BM development. 
 
1.5.3 Role of HNF1α in the intestine and BM     
Hepatocyte nuclear factor 1 α (HNF1α) is a homeodomain-containing transcription 
factor and binds to DNA as homodimers. HNF1α is expressed in the liver, pancreas, 
intestine, stomach, and kidney (Baumhueter et al., 1990; Pontoglio et al., 1996). In 
mouse intestinal epithelium, HNF1α protein is mainly detected in the villus region 
and HNF1α plays a role in regulating intestinal gene expression. Studies demonstrated 
that HNF1α regulated intestinal Si gene transcription by binding to promoter region in 
the Caco2 cell line (human colorectal adenocarcinoma cells) (Boudreau et al., 2002). 
Further studies also suggested that HNF1α worked in combination with CDX2 to 
promote intestinal differentiation in HIEC cells (human intestinal epithelial crypt 
cells)(Benoit et al., 2010).    
 
HNF1α and HNF1β may have complementary roles in regulating intestinal epithelium. 
Hnf1α and Hnf1β double knockout (Hnf1α−/−,Hnf1βflox/flox ; Villin-CreER) mice 
displayed an alteration in the marker expression of both the enterocyte and secretory 
lineage cells, the increase of goblet cell population and the absence of mature Paneth 
cells, suggesting the HNF1 protein family plays an important role in regulating 
intestinal cell differentiation and cell identity (D’Angelo et al., 2010). Hnf1α 
knockout mice also suggest that Hnf1α is required for the normal adult intestinal 
architecture. Hnf1α controls cell growth and cell fate decisions in the adult intestinal 
epithelium (Lussier et al., 2010). In addition, HNF1α becomes expressed in BM tissue 
(Piessen et al., 2007). Therefore, HNF1α may be involved in the development of BM. 
 
1.5.4 Regulatory network of CDX2, HNF1α and HNF4α in the intestine     
Intestinal cell proliferation and differentiation are controlled by a transcription factor 
regulatory network (Olsen et al., 2012). The aberrant expression of one intestinal 
transcription factor could affect the expression of the other intestinal transcription 
factors. The regulatory network among CDX2, HNF1α and HNF4α is the most 
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studied transcription factor network in the intestinal epithelium. Details of CDX2, 
HNF1α and HNF4α interactions are shown in Table 1.1 and the model of their 







Table 1.1. Transcriptional regulatory network in the intestinal epithelium 
Table showing the regulation of the transcription factors CDX2, HNF1α and HNF4α 
in the differentiated intestinal epithelium. * Note that the regulation of HNF4α 
expression by HNF1α and the autoregulation of HNF1α or HNF4α in the intestine has 









CDX2 Autoregulation, Cdx2 activates its own 
enhancer and promoter  
(Xu et al., 1999; 
Boyd et al., 2010) 
HNF1α 
 
Activates CDX2 binds to HNF1α 
promoter 
(Gao et al., 2009) 
HNF4α 
 
Activates HNF4α expression through 
HNF4α enhancer and promoter 
(Boyd et al., 2010; 
Gao et al., 2009) 
HNF1α CDX2 Activates CDX2 gene expression 
through CDX2 enhancer 
(D’Angelo et al., 
2010) 
HNF1α* Autoregulation, inhibits HNF1α 
expression through its own promoter  
(Kritis et al., 1993) 
HNF4α* Activates HNF4α gene expression 
through HNF4α promoter 
(Odom et al., 2004) 
HNF4α 
 
CDX2 Activates CDX2 gene expression 
through CDX2 promoter 
(Boyd et al., 2009) 
HNF1α Activates HNF1α gene expression 
through HNF1α promoter 
(Lussier et al., 2008; 
Boyd et al., 2009) 
HNF4α* Autoregulation, inhibits HNF4α 
expression through its own promoter 













Figure 1.5. Model of transcriptional regulatory network in the intestinal 
epithelium 
Figure is the summary of Table 1.1 and illustrates the regulatory network of CDX2, 
HNF1α and HNF4α in the differentiated intestinal epithelium. CDX2, HNF1α and 
HNF4α activate each other’s expression. CDX2 positively autoregulates its own 
expression, but HNF4α and HNF1α might negatively autoregulate their own 
expression. The regulation presented in solid line is based on studies in the intestine 




1.5.5 Role of FOXA2 in the intestine and BM 
Forkhead box A2 (FOXA2) (also known as hepatocyte nuclear 3β (HNF3β)) belongs 
to the forkhead DNA-binding protein family. FOXA2 protein functions as a 
transcription factor binding to DNA through a winged helix motif (Besnard et al., 
2004). In the developing mouse intestine, Foxa2 can be detected at E10.5 stage and in 
the adult, Foxa2 is mainly expressed in the crypt region (van der Sluis et al., 2008; 
Suzuki et al., 2009). FOXA2 regulates intestinal gene expression. For example, Foxa2 
controls Muc2 expression via binding to the Muc2 promoter in CMT-93 cells (mouse 
rectal carcinoma cells) (van der Sluis et al., 2008). Loss of Foxa2 in mice (Foxa2-/-) 
is embryonic lethal and this is primarily due to the failure of normal node and 
notochord formation (Ang & Rossantt, 1994). Studies of Foxa1 and Foxa2 deletion in 
the intestine have been reported (Ye & Kaestner, 2009). Animal models of intestinal 





mice. Intestinal Foxa1 and Foxa2 null mice demonstrated the decrease of goblet and 
enteroendocrine cell population. It was found that the ablation of Foxa1 and Foxa2 
decreased the expression of enteroendocrine cell transcription factors including paired 
box transcription factors 6 (Pax6) and Islet-1 (Isl-1). The reduction of Pax6 and Isl-1 
resulted in the down-regulation of their downstream targets, preproglucagon gene 
(glucagon-like peptide 1/2, Glp 1/2) and Somatostatin respectively (Leonard et al., 
1992; Hill et al., 1999; Ye & Kaestner, 2009). In addition, Foxa1 and Foxa2 ablation 
also decreased Muc2 at the transcription level. These results suggest that Foxa1 and 
Foxa2 regulate intestinal enteroendocrine cell and goblet cell differentiation (Ye & 
Kaestner, 2009) .   
 
1.5.6 Other transcription factor involved in BM 
Pancreatic and duodenal homeobox 1 (PDX1) transcription factor may be involved in 
the development of BM. PDX1 expression is found in the anterior part of the intestine, 
pancreas and stomach (Miller et al., 1994; Larsson et al., 1996). It was shown that 
Pdx1 promoted the differentiation toward the enteroendocrine cell lineage in the 
undifferentiated rat intestinal IEC-6 cells (Yamada et al., 2001). In addition, Pdx1 
conditional deletion in mouse intestine (Pdx1
flox/flox
;Villin-Cre) led to the reduction in 
gene expression of enterocytes (such as alkaline phosphatase 3) and enteroendocrine 
cells (such as gastric inhibitory polypeptide and somatostatin) (Chen et al., 2009; 
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Chen & Sibley, 2012). Pdx1 also regulates enterocyte gene expression including Si, 
fatty acid binding protein 1 and Lactase (Wang et al., 2004; West & Oates, 2005; 
Chen et al., 2012b).  
 
Intestinal transcription factors GATA-binding protein 4 (GATA-4), GATA-6, KLF4 
and SRY-box containing gene 9 (SOX9) have been reported to have a potential role in 
the development of BM (Chen et al., 2008; Haveri et al., 2008; Wang et al., 2010; 
Kazumori et al., 2011). For example, it was proposed that bile acid triggers 
oesophageal epithelial cells to produce Sonic hedgehog (SHH) protein. SHH 
stimulates mesenchymal cells to produce BMP4 which then induces SOX9 expression 
in the oesophageal epithelium. Ectopic SOX9 expression drives columnar 
differentiation of oesophageal squamous epithelium and also induces the expression 
of glycoprotein A33. A33 glycoprotein is exclusively expressed in the intestine and 
A33 is also a BM marker (Wong et al., 2006; Clemons et al., 2012; Wang et al., 
2010).  
 
Homeobox (HOX) genes may play a role in BM. The HOX gene family is known to 
play a central role in patterning anterior-posterior axis during the embryonic 
development (McGinnis & Krumlauf, 1992). It was shown that the HOX gene 
subfamily HOXB5, 6, and 7 (which are highly expressed in the colon) are expressed in 
BM but not the normal stratified squamous epithelium. Indeed, forcing HOXB5, 6, 
and 7 expression in the normal human oesophagus-derived NES cells induces BM 
phenotype with VILLIN, K20 and MUC2 expression all detected (di Pietro et al., 
2012).   
 
1.5.7 Squamous epithelial transcription factor, p63 
Activation of intestinal transcription factors in oesophageal epithelium might cause 
intestinal metaplasia. In contrast, down-regulation of the key transcription factor in 
squamous epithelial differentiation is also observed. p63, a homologue of the tumour 
suppressor p53, is required for squamous epithelial development and is essential for 
squamous cell differentiation as mice lacking p63 fail to develop stratified squamous 
epithelium (Mills et al., 1999; Yang et al., 1999). In the oesophagus, p63 is expressed 
in the basal layer of epithelium (Glickman et al., 2001a; Daniely et al., 2004). 
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However, p63 expression is absent in BM (Glickman et al., 2001a; Wang et al., 2011). 
There is a potential link between bile acid and p63 expression. It was shown that bile 
acid exposure is able to down-regulate the level of p63 in primary oesophageal cell 
culture (Roman et al., 2007).
 
1.6 Inflammation and BM 
Inflammation may be defined as the response of the immune system to tissue injury or 
infection. The purpose of an inflammatory response is to protect the tissue from 
infection and restore homeostasis (Medzhitov, 2010; Ben-Neriah & Karin, 2011). 
However, there is increasing evidence showing that chronic inflammation can 
promote cancer formation. It has been estimated that about a quarter of cancer cases is 
associated with inflammation suggesting a potential link between the two (Eiró & 
Vizoso, 2012).  
 
Two pathways connecting inflammation and cancer have been defined: the intrinsic 
pathway and the extrinsic pathway. In the extrinsic pathway, inflammation and 
infection of extrinsic stimuli may promote cancer development. However, the intrinsic 
pathway is linked to genetic alterations which cause neoplasia leading to an 
inflammatory microenvironment. The activation of these two pathways result in 
activation of transcription factors such as nuclear factor kappa B (NF-κB) and signal 
transducer and activator of transcription 3 (STAT3) which then increase the 
production of inflammatory mediators including cytokines, chemokines (such as 
IL-1β and tumour necrosis factor α (TNF-α)) and cyclooxygenase 2 (COX2). The 
inflammatory mediators further recruit inflammatory cells and also activate 
transcription factors including NF-κB and STAT3 in the inflammatory cells to 
produce more inflammatory mediators. Therefore, a cancer-related inflammatory 
environment is generated which results in cell transformation and tumour-promoting 
effects (Mantovani et al., 2008; Gibson et al., 2013).  
 
In BM development and carcinogenesis, the extrinsic pathway of inflammation is 
activated by the chronic bile acid irritation caused by GORD. Bile acid exposure also 
induces the intrinsic pathway. This is due to bile acid exposure in oesophageal cells 
inducing reactive oxygen species (ROS) and nitric oxide (NO) production which in 
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turn leads to DNA damage (Dvorak et al., 2007; Jenkins et al., 2007, 2008; Jolly et al., 
2009; McAdam et al., 2012). A number of studies have shown that exposure to bile 
acid can activate the pro-carcinogenic NF-κB pathway in both the oesophageal 
epithelial cell lines and the human oesophageal biopsy cultures (Jenkins et al., 2004, 
2008). The STAT3 pathway (in response to IL-6) is activated in BM (Dvorakova et al., 
2004). In addition, the production of cytokines and chemokines such as IL-1β, IL-6, 
IL-17, TNFα and interferon-γ (IFN-γ), and COX2 are increased in BM (Dvorakova et 
al., 2004; Bannister et al., 2012; Taddei et al., 2013). Taken together, the activation of 
both extrinsic and intrinsic pathway generate an inflammatory microenvironment and 
lead to BM (Gibson et al., 2013).  
 
It is possible that the NF-κB pathway might initiate BM development through 
activating CDX2 expression. NF-κB acts a transcription factor. In the cytoplasm, 
NF-κB binds to the inhibitory protein nuclear factor of κ light polypeptide gene 
enhancer in B-cells inhibitor α (IκBα), so NF-κB is maintained in the inactive state. 
Once IκBα is phosphorylated by IκB kinase (IKK) following an extracellular 
stimulation, IκBα will be degraded. NF-κB will then translocate into the nucleus and 
enhance gene transcription. NF-κB targets include inflammation-related genes 
(Bollrath & Greten, 2009). Interestingly, it was found that there are two putative 
NF-κB binding sites in the CDX2 promoter region. In addition, bile acid treatment 
was able to induce CDX2 promoter activity and initiate CDX2 protein expression in 
rat oesophageal epithelial cells (Kazumori et al., 2006). However, using 
telomerase-immortalized NES cells as a model, bile acids (a mixture of glycocholic 
acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, 
glycodeoxycholic acid, and taurodeoxycholic acid) only activated CDX2 mRNA and 
protein expression in NES cells which were derived from GORD patients with BM, 
but not in the NES cells which were originated from GORD patients without BM. It 
was also found that the CDX2 promoter activity is increased through NF-κB 
signalling activation (Huo et al., 2010). Whether the different results observed are due 
to the difference in of cell types used and/or bile acid utilized remains to be 






1.7 Models for BM studies 
Current models used for studying BM or BM-related carcinogenesis research include 
tissue culture, organotypic culture and in vivo studies on animals (Pavlov & Maley, 
2010). Cell culture models can be subdivided into cells originating from oesophageal 
squamous epithelium, BM tissue or oesophageal adenocarcinoma. In cell culture 
models, HET-1A, NES and EPC2-hTERT cell lines have been used for the research 
of BM development. HET-1A cell line is SV40 T antigen immortalized human 
oesophageal epithelial cells (Stoner et al., 1991). NES and EPC2-hTERT cell lines 
both are human telomerase reverse transcriptase transformed oesophageal epithelial 
cells but were developed by different groups (Morales et al., 2003; Harada et al., 
2003). BAR-T, CP-A, CP-B, CP-C and CP-D cell lines are derived from human BM 
tissue and are all immortalized by hTERT transfection. BAR-T and CP-A are 
non-dysplastic BM cell lines, and CP-B, CP-C and CP-D are high-grade dysplastic 
BM cell lines (Palanca-Wessels et al., 2003; Jaiswal et al., 2007). Cell lines derived 
from human oesophageal adenocarcinoma includes OE33 and FLO cell lines (Rockett 
et al., 1997; Boonstra et al., 2010). 
 
Two-dimensional tissue culture of primary human normal oesophageal squamous cell 
has been tested. However, the cell replicative life span is limited and the telomere 
length was progressively shortened (Harada et al., 2003). Three-dimensional 
organotypic culture models have been developed. Three-dimensional organotypic 
models have the advantage of prolonged viability in primary cells and more 
importantly, it mimics the in vivo microenvironment which is important for BM 
initiation and malignant progression (Okawa et al., 2007; Souza et al., 2011). In 
organotypic culture system, oesophageal epithelial cells grow on the top of a 
fibroblast layer. EPC2-hTERT cells, mouse and human primary oesophageal 
epithelial cells have been shown to differentiate and recapitulate the stratified 
squamous epithelium structure in the organotypic culture system (Harada et al., 2003). 
 
Rat surgical models are the most commonly used BM animal models (Pavlov & 
Maley, 2010). Rat surgical models include oesophagogastroduodenal anastomosis 
(OGDA), oesophagogastrojejunostomy (OGJ), oesophagoduodenal anastomosis 
(ODA), oesophagojejunostomy (OJ) and total gastrostomy (Kresty et al., 2011). The 
surgery induces stomach acid and/or bile salts reflex to the lower end of the 
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oesophagus in order to induce oesophagitis, BM, dysplasia and adenocarcinoma (Su 
et al., 2004; Cheng et al., 2005; Lu et al., 2009; Aiyer et al., 2011). Nevertheless, it is 
also to worth noting that, unlike rodent, human oesophageal epithelium lacks 
cornified layers (Seery & Watt, 2000), but contains papillae structures, mucosal and 
submucosal glands. In addition, in humans, the squamous-columnar junction of gut is 
between oesophagus and stomach (Seery & Watt, 2000; Croagh et al., 2008), but the 
squamous-columnar junction in rodent is shifted posteriorly to the middle of the 
stomach (Wang et al., 2011). Therefore, using rat surgical models for BM research 
may not fully represent the BM pathogenesis in human.                                                                                                                     
 
1.8 Aims   
The current hypothesis is that the intestinal transcription factors HNF4α CDX2, 
HNF4α, HNF1α, PDX1 and FOXA2 are linked to intestinal metaplasia. Exogenous 
factors including bile acids and inflammatory mediators may be a key stimulus for 
BM development. The aims of the project were to                            
(1) Test the role of ectopic HNF4α expression in the development of BM.         
(2) Test the role of ectopic CDX2, HNF4α, HNF1α, PDX1 and FOXA2 in the 
development of BM.                                                   








Chapter 2                    






2.1 Isolation and culture of mouse embryonic oesophagus 
Pregnant female CD1 mice were scarified by cervical dislocation and the uteri were 
transferred to ice-cold PBS (Fig. 2.1). Embryos at E11.5 stage were then separated 
from the uteri and placed in ice-cold dissection medium Minimum Essential Medium 
(MEM medium (Sigma) with 10% fetal bovine serum (FBS)(GIBCO), 2 mM 
L-glutamine (Sigma), penicillin/Streptomycin (50U, Sigma), Gentamycin 
(20mg/ml ,GIBCO) and Fungizone (1U/ml, GIBCO)). The oesophagus was then 
isolated using forceps and tungsten needles under a Leica MZ6 stereomicroscope (Fig 
3.1). For plating, 35mm diameter round coverslips were placed in 4-well plate and 
35μl of fibronectin (50 µg/ml, Invitrogen) was added to the middle of coverslip. After 
the fibronectin was dry, a plastic cloning ring was placed onto the fibronectin-coated 
region. 0.5 ml complete Basal Medium Eagle (BME) medium (BME medium (Sigma) 
with penicillin/streptomycin, 2 mM L-glutamine and 10% FBS) was added to the well 
and the oesophagus was then transferred into the centre area inside the plastic ring. 
Embryonic organs were cultured in in a humidified incubator at 37
o
C supplied with 
5% CO2/95% air. The plastic cloning rings were removed the next day and the BME 
medium was replaced with fresh BME medium. Medium was then changed every 2 
days thereafter.  
 
2.2 Adult mice oesophageal epithelium culture  
Adult CD1 mice were sacrificed by cervical dislocation. The oesophagus was isolated 
and transferred to ice-cold dissection medium (Fig. 2.2). The oesophagus was opened 
longitudinally using scissors under a Leica MZ6 stereomicroscope. The epithelium 
was then stripped from the submucosal tissue and then cut into 1-2 mm
2
 pieces. 
Approximately 15 pieces of oesophageal epithelium were placed on the furrows of a 
scratched plastic coverslip in a 35mm dish with 2ml of complete BME medium or 
Epilife medium (Invitrogen). The epithelial tissue was cultured in a 37
o
C incubator 
supplied with 5% CO2/95% air. The medium was first changed after 2-days of 






Figure 2.1. Isolation of mouse embryonic oesophagus   
(A) CD1 mouse embryonic day12.5 (E12.5) embryo in the uterus. (B) E12.5 mouse 
embryo was removed from the uterus and the organ tree was isolated. Figures show 
(C) front view and (D) back view. (E) After liver and heart were removed, 
















Figure 2.2. Dissection of adult mouse oesophageal epithelium  
(A) Adult CD1mouse was opened and oesophagus was identified. (B) Closer view of 
oesophagus. (C) Oesophagus was removed and was placed in the dissection medium. 
(D) Oesophagus was longitudinally opened. Oesophageal epithelium and the 
muscular layer were seen. (E) Oesophageal epithelium was isolated and (F) was cut 
into small pieces (approximately 1-2 mm
2
) for culturing in a scratched plastic slide 















2.3 Culture of cell lines 
HET-1A cells were obtained from American Type Culture Collection (ATCC, 
Middlesex, UK). OE33, KYSE30 cells, HT29, HEK-293 and Caco2 cells were 
obtained from European Collection of Cell Cultures (ECACC, Porton Down, U.K). 
HET-1A cells were maintained in complete BME medium (Sigma), OE33 and 
KYSE30 cells were maintained in complete RPMI-1640 medium (Sigma), HT29 and 
HEK-293 were maintained in complete Dulbecco’s Modified Eagle’s medium 
(DMEM) (Invitrogen), and Caco2 cells were maintained in MEM medium (Sigma). 
All cell lines were cultured at 37
o
C under an atmosphere of 95% air, 5% CO2. BME, 
RPMI and DMEM complete medium all contains 10% (v/v) fetal bovine serum (FBS, 
GIBCO), 2 mM L-glutamine (Sigma), penicillin/Streptomycin (50U, Sigma). 
Culture medium was replaced every 2 days, and cells were subcultured (1:10-20) 
every 5 to 7 days. Subculturing of cell lines included the following steps. After 
washing the cells with PBS, cells were incubated with 5ml 
Trypsin/Ethylenediaminetetraacetic acid (Trypsin/EDTA) (Gibco) at 37
 o
C for 5 
minutes. 5 ml of the appropriate complete medium was added to stop the reaction. 
The side of the flask was tapped gently then the cells were transferred to a 15 ml 
tube. After centrifugation at 1000 rpm for 3 minutes, the supernatant was discarded, 
and 1ml of complete medium was added to re-suspend cells. Finally, 100 µl of cell 
suspension was transferred into a T75 flask supplied with 10 ml completed medium.  
 
2.4 Storage of cell lines 
To store cell lines, cell pellets were resuspended in freezing medium containing 90% 
FBS and 10% v/v Dimethyl sulfoxide (DMSO) (Sigma). The cell suspension in a 
cryogenic vial was then transferred to a Mr. Frosty
TM
 freezing container and was 
frozen at -80
o
C overnight. Cells were then transferred into liquid nitrogen for 
long-term storage.  
 
To resuscitate cells, cells from the liquid nitrogen were thawed in a 37 oC water bath 
and then were slowly added into 10ml culture medium in a 15 ml tube. The cell 
suspension was then centrifuged at 1000rpm for 3 min. The supernatant was 
discarded and the cell pellet was resuspended in 10 ml culture medium before 
transfer to a T75 culture flask. 
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2.5 Adenovirus preparation 
To amplify adenovirus for large scale preparation (as a prestock), 1, 2, or 8 μl of 
adenovirus stock was added to 70% confluent HEK-293 cells cultured in a T75 flask 
in complete DMEM medium. After 2 days of infection, about 50% cells showed 
morphological changes with the cells displaying more rounded characteristics 
(cytopathic effect), cells were then removed by tapping the edge of the flack and 
then transferred into a 15ml tube. Cells were harvested by centrifuging at 1000rpm 
for 4 minutes and the supernatant was then discarded. Cells were suspended in 1 ml 
of complete DMEM medium. Four freeze/thaw cycles were used to lyse the cells and 
release virus particles. This was performed on a dry ice/ethanol bath before 
switching to a water bath at 37
o
C. To test the amount of the virus needed for the 
large scale preparation, 1,10 or 100 μl of adenovirus prestock was added to 70% 
confluent HEK-293 cells cultured in a T75 flasks in complete DMEM medium. The 
cytopathic effects were observed 2 days after infection. To prepare the virus on a 
large scale, 10 x T175 flasks of HEK-293 cells were infected with prestock virus for 
2 days. The amount of virus added was referred to the prestock testing step which 
caused cytopathic effects in about 50% cells. Cells were then centrifuged at 2000rpm 
for 10 minutes and the medium was removed. 5 ml of 100mM 
Tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCl), pH 8 was used to 
resuspend cell pellets and 4 cycles of freeze/thaw were performed to lyse cells. Cells 
were spun at 2000rpm for 5 minutes and the virus in the supernatant was transferred 
to a 50ml tube. 0.6 volume of caesium chloride (CsCl) supersaturated 100mM 
Tris-HCl, pH 8 of supernatant was added and transferred to 2 centrifuge tubes 
(Beckman 342412). After centrifuging at 65000rpm for 4 hour (Beckman 
ultracentrifuge LL-TB003, Vti90 rotor) a 25G needle was used to remove the virus 
particles band. Virus particles was added to [one volume of 100mM Tris-HCl: 0.6 
volume CsCl saturated supersaturated 100mM Tris-HCl, pH 8] and centrifuged at 
65000rpm for 18 hours. Virus particles were transferred to a Gamma irradiated 
slide-A-Lyzer
TM
 dialysis cassette (Pierce Biotechnology) and then dialysed overnight 
in [10mM Tris-HCl, pH 7.5, 1mK MgCl2, 135mN NaCl]. The virus particles were 





2.6 Adenoviral infection of oesophageal epithelial explants and HET-1A 
For adenoviral infection of adult mice oesophageal epithelium, explants were 
cultured for 7 days in a 35mm dish. Complete medium (2ml) which contained 5.1 x 
10
5 
of Ad-CMV-HNF4α or the equivalent titre of Ad-Null viral particles (Table 2.1) 
was added to explants cultures. For HET-1A cells, 10
5
 cells were seeded in a 6 cm 
plate 24 hrs prior to infection. Adenoviral particles (Table 2.1) were diluted in 
culture maintenance medium supplied with dextran (5µg/ml) (Sigma) and were then 
added to the cultures. For both explants and HET-1A cells, after 24 hours infection, 
culture medium was replaced by complete medium. Medium was then changed every 
two days. 
 
Table 2.1. Adenoviral constructs  














Wei-Yuan Yu, University of 
Bath, UK 
Ad-CMV-HNF1α 7.3 x 109   Marco Pontoglio, Paris 
Descartes University, France 
Ad-CMV-HNF4α  
(HNF4α-A)                                                 
(HNF4α-B)                                 
 
5.1 x 10
10   
2.0 x 10
11
Ramiro Jover, Unidad de 
Hepatologia Experimental, 
Valencia, Spain 




 Harry Heimberg, Vrije 
Universiteit Brussel, Belgium 
Ad-RSV-GFP  9.9 x 10
10
 Emma Regardsoe, University 
of Oxford, UK 
Ad-Null 6.6 x 10
10 
  Harry Heimberg, Vrije 
Universiteit Brussel, Belgium 
IU/ml: Infectious units per milliliter  
 
2.7 Creation of Lentiviral plasmid  
Lenti-HNF4α-50FCD2 (Lenti-mutant HNF4α) 
To create a cloning site, N’ and C’ truncated HNF4α insert DNA was amplified from 
pcDNA3-HNF4α-50FCD2 construct by PCR (provided by Dr Chia-Ning Shen) and 
the (BamHI)- HNF4α-50FCD2-(BamHI) insert DNA was created. The primers 
designed are shown in Table 2.2. Insert DNA was then ligated into the pL-S-PURO 
vector, which was obtained by removing FOXA2 from pL-S-FOXA2-PURO 





FMDV (Foot and Mouth Disease Virus) 2A sequence from 
Ad-Pdx1-2A-Ngn3-2A-MafA polycistronic construct (generously provided by Dr 
James Dutton, University of Minnesota) was amplified by PCR to create EcoRI and 
EcoRV restriction enzyme sites. The primer sequence is shown in Table 2.2. The 2A 
sequence was ligated into the pcDNA3 plasmid at EcoRI and EcoRV sites to create 
pcDNA3-2A plasmid. (EcoRV)-CDX2-(XbaI) cDNA fragment was amplified from 
HT29 cells by PCR with the translational termination codon replaced by XbaI site. 
By using EcoRV/XbaI site, CDX2 was cloned into pcDNA3-2A as 
pcDNA3-2A-CDX2 plasmid. Similarly, (EcoRV)- HNF1α-(XbaI) was created and 
was cloned into pcDNA3-2A as pcDNA3-2A-HNF1α, but the translational 
termination codon of  HNF1α was still maintained. HNF4α cDNA was amplified 
from HT29 cells as (KpnI-BamHI)-HNF4α-(EcoRI) fragment and the translational 
termination codon was replaced by EcoRI site. The fragment then was ligated into 
pcDNA3-2A-CDX2 by using KpnI/EcoRI sites as pcDNA3-HNF4α-2A-CDX2. PCR 
was then performed in order to create (XbaI)-2A-HNF1α- (BamHI-XbaI) fragment 
from pcDNA3-2A-HNF1α. XbaI site was used to clone 
(XbaI)-2A-HNF1α- BamHI-(XabI) into pcDNA3-HNF4α-2A-CDX2 as 
pcDNA3-HNF4α-2A-CDX2-2A-HNF1α. Finally, by using the BamHI site, 
HNF4α-2A-CDX2-2A-HNF1α was cloned into lentiviral vector which was obtained 
by removing FOXA2 from lenti-FOXA2 plasmid. Therefore, 






Table 2.2. Sequence of primers used for cloning 
HNF4A BamHI 50FCD2 F gCGGATCCatgctgtgtgccatctgt 
HNF4A BamHI 50FCD2 R cCGGATCCtcaggtaatgctctgcag 
EcoRV HNF1A_F CAGATATCatggtttctaaactgagccagc 
XbaI HNF1A_R aaTCTAGAttactgggaggaagaggcca 
EcoRV CDX2_F CAGATATCatgtacgtgagctacctcct 
XbaI CDX2_R ttTCTAGActgggtgacggtggggttta 
XbaI 2A_F agTCTAGAAAAATTGTCGCTCCTGTCAA 
XbaI BamHI HNF1A_R aaTCTAGAGGATCCttactgggaggaagaggcca 
KpnI BamHI HNF4A_F TTGGTACCGGATCCatgcgactctccaaaaccctcgtTga 
EcoRI HNF4A_R TTGAATTCgataacttcctgcttggtga 
 
2.8 Cloning methods 
To clone and insert the transgene DNA into the plasmid, insert DNA was amplified 
by PCR using Phusion high-fidelity DNA polymerase (Thermo). Insert and vector 
DNA were then digested with the appropriate restriction enzymes. Calf intestinal 
alkaline phosphatase (CIAP) (Promega) digestion step was performed for vector 
DNA if only one type of restriction enzyme was used for digestion. Insert and vector 
DNA was then run on an agarose gel and the percentage of the gel (0.6~2% w/v) 
varied depending on the DNA size. The required DNA fragment was visualised and 
cut out on a UV transilluminator (UVP). DNA was purified by using SV Gel and 
PCR clean-up kit (Promega). In the ligation step, T4 DNA ligase (Promega) was 
used, and the vector and insert DNA molar ratio was 1:3. In the transformation step, 
10 µl of ligation mixture was incubated with DH5α competent cells on ice for 30 
minutes and was then heated at 42
o
C for 90 seconds. 200 µl of LB medium was 
added and the competent cell culture was shaken at 225 rpm for 1 hour at 37
o
C. 
Competent cells were spread on an ampicillin (100µg/ml) LB agar plate and the plate 
was incubated at 37
 o
C for 16 hours. Single colonies were picked and further cultured 
in 5 ml of LB with ampicillin (100µg/ml) at 37
 o
C for 16 hours.1.5 ml of bacteria in 
LB medium was transferred in to a 1.5ml tube. The bacteria lysate was collected by 
centrifuging at 12000rpm for 1 minute and then the supernatant was discarded. 
Plasmid was purified from bacteria lysate by using SV Miniprep kit (Promega). 
Plasmid was assessed by restriction enzyme digestion or PCR before sending for 
sequencing (Source bioscience). Large amounts of plasmid for lentiviral particles 
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production was prepared from100ml bacteria culture by using Endo Free Plasmid 
Midi kit (Qiagen).         
 
2.9 Lentivirus preparation  
The lentiviral expression plasmid pL-S-HNF4α-I-EGFP and pL-S-FOXA2-I-PURO 
was a gift from Dr Michael Bock (Hannover Medical School, Germany) and the 
plasmid constructs were previously reported (Iacob et al., 2011). Plasmid 
pL-S-mutant HNF4α (50FCD2), pL-S-HNF4α-2A-CDX2-2A-HNF1α construction 
was created as described in session 2.7. To prepare lentiviral particles, 3.75 ×10
6
 
HEK293T cells were seeded in a T75 flask one day before transfection. Four hours 
prior to transfection, the medium was replaced with fresh 10 ml of HEK 293T 
maintenance medium. To prepare plasmid and transfection reagent mixture, the viral 
vector (12.84µg), pREV (7.71µg), pGAG/Pol/PRE (7.71µg) and pVSV-G (3 µg) 
were mixed and ddH2O was added to a total volume of 62.75 µl. 90 µl of the 
transfection reagent TransIT-LT1 (MIR 2300, Geneflow UK) and 750 µl of plain 
RPMI/25mM HEPES media were mixed and then incubated at RT for 5 minutes. 
Plasmid mixture was then slowly added into the mixture of the RPMI/25mM HEPES 
medium and the transfection reagent. The transfection mixture was incubated at 
room temperature for 45 minutes before adding to HEK293T cells. After 48 hours 
incubation, the medium which contained viral particles was collected and was 
centrifuged at 1000 rpm for 3 minutes. The supernatant containing the viral particles 




2.10 Lentiviral infection and stable clone selection 
The day before lentiviral infection, 6.9×10
4
 Het1a cells were seeded in a 35mm dish. 
On the day of infection, the lentivirus stock was thawed on ice for 2 hour. The 
lentivirus was diluted in culture maintenance medium supplied with Dextran (5µg/ml) 
and then added to the culture medium. Twenty-four hours after virus infection, the 
medium was changed and thereafter the medium was changed every 2 days. To 
select single colonies, cells were split and seeded into a 96 well format at a density 
of 1 cell per well. Single cells were subsequently selected and expanded. Transgene 




2.11 Analysis of mRNA expression (RT-PCR) 
RNA purification 
Cells cultured on a 6cm-dishes were washed with PBS twice and 1ml of TRI reagent 
(Sigma) was added to harvest cells. Cells from explants were further homogenized 
by using a sterile homogenizer in TRI reagent in RNase-free sterile 1.5 ml tubes and 
incubated for 5 minutes at RT. 200 μl of chloroform (Sigma) was then added to 
separate the RNA aqueous phase. The tubes were vortexed for 15 seconds and then 
incubated at RT for 15 minutes. The RNA aqueous layer was separated by 
centrifuging for 15 minutes at 12000 x g at 4
 o
C, and then the top RNA aqueous layer 
was transferred into a new 1.5 ml tube without taking any of the white DNA phase at 
the interface. 500 μl of isopropanol was added to precipitate the RNA and the 
solution was shaken briefly. Samples were incubated at RT for 10 minutes before 
collecting the RNA by centrifuging for 10 minutes at 12000 x g at 4
 o
C. After 
centrifugation, the supernatant was carefully removed so as not to disrupt the pellet 
and discarded. The RNA pellet was then washed with 1ml 75% ethanol, and samples 
were centrifuged for 5 minutes at 7600 x g at 4
 o
C. The ethanol was discarded and 
the remaining ethanol was removed by air drying at 37
 o
C on a heated plate until the 
RNA pellet appeared glassy. Finally, the RNA was dissolved in 20μl 
diethylpyrocarbonate (DEPC)-treated ddH2O and then incubated for 10 minutes at 
60
o
C. RNA concentration was measured by NanoPhotometer
Tm
 (Implen) and the 





DNase treatment was used to remove contaminating DNA by using an Ambion Kit. 
The process included preparing a mixture of 3 μg RNA with 1μl DNase, 3μl 10x 
Buffer, and RNase-free water to a final volume of 30 μl and the mixture was 
incubated at 37
 o
C for 30 minutes. 0.77 μl of 200 mM EDTA was then added to the 
sample and incubated at 75
 o
C for 10 minutes. After DNase treatment, genomic DNA 
contamination can be checked by amplifying β-actin gene by PCR (35 cycles) in a 







Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
To generate the cDNA from RNA, SuperScript
TM
 II Reverse Transcriptase kit 
(Invitrogen) was used. 9μl RNA from DNase-treated RNA sample, 1μl 10mM dNTP 
(Invitrogen), 1μl oligo (dT) primer (0.5μg/ul) (Invitrogen) and 1μl RNase-free H2O 
to the final volume of 12 μl were mixed and then incubated at 65oC for 5 minutes. 
The mixture was then placed on ice for 1 minute, and 8μl of prepared PCR mixture 
including 4μl 5x First-Strand buffer, 2μl 0.1M DTT, 1μl RNase-free water and 1 μl 
SuperScript
TM
 II Reverse Transcriptase was added. Samples were then incubated at 
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C for 52 minutes and followed by 70
 o





Polymerase Chain Reaction (PCR) 
To check for DNA contamination after DNase treatment or to analyse cDNA after 
RT-PCR, genomic DNA or cDNA was amplified by PCR. For PCR, the forward and 
reverse primers (Table 3.3), and H2O were mixed in a 10μl volume, prior to addition 
of 10μl 2X PCR Master Mix (Thermo). The reaction was carried out in PCR 
machine using the following program: 94
 o
C for 5 minutes, amplify the products (24 
to 35 cycles) of 94
 o
C for 1 minute, annealing temperature for 1 minute, and 72
 o
C 
for 30 seconds, and followed by the final extension at 72
 o
C for 10 minutes. PCR 
products then run on 1.5% agarose gel with 100 base pair (bp) DNA ladder (Thermo) 
and images were obtained by using an Alpha Imager
TM





Table 2.3. Primers for PCR 









(M)β-ACTIN AAGAGCTATGAGCTGCCTGA TACGGATGTCAACGTCACAC 54 160 





(M)FOXA2 CAAGTGTGAGAAGCAACTGG GATAGAGAAGGGGTGGTTGA 58 373 
(M)HNF4Α ACAGGAGAGGGTCAGAAGCA GATGTTTGCACAACCACAGG 58 180 
(M)HNF4Α-2** GAAGTGCTTCCGGGCTGGC CTGCAGCTCTTGGAAGGGC 58 487 
(M)MUC2 GCAGTATCAGGCCTGTGGC CACAATCTCGGTCTTCACTTCG 56 430 
(M)PDX1 TGTAGGCAGTACGGGTCCTC CCACCCCAGTTTACAAGCTC 58 325 
(M)TFF3 AGATTACGTTGGCCTGTCTCC TCAGATCAGCCTTGTGTTGGC 56 341 
(M)SI GGCAAGATCCTGTTTCCTGGA CGAGCCTTAGGAACATAGCCA 56 271 
(M)VILLIN1 TATGATATCCACTACTGGATTGGC GCTTGAGTGCAGCCTTAGCG 54 586 
(H)β-ACTIN ATGGATGATGATATCGCCGC ATCTGGGTCATCTTCTCGCG 58 365 











(H)FOXA2 GCGACCCCAAGACCTACAG GGTTCTGCCGGTAGAAGGG 58 162 
(H)K14 CTGGACGAACTGACCCTGGC TCTCGCTCTTGCCGCTCTGC 58 319 
(H)K18 AGAACGAGAAGGAGACCATGC GGCATTGTCCACACTATTTGC 58 212 
(H)K20 AACCTAAATGACCGTCTAGCG ATCAATTTGCAGGACACACC 58 213 
(H)MUC2 AACAACCTGCTCAACGTCATC CAAATGCTGGCATCAAAGTTGG 58 281 
(H)SI CCGCTGGATGCAACTTGGAGCA ACCACCGAGCATTGGGGACG 58 341 
(H)LGR5 TGCTGGCTGGTGTGGATGCG GCCAGCAGGGCACAGAGCAA 58 242 
(H)ISX GCCAAGGAGAGGTTGTTTGTTC GGCTTTCGAGGACAGAGTGAG 58 422 
(H)K20 AACCTAAATGACCGTCTAGCG ATCAATTTGCAGGACACACC 58 213 
(H)VILLIN1 ATGGATGACTTCCTGAAGGGC TCTCCATACGGGTGCTTTCCG 56 308 
*Primers are for: (M) mouse genes or (H) human genes. **For checking full length 





For paraformaldehyde (PFA) fixation, cells cultured on glass coverslips in 35mm 
dishes were washed twice with 2ml PBS and then fixed with 1.2 ml 4% (v/v) PFA 
(Sigma) for 20 minutes. After fixation, cells were washed three times with PBS and 
were then topped-up with PBS and left in the fridge until needed. 
 
Acetone:Methanol fixation 
In acetone: methanol fixation, cells in 35mm dishes were washed twice with PBS 
and fixed with 1.2 ml ice cold acetone:methanol (1:1 v/v) for 10 minutes. After 
fixation, cells were washed three times with PBS and were then topped up with PBS 
at 4
o
C until required.   
 
Permeabilization, antigen retrieval and blocking 
Permeabilization was only performed on PFA-fixed cells. For samples of cell culture, 
0.5 ml of 1% (v/v) Triton-X100 (Sigma) in PBS was added and incubated for 30 
minutes. For cells which required antigen retrieval, prior to the blocking step, cells 
were incubated in 1X citrate buffer (Lab vision) at 37
 o
C for 1 hour. Blocking was 
carried out by adding 1.2 ml of 2% (v/v) blocking buffer (Roche) for 30 minutes. 
 
Antibody staining 
After blocking, the blocking buffer was removed and the cells were then incubated 
with 200μl of primary antibody diluted in 2% blocking buffer overnight at 4 oC. 
Antibodies are listed in Table 2.4. After the antibody binding step, cultures were 
washed gently with PBS three times for 15 minutes on a shaker. To avoid fluorescent 
bleaching of the signals, the following steps were performed in the dark. 200μl of 
fluorescent secondary antibody (Table 2.5) diluted in 2% blocking buffer was 
applied for 2 hours, and any unbound secondary antibody was removed by washing 
with PBS as described above. To counterstain the nuclei, cells were stained with 1ml 
4',6-diamidino-2-phenylindole (DAPI) (0.5 μg/ml) solution (Sigma) for 10 minutes 
and then washed with PBS three times for 15 minutes. The slides were then mounted 
with mounting gel (Thermo). Immunostaining images were observed by using Leica 
DMRB microscope or Zeiss LSM510META confocal microscope. 
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Table 2.4. Primary antibodies used in the immunostaining  




4% PFA or 
Acetone/Methanol 
1:200 
Cdx2 (88) Mouse BioGenex 4% PFA 1:100 
E-cadherin (C36) Mouse Transduction labs 
4% PFA or 
Acetone/Methanol 
1:100 
HNF4α (H171) Rabbit Santa Cruz 4% PFA 1:100 
K14 (LL002) Mouse Neomarkers Acetone/Methanol 1:200 
K14 Rabbit Thermo Acetone/Methanol 1:200 




K4 Mouse Sigma Acetone/Methanol 1:200 
K20 Mouse Dako Acetone/Methanol 1:200 
p63 (4A4) Rabbit Santa Cruz 4% PFA 1:50 
Sucrose isomaltase Mouse Santa Cruz 4% PFA 1:100 
Villin (CWWB1) Mouse Abcam Acetone/Methanol 1:100 
 
Table 2.5. Secondary antibodies used in the immunostaining  
Name Host Supplier Dilution 
Anti-rat texas red Rabbit Vector 1:100 
Anti-rabbit fluorescein Horse Vector 1:100 
Anti-rabbit texas red Goat Vector 1:100 
Anti-mouse fluorescein Goat Vector 1:100 
Anti-mouse texas red Goat Vector 1:100 
Anti-rabbit Alexa Fluor 546 IgG Goat Invitrogen 1:250 
Anti-rabbit Alexa Fluor 633 IgG Goat Invitrogen 1:250 
Anti-mouse Alexa Fluor 546 IgG Goat Invitrogen 1:250 




2.13 Quantitative polymerase chain reaction (qPCR) 
Quantitative PCR (qPCR), also known as Real-time PCR, was used to quantify and 
compare gene expression levels. LightCycler FastStart Reaction DNA Master SYBR 
Green I kit (Roche) was used. To perform Real-time PCR, 8 µl mixture of 0.5 µl of 
10mM forward and reverse primers, 0.6 µl of 25mM MgCl2, 1µl enzyme containing 
LightCycler FastStart Reaction Mix SYBR Green I and 5.4 µl H2O was added into 
LightCycler capillary. 2µl cDNA was then added into the same capillary. Capillaries 
were centrifuged briefly and then were transferred to LightCycler instrument. 
Real-time PCR program includes preincubation at 95
o
C for 10 minutes, 
amplification for 40 cycles of 95
o
C for 10 seconds, primer melting temperature (Tm) 
for 10 sec and 72
o
C for (product length/25) seconds. The temperature transition rate 
is at 20 
o
C /second unless otherwise indicated. Melting curves analysis starts at 95
 o
C 
for 0 second, 65
 o
C for 15 seconds and then increases to 95
o
C at rate of 0.1
 o
C 
/second followed by cooling to 40
 o
C. LightCycler software was used to analyse 
Real-time PCR results. Primers used for real-time PCR are shown in Table 2.6. The 
amplification efficiency is between 90 to 110%.  
 
Table 2.6. Primers for real-time PCR 
Primer 
name 









β-ACTIN taggcaccagggtgtgatgg catggctggggtgttgaagg 58 323 
K20 ctgaataaagacctagctctcctcaaa tgttgcccagatgcttgtgt 68 76 





2.14 Western blotting 
Cell lysate preparation 
Cells which were 90-100% confluent in the well of 12-well plate were washed with 
cold PBS 3 times. Cells were then lysed in 100 µl lysis buffer (Table 2.9) on ice for 




Protein concentration measurement 
To measure protein concentration, 5-10 µl protein was mixed with 100 µl protein 
assay dye (BioRad) and ddH2O to a total volume of 500 µl. Bovine Serum Albumin 
(BSA) (Sigma) standard solution was prepared by mixing 0, 2, 5, 10, 15 and 20 µl of 
1 mg/ml BSA with 200µl protein assay dye and ddH2O to the total volume of 
1000µl. After 5 minutes incubation, 200 µl samples and standards solution were 
transfer to a 96-well plate. The absorbance of each standard or sample was measured 
at 595nm on in a spectrophotometer (Tecal Spectra).The standard curve was obtained 
by plotting absorbance against BSA concentration. Protein concentration equation 
was then calculated and the protein concentration was obtained. 
 
SDS-PAGE (Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis) 
BioRad SDS-PAGE system was used for protein electrophoresis. The cell lysate was 
mixed with 4x sample buffer and boiled at 95
o
C for 5 minutes. Cell lysate was then 
loaded into the well of the 8 or 10% SDS-PAGE gel. The gel was run in running 
buffer (Table 2.9) at 80V for 30 min and then 100V for 2 to 3 hours.  
To transfer protein to the membrane, 5 x 9 cm PVDF membrane (BioRad) was rinsed 
with 100% methanol (Sigma) and was then immersed in transfer buffer (Table 2.9). 
Transfer stack was placed following the order from the top to the bottom - filter 
paper, gel, membrane and filter paper on a semi-dry transfer machine. The protein 
transfer step was performed at 25 volt for 1 hour.  
 
After the transfer step, the membrane was incubated in the 5% non-fat milk prepared 
in PBST for 1 hour at room temperature on a rotator. The membrane was incubated 
with primary antibody (detailed in Table 2.7) diluted in 3% non-fat milk in PBST 
overnight at 4 
o
C. The membrane was washed with PBST 3 times, 10 minute each. 
Membrane was then incubated for 1 hour at room temperature with horseradish 
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peroxidase (HRP) conjugated secondary antibody (Table 2.8) diluted in 3% non-fat 
milk in PBST. The membrane was washed with PBST for 3 times, 10 minute each. 
To detect the signal, the membrane was incubated with enhanced chemiluminescence 
(ECL) solution (Thermo) for 1 minute. The membrane was then placed between two 
transparency films in a film cassette. Autoradiography film (Amersham) was 
exposed by placing on the top of the membrane in the dark room. Film was 
processed in an X-ray film processor (Protec).  
 
Table 2.7. Primary antibodies used in western blotting  
Name Species Supplier Dilution 
GAPDH Mouse Ambion 1:40000 
ppERK (MAP kinase) Mouse Sigma 1:1000 
Phopho-NF-κB p65 
(Ser536)(93H1) 
Rabbit Cell signaling 1:1000 
 
Table 2.8. Secondary antibodies used in Western blotting 
Name Host Supplier Dilution 
HRP conjugated Anti-mouse Horse Vector 1:3000 





Table 2.9. Reagent preparation 
Name Supplier Preparation methods 
1m  10mM in DMSO, stored at -20
o
C 










Sigma Dissolved in ethanol to 200mM, store at 4
o
C 


























































Reconstituted in 0.1% BSA to 100µg/ml, stored at -20
o
C 





Name  Supplier  Preparation methods  
LB agar Sigma 
Dissolved 0.8g LB agar and 10g LB in 500 ml H2O, 
autoclaved 
LB Sigma Dissolved 10g LB in 500mL H2O, autoclaved 
4% PFA Fisher 
Add 20g paraformaldehyde into 400ml PBS, heated at 60
o
C 
till dissolved. Adjust pH to 7.4 with 1M NaOH. Add PBS to 




Dissolved 477.5g PBS in H2O to 5L as 10X PBS stock. Dilute 




Sigma Dissolved in H2O, stored in dark at 4
o
C  
2% blocking buffer Roche 
50g blocking buffer powder dissolved in Maleic acid buffer 
(100mM Maleic acid, 150mM NaCl, pH 7.5) to 500ml as 
10% blocking buffer. Further diluted in PBS to make 2% 
blocking buffer, stored at -20
o
C   
Transfer buffer   24.8mM Tris, 192mM Glycine, 20% methanol 
4x protein sample 
buffer 
 
200mM Tris-Cl (pH6.8), 400mM dithiothreitol (DTT), 2% 




PBST   PBS with 0.1% Tween-20 
SDS-PAGE 
Running buffer 
 24.8mM Tris, 192mM Glycine, 3.5mM SDS  
Cell lysis buffer   
75mM NaCl, 0.5mM EDTA, 3mM DTT, 10mM 
HEPES-KOH pH7, 0.5% Triton X-100, with freshly added 
0.1mM Na3VO4, 50mM β-Glycerophosphate, 50mM NaF and 








Chapter 3                        






3.1.1 Intestinal transcription factor CDX2 involved in BM development 
The induction of intestinal transcription factors is associated with the development of 
intestinal metaplasia. For example, CDX2 is an intestinal-specific transcription 
factor and whose expression can be found induced in tissue displaying intestinal 
metaplasia. It has been demonstrated that Foxa3-Cdx2 transgenic mice (in which 
CDX2 is ectopically expressed in the murine gastric mucosa) display an intestinal 
metaplasia phenotype (Silberg et al., 2002). In BM, CDX2 has also been considered 
as a key marker and a master transcription factor for BM 
 
(Eda et al., 2003; Moons 
et al., 2004; Vallböhmer et al., 2006). However, in contrast, in vitro studies have 
suggested that CDX2 overexpression in reconstituted oesophageal epithelium 
cultures did not induce a columnar phenotype (Clemons et al., 2012). In addition, in 
vivo studies on K14-Cdx2 transgenic mice in which CDX2 is expressed in the basal 
squamous epithelial cells, also did not develop an intestinal phenotype. Interestingly, 
when DNA methylation was inhibited by treating the K14-Cdx2 mice with 5’Aza, 
BM-like phenotype was observed with the increase expression of K18 and Cdx1 
genes (Kong et al., 2011b). These findings imply that CDX2 alone is not sufficient to 
induce BM and that further epigenetic modification might be involved in promoting 
CDX2-related BM formation.  
 
3.1.2 HNF4α is a candidate transcription factor for the development of BM 
In addition to CDX2, HNF4α is a potential intestinal transcription factor candidate 
for the development of BM. In the intestine, HNF4α is expressed at the crypt region 
(Babeu et al., 2009). HNF4α in the intestinal epithelium regulates the 
cytodifferentiation, homeostasis, cell architecture and barrier functions (Babeu et al., 
2009; Cattin et al., 2009). Conditional knockout of Hnf4α in adult mice 
(Villin-Cre-ERT2; Hnf4αloxP/loxP) demonstrated that the cell growth rate in the crypt 
area was increased (Cattin et al., 2009). Hnf4α deletion also affected cell 
differentiation of the intestinal epithelium as goblet cell numbers were increased. 
The maturation of enterocytes and enteroendocrine cells was affected. There was a 
decrease in the enterocyte gene expression including microsomal triglyceride 
transfer protein (Mttp), apolipoprotein B (ApoB) and ApoA-IV and intestinal fatty 
acid binding protein (iFabp). There was also a reduction in the gene expression of 
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enteroendocrine cell markers such as gastric inhibitory polypeptide (Gip) and 
Somatostatin. In addition, Hnf4α deletion disturbed cell structure and cell-cell 
contact of the intestinal epithelium. The intercellular space of the tight junction is 
distended and the paracellular permeability is increased. Conditional deletion of 
Hnf4α in embryonic mice (Villin-CRE; Hnf4α loxP/floxP), between E12.5 and E13.5 has 
been reported (Babeu et al., 2009). The results showed that compared with the wild 
type mouse, the number of goblet and enteroendocrine cells is increased in 
transgenic mice. The results also demonstrated a minor reduction in gene expression 
of different cell lineage markers, such as Si (enterocytes) and Lysozyme (goblet cells), 
but Chromogranin A (enteroendocrine cells) expression was slightly increased. 
These results suggest that HNF4α regulates cell proliferation and cytodifferentiation 
of the intestinal epithelium. . In addition, transgenic mice in which Hnf4α 
(Foxa3-CRE; Hnf4α loxP/floxP ) was deleted from the E8.5 stage of development 
lacked crypts in the colon region and goblet cell maturation was also diminished 
(Garrison et al., 2006). The number of the immature goblet cells was increased and 
the number of the mature goblet cells decreased in the Hnf4α null mice. These results 
from transgenic mice studies all point to the fact that HNF4α is required for normal 
intestine function.     
 
Since HNF4α is essential for normal intestinal development it is possible that ectopic 
expression of the transcription factor might play a role in the initiation of intestinal 
metaplasia. It has been shown that forced HNF4α expression in NIH-3T3 cells 
(mouse embryonic fibroblasts) and Mia PaCa-2 cells (human pancreatic carcinoma 
cell line) induced intestinal gene expression including VILLIN, APOA-IV and TFF3 
(Babeu et al., 2009). These observations combined with the fact that HNF4α is 
expressed in BM (Piessen et al., 2007) and that ectopic expression of HNF4α induces 
VILLIN protein expression in adult mouse oesophageal epithelial explants 
(Colleypriest and Tosh personal communication) suggests that HNF4α may be 
involved in initiation of BM. However, whether HNF4α is a key driver in the 






3.1.3 Methods of ectopic gene expression 
Viral vectors have been used to deliver and express gene in the host cells (Benihoud 
et al., 1999). In this thesis, lentiviral and adenoviral vectors were utilized for ectopic 
gene expression in oesophageal epithelial cells. I will now briefly discuss the use of 
each type of expression system.   
 
Lentiviral vectors 
Lentivirus is derived from human immunodeficiency virus type 1(HIV-1).  
Lentivirus transduces genes into both dividing and not-dividing cells. The transgene 
integrates into the host genome, so the transgene is stably expressed long-term. In 
the present study I utilized a third generation of lentiviral packing system (Tiscornia 
et al., 2007; Iacob et al., 2011). In this system, lentiviral vectors contain four 
plasmids: one transfer plasmid, two packaging plasmids and one envelope plasmid. 
The transfer vector contains the transgene. The packaging plasmid pMDLg/pRRE 
encodes the Gag, Pol and RRE proteins. Gag is required as a viral structural protein 
for viral particle production. Pol is necessary for reverse transcriptase and integrase 
activity. The second packaging plasmid pRSV-REV contains the REV protein which 
binds to the RRE (Rev-responsive element) sequence on the pMDLg/pRRE plasmid 
to facilitate viral RNA export. Envelope plasmid pVSV-G is required for the envelop 
protein which integrates into viral membrane for the transduction of a broad range of 
cell types. The four plasmids are transfected into HEK-293T cell to produce 
lentiviral particles which can then be recovered prior to infection of target cells 
(Tiscornia et al., 2007; Dropulicć, 2011).  
 
Adenoviral vectors 
Human adenovirus serotype 5 derived adenoviral vector system (in which the viral 
transcription units E1 and E3 were deleted) was used in the present study. E1 
ablation results in the infectious virus no longer being able to be propagated in the 
target cells, but adenoviral particles still can be produced in the E1-expressing 
HEK293 cells. The E3 unit is necessary for evading host immunity and is not 
required in this system. Adenovirus infects both proliferating and non-dividing cells 
and adenovirus targets a wide variety of cell types. Adenoviral vector remains 
epichromosomal in the host cell, and thus the transgene is only transiently expressed 
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(Graham et al., 1977; He et al., 1998; Benihoud et al., 1999; Luo et al., 2007).  
 
3.1.4 Aim  
We propose that HNF4α might drive the conversion of oesophageal stratified 
squamous epithelial cells to columnar intestinal cells. In the first part of this chapter, 
the HET-1A cell line was used as the study model. The HET-1A cell line originates 
from human oesophageal epithelium tissue and was immortalized by introduction of 
simian virus 40 (SV-40) large T-antigen sequence (Stoner et al., 1991). HET-1A cells 
have previously been used for the research into Barrett’s metaplasia or oesophageal 
adenocarcinoma (Liu et al., 2007; Kong et al., 2009; Goldman et al., 2010).  
 
In order to observe the effects of HNF4α ectopic expression in the oesophageal 
epithelial cells, a lentiviral vector which carries the Hnf4α gene (and hereafter 
referred to as Lenti-HNF4α) was utilized to ectopically express HNF4α in HET-1A 
cells. To observe the long-term effects of HNF4α and also to obtain the homogenous 
HNF4α-expressing cell population, stable HNF4α-expressing HET-1A clones were 






3.2 Results  
3.2.1 Characterisation of HET-1A cells 
During the progress of this research we characterized the phenotype of the HET-1A 
cell line. Somewhat surprisingly, immunostaining results showed that HET-1A cells 
did not express the squamous transcription factor p63 (Fig. 3.1). However, the 
transcription factor was expressed in the mouse oesophageal epithelial explants (Fig. 
3.1A, B). Immunostaining results also demonstrated that HET-1A cells did not 
express K14 a marker for basal squamous epithelial cells, but K14 was expressed in 
the mouse oesophageal epithelial explants when cultured in BME medium (Fig. 3.1C, 
D). Interestingly, HET-1A cells expressed the columnar marker K18 and 
mesenchymal marker Vimentin (Fig. 3.1E, F). In addition, the epithelial adhesion 
protein E-Cadherin was not detected in HET-1A cells, but was robustly detected in 
mouse oesophageal epithelial explants (cultured in BME medium) (Fig. 3.2A, B). 
We also confirmed using immunostaining that the intestinal transcription factors 
HNF4α and CDX2 were not expressed in either HET-1A cells or the mouse 
oesophageal explant model (Fig. 3.2C, D, E, F). Confirmation of the HNF4α and 
CDX2 antibodies was carried out in Caco-2 cells (a colorectal adenocarcinoma cell 
line).  
 
3.2.2 Ectopic HNF4α expression in HET-1A cells 
We initially used the lentivirus-mediated method to achieve ectopic HNF4α 
expression in the HET-1A cells. Hnf4α expression can be detected 2 days after 
lentiviral-HNF4α (lenti-HNF4α) infection (Fig. 3.3A). Examination of gene 
expression at day14 showed that forced HNF4α expression did not initiate the 
transcription of intestinal genes including CDX1, CDX2 and SI, but HNF4α induced 
intestinal VILLIN gene expression (Fig. 3.3B). 
 
3.2.3 Establishment of Hnf4α-expressing HET-1A clones and the examination of 
gene expression 
In order to establish HNF4α-expressing HET-1A cells, HET-1A cells were infected 
with lenti-HNF4α for 24 hours and then the medium was replaced with fresh 
medium. Two days after infection, cells were sub-seeded into 5 x 96-well plates. 
Single cells from lenti-HNF4α infected cultures were selected and expanded. Five 
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clones were obtained. The further expansion of HNF4α clone 2, 3 and 4 was not 
successful due to the poor proliferation and cell death. Finally, HNF4α clone 1 
(HNF4α-c1) and HNF4α clone 5 (HNF4α-c5) were obtained. Immunostaining results 
confirmed that HNF4α-c1 and HNF4α-c5 expressed HNF4α (Fig. 3.4A). There was 
no morphological change following HNF4α ectopic expression in both HNF4α-c1 
and HNF4α-c5 (Fig. 3.4B). However, the growth rate of both HNF4α-c1 and 
HNF4α-c5 was lower than the control HET-1A cells (Fig. 3.4C).    
 
The lenti-HNF4α vector as well as encoding the sequence for HNF4α also encodes a 
sequence for green fluorescence protein (GFP). GFP was co-expressed with the 
transgene and allows the real-time indication of the transgene expression. 
Surprisingly, the green fluorescent signal from GFP protein was not visible in the 
HNF4α-c1 and HNF4α-c5 HET-1A cells under epifluorescence microscopy 
(Fig. 3.5A). However, immunostaining for GFP confirmed that GFP was indeed 
expressed albeit weakly (Fig. 3.5B). The absence of green fluorescence from GFP 
might be due to a low expression level of GFP protein. Immunostaining results also 
showed that HNF4α did not induce E-cadherin expression (Fig. 3.5C).  
 
RT-PCR analysis technique was used to examine whether HNF4α ectopic expression 
of HNF4α induced intestinal genes (Fig. 3.6). The results showed that VILLIN gene 
expression was induced, but CDX2 expression was not detected in the HNF4α-c1 
and HNF4α-c5 HET-1A cells. Moreover the expression of the squamous epithelial 
cell marker K14 was slightly down-regulated, but the columnar cell marker K18 was 
unchanged in both HNF4α-c1 and HNF4α-c5 HET-1A cells.   
 
3.2.4 Mutant HNF4α does not induce intestinal VILLIN gene expression 
As well as testing the ectopic expression of a lentiviral vector containing a normal 
version of Hnf4α, we also created one lentiviral vector which carried both N and 
C-terminal truncated Hnf4α transgene. Lenti-mutant HNF4α or Lenti-HNF4α viral 
particles were prepared and used to infect HET1-1A cultures. RT-PCR results 
showed that the conserved Hnf4α sequence region between Hnf4α and the mutant 
Hnf4α can be amplified by the Hnf4α-1 primer set, but only normal Hnf4α can be 
amplified by the Hnf4α-2 primer set (Fig. 3.7A,B). RT-PCR results also confirmed 
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that mutant HNF4α was unable to induce VILLIN gene expression (Fig. 3.7B). 
Furthermore, immunostaining results demonstrated that the wild type HNF4α can be 
recognized by the HNF4α antibody which bound to the 295-465 amino acid at the 
C-terminal of HNF4α (Fig. 3.7C). However, the truncated HNF4α was not detected 










Figure 3.1. Characterisation of the HET-1A cell line 
Immunostaining was carried out in order to characterise the phenotype of the 
HET-1A cells. (A, C) p63 and K14 were not detected in HET-1A cells. (B, D) p63 
and K14 expression in mouse oesophageal epithelial explants were used as positive 
controls. (E, F) HET-1A cells are positive for K18 and Vimentin. Nuclei were stained 







Figure 3.2. Characterisation of epithelial and intestinal markers in the HET-1A 
cell line 
Immunostaining was performed to characterise the HET-1A cells for epithelial and 
intestinal markers. E-cadherin was not expressed in HET-1A cells (A), but was 
detected in the mouse oesophageal epithelial explants (B). Intestinal transcription 
factors CDX2 and HNF4α were not expressed in HET-1A cells (C, D) but were 
expressed in Caco-2 cells which were used as the positive controls (E, F). Nuclei 













Figure 3.3. Effects of ectopic expression of HNF4α in HET-1A cells 
(A) HET-1A cells were infected with Lenti-HNF4α virus. Twenty-four hours after 
infection, the culture medium was replaced and cells were fixed at day 2. 
Immunostaining results showed that HNF4α can be detected 2 days after 
Lenti-HNF4α infection. No virus infected cells (control) were negative for HNF4α. 
(B) RT-PCR was performed on RNA isolated from HET-1A cells 14 days after 
Lenti-HNF4α infection. The expression of intestinal genes including CDX1, CDX2, 
SI and VILLIN were examined. Note that Hnf4α transgene is of mouse origin. 
β-ACTIN was used as a loading control. Controls include HT-29 cells (positive, +) 







Figure 3.4. Creation of stable HNF4α-expressing Het1a clones  
HET-1A cells were infected with Lenti-HNF4α virus for 24 hours and then the 
medium was replaced. At day 2, single-cells were clonally expanded in a 96 well 
format. (A) HNF4α expression was analysed by immunostaining. Two out of 5 
HNF4α-expressing stable clones were obtained (termed HNF4α clone 1 (HNF4α-c1) 
and HNF4α clone 5 (HNF4α-c5)). (B) Phase contrast images of HNF4α-c1, 
HNF4α-c5 and control HET-1A cells. (C) At day 0, cells were seeded at 30000 cells 
in a 35 mm dish and cultured. Cells were trypsinized and the cell number was 





Figure 3.5. Phenotypic characterisation of the stable HNF4α-expressing Het-1A 
clones 
HNF4α-c1 or HNF4α-c5 cells were seeded on a glass coverslip in a 4-well plate. At 
day 3, cells were fixed. (A) Lenti-HNF4α construct contains a green fluorescence 
protein (GFP) gene, but the green fluorescence was not visable under the 
fluoresecence microscopy. (B) Immunostaining for GFP demonstrateed that GFP is 
expressed in the HNF4α-c1and HNF4α-c5 cells. (C) HNF4α-c1and HNF4α-c5 cells 
did not express E-Cadherin, as visualised by immunostaining. Nuclei were stained in 





Figure 3.6. Examination of intestinal gene expression in Hnf4α-Het1a clones 
HNF4α-c1 or HNF4α-c5 cells were seeded into 6-cm dishes. Seven days later, cells 
were harvested. RT-PCR result shows that CDX2 mRNA expression is not detected. 
Intestinal marker VILLIN expression is founded in both HNF4α-c1and HNF4α-c5 
cells. Expression of the squamous cell marker K14 was slightly decreased in 
HNF4α-c1 and HNF4α-c5 cells, but the columnar cell marker K8 was unchanged. 
β-ACTIN was used as a loading control. The experiments were performed in 











Figure 3.7. RT-PCR and HNF4α immunostaining for HET-1A cells infected 
with Lenti-HNF4α or Lenti-mutant HNF4α 
5’ and 3 truncated HNF4α lentiviral constructs were created and the viral particles 
were produced. HET-1A cells were infected with Lenti-HNF4α or Lenti-mutant 
HNF4α viruses. The medium was replaced with fresh medium 24 hours later. 
Fourteen days after infection, HET-1A cells were harvested for RT-PCR. (A) Figure 
displays the primers used for Hnf4α PCR (B) RT-PCR results showed that HNF4α-1 
primer set amplified both the truncated and wild type Hnf4α, whilst the HNF4α-2 
primer set only amplified the wild type Hnf4α. VILLIN expression was only found in 
the Lenti-HNF4α infected cultures. (C) HNF4α antibody which recognises the 
295-465 amino acids at the C-terminus of HNF4α was used for immunostaining. 
Lenti-HNF4α infected cells were positive for HNF4α staining, but Lenti-mutant 
HNF4 α infected cells were negative for HNF4α staining. One of two experiments is 
shown.   




3.3.1 Characterisation of HET1-A cells 
We initially examined the phenotype of the HET-1A oesophageal cell line.  This 
cell line has been used extensively in studies on Barrett’s oesophagus (Liu et al., 
2007; Vaninetti et al., 2009; Rafiee et al., 2009; Goldman et al., 2010).  
Examination of HET-1A cells by immunostaining showed that the HET-1A cells did 
not express either p63 or K14. p63 is the master transcription factor for stratified 
squamous epithelium and is expressed in the basal region of some epithelial tissue 
including epidermis, oesophagus, cervix, urothelium and prostate (Yang et al., 1998). 
In the oesophageal epithelium, p63 is expressed in the cell nucleus at the basal or 
parabasal region of the epithelium (Yang et al., 1999; Chen et al., 2008). K14 is a 
marker for differentiated squamous epithelial cells and is expressed in the cytoplasm 
of the basal stratified squamous epithelium (Yu et al., 2005; Chen et al., 2008). 
Although the HET-1A cells did not express p63 and K14, they did express K8. K8 is 
a columnar epithelial marker and can be detected in the intestinal epithelium. Studies 
showed that in mouse, K8 is expressed in the oesophageal epithelium at embryonic 
and postnatal stages, but K8 is not detected in the oesophageal epithelium at adult 
stage (Yu et al., 2005). Interestingly, the epithelial adhesion protein E-cadherin is not 
expressed in HET-1A cells. Instead, the mesenchymal marker Vimentin was 
expressed. Vimentin is also considered as an epithelial-mesenchymal-transition 
(EMT) marker in the progression of cancer metastasis (Zeisberg & Neilson, 2009). 
These results suggest that HET-1A cells might have lost some of the characteristics 
of oesophageal squamous epithelial cells and gained a columnar phenotype.   
 
It has been reported that HET-1A cells are SV-40 large T-antigen transformed  
oesophageal epithelial cells (Stoner et al., 1991). In previous studies, HET-1A cells 
were tested in an organotypic culture system in which cells were co-cultured with 
fibroblasts (Underwood et al., 2010). Unlike the normal human primary oesophageal 
epithelial cells which were able to develop the stratified structure with a basal layer, 
resembling the in vivo oesophageal squamous epithelium, HET-1A cells developed a 
disordered dysplastic phenotype (Underwood et al., 2010). At present there is 
currently a lack of a cell line which fully represents the normal oesophageal 
epithelial cells. Additionally, the HET-1A cell line has been widely used for BM 
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studies (Liu et al., 2007; Kong et al., 2009; Goldman et al., 2010). There are 
therefore limitations when using HET-1A cell line as a BM study model. However, 
these limitations were found at a late stage of my PhD. Therefore, the HET-1A cell 
line was used as a model for BM research in this thesis.    
 
NES (normal esophageal squamous) cell line has also been used as an in vitro model 
for BM research (Jaiswal et al., 2006; Zhang et al., 2008; di Pietro et al., 2012). NES 
cells were derived from normal human oesophageal epithelial cells and are 
immortalized by introducing human telomerase reverse transcriptase (hTERT) 
(Morales et al., 2003; Zhang et al., 2008). It was shown that NES cells maintain the 
squamous epithelial cell characteristics with the expression of squamous epithelial 
marker such as K13 and K4 (Morales et al., 2003; di Pietro et al., 2012). However, 
whether NES cells represent the normal oesophageal epithelial cells and whether 
NES cells are suitable for the studies of BM development remains to be investigated. 
For example, one report showed that NES cells do not express columnar cell marker 
K8 (di Pietro et al., 2012). However, another report indicated that NES cells are 
positive for K8 expression (Morales et al., 2003). The characteristics of NES cells 
therefore still need to be investigated. In future, the development of an oesophageal 
epithelial cell line which maintains oesophageal epithelial characteristics will be of 
great benefit to BM research.     
 
3.3.2 Ectopic HNF4α expression in HET-1A cells  
We initially tried overexpressing Hnf4α in HET-1A cells using a lentiviral expression 
system. The purpose of generating stable clone was to obtain sustained and long term 
transgene expression in a genetically homogenous cell population. 
HNF4α-expressing HET-1A clones were successfully created and the ectopic Hnf4α 
expression suppressed cell proliferation. In the liver, HNF4α is an important 
transcription factor for hepatocyte differentiation (Li et al., 2000; Watt et al., 2003). 
HNF4α regulates liver transcription factors such as HNF1α and pregnane-x-receptor 
(PXR) (Li et al., 2000). HNF4α also regulates some genes which are important for 
normal hepatocyte functions such as ApoCIII, transthyretin (TTR) and cytochrome 
P450 3A4 (CYP3A4) (Sladek et al., 1990; Tirona et al., 2003). In addition, it has 
been reported that the deletion of Hnf4α in mice liver (Hnf4αFlox/Flox; 
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Albumin-ERT2cre) increased both hepatocyte proliferation and liver-body mass ratio. 
These changes were due to the upregulation of mitogenic genes including c-Myc, 
cyclin dependent kinase 1 (Cdk1), and cyclin D1 and the reduction of basal apoptotic 
activity (Bonzo et al., 2012; Walesky et al., 2013). The inhibition of cell proliferation 
by HNF4α has also been reported in cell types such as HET293 (human embryonic 
kidney cells) and F9 cells (murine embryonic carcinoma cell) (Lucas et al., 2005; 
Chibaa et al., 2005). Therefore, it would be interesting to investigate whether the 
suppression in cell proliferation is linked to the decreased expression of mitogenic 
genes in the HNF4α-expressing HET-1A clones. Cyclins, CDKs and c-MYC of 
mitosis-related genes expression cloud be examined.   
 
VILLIN is an actin-binding protein and is the key component of the brush border of 
absorptive cells in the intestine and renal proximal tubule epithelium (Maunoury et 
al., 1992; Maclennan et al., 1999). VILLIN is considered as a marker for BM. Two 
studies in which VILLIN expression was assessed by immunohistochemistry method 
demonstrated that 81% or 100% of BM biopsy samples were positive for VILLIN 
staining (Maclennan et al., 1999; Shi et al., 2008), but VILLIN was not detected in 
the normal oesophageal epithelium or gastric columnar cells (Maclennan et al., 
1999). In this chapter, although more intestinal and BM markers such as TFF3, K20 
and MUC2 need to be examined (Lao-Sirieix et al., 2009; di Pietro et al., 2012), the 
induction of VILLIN expression by HNF4α implicated the development of intestinal 
metaplasia. In fact, the induction of VILLIN gene expression by HNF4α has been 
observed in NIH-3T3, Mia PaCa-2 and HEK293 cells (Lucas et al. 2005; Babeu et al. 
2009), but the mechanism of induction has not yet been explored. VILLIN expression 
might be directly regulated by HNF4α. We identified two potential HNF4α binding 
sites (−26 ~ −14 bp GGGACAAAGGTCG and −1248 ~ −1260 bp 
GGGTCAGGGGTCA) in the −2 kb to +1 bp region of the VILLIN promoter by 
using web-based tool (HNF4 Motif Finder, http://nrmotif.ucr.edu) developed by the 
Sladek lab (Bolotin et al., 2010). In the future, the interaction between HNF4α and 
VILLIN expression could be examined by using a luciferase reporter assay. The 
luciferase reporter assay could be potentially performed in HET-1A cells or NES 
cells by co-transfecting HNF4α expression vector and the luciferase reporter vector 
in which the luciferase expression is driven by the wild type or the HNF4α-binding 
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site mutated VILLIN promoter. The luminescence signal intensity will positively 









Chapter 4                      
The role of candidate transcription 





The development of BM is linked to the ectopic expression of candidate transcription 
factors (particularly those of the intestine). In Chapter 3, it was shown that forced 
HNF4α expression in adult mouse oesophageal epithelium induced a partial 
squamous-to-columnar cell type change (based on induction of K8 and VILLIN and 
loss of K14 and p63). While HNF4α alone was able to bring about this phenotypic 
change, it did not result in a mature intestinal phenotype. It is therefore possible that 
intestinal transcription factors other than HNF4α may be involved in development of 
BM. These candidates include CDX2, HNF1α, PDX1 and FOXA2. The role of 
CDX2 in the intestine and BM has been reviewed in the introduction to Chapter 
3.1.1 and therefore will not be examined here.   
 
4.1.1 HNF1α 
HNF1α is expressed along the crypt-villus axis in small intestinal epithelium 
(Escaffit et al., 2005; D’Angelo et al., 2010). The study of Hnf1α knockout mice 
demonstrated that Hnf1α is important for Paneth, enterocyte and Goblet cell 
differentiation. Hnf1α deletion reduced the gene expression of enterocyte 
differentiation marker dipeptidyl peptidase IV (DppIV) (D’Angelo et al., 2010). 
Hnf1α deletion also decreased the gene expression of Cdx2 which is a key regulator 
for enterocyte maturation (Suh & Traber, 1996; D’Angelo et al., 2010). In addition, 
knockout of Hnf1α moderately reduced the expression of genes that are associated 
with Goblet cell differentiation (such as Gob5) and Paneth cell differentiation (such 
as Lysozyme) (D’Angelo et al., 2010). In another study of Hnf1α knockout mice, the 
authors observed abnormalities such as the intestinalomegaly and increased cell 
proliferation in the crypt region. Hnf1α deletion also caused the disruption in Paneth 
cell differentiation and in enteroendocrine cell number (Lussier et al., 2010). 
Furthermore, HNF1α directly regulates intestinal genes such as Solute carrier family 
26 member 3 (Slc26a3), Lactase and DppIV (Erickson et al., 1999; van Wering et al., 
2002; Piessen et al., 2007; D’Angelo et al., 2010; Benoit et al., 2010). These data all 
point to the possibility that HNF1α is important for normal cell function and 
cytodifferentiation of the intestine epithelium. In terms of BM, HNF1α is not 
expressed in the normal oesophageal epithelium, but is detected in BM tissue and 
oesophageal adenocarcinoma (Piessen et al., 2007). Therefore, HNF1α might 
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potentially play an important role in the development of BM. 
 
4.1.2 FOXA2 
In the intestine, FOXA2 is coexpressed with MUC2. MUC2 is the mucus component 
of intestinal epithelium and a Goblet cells cell marker. FOXA2 regulates Muc2 
transcription and is essential for normal expression (van der Sluis et al., 2008). Mice 
in which Foxa2 is deleted die by E10.5 due to the failure in forming the organizer 
node and notochord (Ang & Rossantt, 1994; Weinstein et al., 1994). The effects of 
conditional Foxa2 deletion in the intestine have not been reported. However, a report 





;Villin-Cre) affected goblet cell differentiation with the 
reduction of goblet cell number and mucin granules. Foxa1/a2 deletion also reduced 
the number of differentiated enteroendocrine cells (Ye & Kaestner, 2009). 
Importantly, although FOXA2 expression was not detected in the mouse oesophageal 
epithelium in adult life, FOXA2 expression has been investigated in E15.5 and E18.5 
mouse oesophageal epithelium and FOXA2 was found to be expressed (Besnard et 
al., 2004). The expression of FOXA2 before the E15.5 stage of development remains 
to be investigated. Because K8 was also expressed in the oesophageal epithelium in 
the embryonic stage, but not in adult life, this may implicate a potential link between 
FOXA2 expression and the columnar phenotype.  
 
4.1.3 PDX1 
Pancreatic and duodenal homeobox 1 (PDX1) is a transcription factor expressed in 
the anterior part of the intestine, pancreas and posterior part of the stomach (Miller et 
al., 1994; Larsson et al., 1996). PDX1 is expressed along the villi and crypt region in 
the duodenum where it is believed to regulate intestinal cell differentiation. 
Overexpression of PDX1 in the undifferentiated rat intestinal IEC-6 cells drives cell 
differentiation towards the enteroendocrine cell type (Yamada et al., 2001).  
Conditional knockout of Pdx1 in mouse intestine (Pdx1
flox/flox
;Villin-Cre) disrupted 
the gene expression profile of enterocytes and enteroendocrine cells in the proximal 
small intestine. The genes which are decreased by Pdx1 deletion include alkaline 
phosphatase 3 (Akp3) of the enterocytes, and Gip and somatostatin of the 
enteroendocrine cells (Chen et al., 2009; Chen & Sibley, 2012). Furthermore, it was 
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shown that PDX1 regulates enterocyte gene transcription such as Si, fatty acid 
binding protein 1 (Fabp1) and Lactase, suggesting a regulatory role for PDX1 in 
nutrient metabolism (West & Oates, 2005; Chen et al., 2012b; Wang et al., 2004). 
Indeed, Pdx1 conditional deletion mice (Pdx1
flox/flox
;Villin-Cre) were born 
underweight and weight gain was delayed (Chen et al., 2012a). More importantly, 




) (tTA: tetracycline 
transactivator; Tg
Pdx1
:tTA-responsive Pdx1 transgene) showed hematoma formation 
with the intercalary regeneration in which the ectopic stratified squamous epithelium 
was integrated between the columnar epithelium at the gastro-duodenal junction. 
This suggests a pivotal role of PDX1 in the maintenance of positional identity in the 
gut (Holland et al., 2013).    
 
4.1.4 Network of intestinal transcription factors  
Intestinal gene expression is regulated by a combinatorial network of intestinal 
transcription factors (Traber & Silberg, 1996). For example, HNF4α interacts with 
the CDX2 and HNF1α promoter regions in Caco2 cells and mouse small intestinal 
mucosa according to ChIP-chip (Chromatin Immunoprecipitation-chip) and 
ChIP-qPCR results respectively (Boyd et al., 2009). CDX2 partners with GATA-6 to 
interact with chromatin regions during proliferation, but during differentiation, 
CDX2 is accompanied by HNF4α to co-occupy the different chromatin regions 
(Verzi et al., 2010). Ectopic expression of HNF1α or CDX2 alone in human 
embryonic intestinal crypt (HIEC) cells does not induce SI gene expression, but the 
combination of HNF1α and CDX2 induced SI gene expression. HNF1α and CDX2 
co-expression initiated intestinal differentiation, but only with the addition of 
GATA-4, did HIEC cells develop the differentiated features typical of intestinal cells 
such as microvilli (Benoit et al., 2010). These observations indicate that the 
transcription factor network is essential for modulating intestinal differentiation and 
intestinal cell function. 
 
4.1.5 Aims 
Firstly, given that HNF1α, PDX1 and FOXA2 are involved in intestinal 
differentiation they may act as potential drivers of BM. I therefore set out to 
determine the effects of ectopic expression of these intestinal transcription factors in 
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the HET-1A cell line. Secondly, because the network of master transcription factors 
is required for normal intestinal epithelial development and function, it is likely that 
multiple transcription factors are required for initiating BM. The expression of 
intestinal genes after ectopic expression of the multiple intestinal transcription 





4.2.1 Determination of a suitable adenoviral MOI in HET-1A cells 
To determine the amount of adenoviral particles required for transgene 
overexpression, different MOI (multiplicity of infection) of an adenoviral vector 
expressing Green fluorescent protein (Ad-GFP) was tested in HET-1A cells for 24 
hours (Fig. 4.1). At day 3, no green fluorescence was observed in the absence of 
Ad-GFP. At an MOI of 5, about 60 % of cells expressed green fluorescence 
following Ad-GFP exposure and with an MOI of 10, around 80% of cells expressed 
green fluorescence. Although nearly 100% of cells expressed intense green fluoresce 
at an MOI of 20, the cell viability was lowest among all the tested cultures. 
Therefore, an MOI of 10 was chosen for adenoviral infection experiments in the 
HET-1A cells. 
 
4.2.2 Forced CDX2 and HNF4α expression induced intestinal gene expression  
To investigate the effect of CDX2 and HNF4α ectopic overexpression, HET1-A cells 
were treated with Ad-CDX2 and Ad-HNF4α (MOI 10 in total) for 24 hours, and cells 
were harvested at different time points after infection up to day 6. RT-PCR reveals 
that the CDX2 reached the highest expression level by day2 and decreased thereafter 
whereas HNF4α, expression appeared relatively stable over the time course (Fig. 
4.2). Intestinal gene expression was also evaluated. VILLIN gene expression was 
induced in Ad-HNF4α-infected cultures either in the absence or presence of 
Ad-CDX2. VILLIN expression showed similar levels at day 2, 4 and 6 of culture. SI 
expression was provoked by Ad-CDX2, and both Ad-CDX2 and Ad-HNF4α 
infection and SI expression level is higher at day 2 and day 4. There was no 
significant change in K14 and K18 expression following overexpression of either 
CDX2 or HNF4α.  
 
4.2.3 Forced PDX1 expression did not provoke intestinal gene expression   
To understand whether ectopic PDX1 overexpression induces intestinal gene 
expression, HET-1A cells were infected with Ad-PDX1, Ad-CDX2, Ad-HNF4α 
alone or in combination (Fig. 4.3). Results from the RT-PCR showed that PDX1 did 




4.2.4 Ectopic CDX2, HNF1α and HNF4α expression induced intestinal gene 
expression  
We further refined the experimental approach to investigate the effects of forced 
HNF1α expression in HET1-A cells. RT-PCR result showed that HNF1α, CDX2 and 
HNF4α alone or in combination all weakly induced intestine-specific homeobox 
(ISX) expression (Fig. 4.4). ISX encodes ISX intestinal transcription factor and is 
exclusively expressed in the intestinal epithelium in the adult (Choi et al., 2006). ISX 
regulates β,β-carotene absorption and vitamin A production (Lobo et al., 2010). 
Interestingly, SI and K20 were induced by the CDX2 alone or the transcription factor 
combinations which contained CDX2. In contrast, VILLIN was induced by the 
HNF4α alone or the transcription factor combinations including HNF4α. LGR5 was 
increased in CDX2 or the CDX2 containing combinations. In the intestine, LGR5 is 
expressed in the crypt base columnar cells and is considered as an intestinal stem cell 
marker (Barker et al., 2007). The CDX2 transgene in Ad-CDX2 originates from the 
mouse. We can therefore use different primers to distinguish the exogenous mouse 
Cdx2 gene from the endogenous human CDX2 gene expression. The expression of 
endogenous human CDX2 was not provoked nor was MUC2 induced. There was also 
no significant change in K14 and K18 expression level following CDX2 ectopic 
expression. 
 
We extended this study to perform quantitative PCR (qPCR) analysis for VILLIN and 
K20 mRNA following overexpression of CDX2, HNF4α and HNF1α (Fig. 4.5). 
VILLIN qPCR measurements showed that Ad-CDX2 and Ad-HNF4α co-infection 
induced the highest VILLIN level followed by Ad-HNF4α infection alone. In 
addition, the K20 qPCR result demonstrated that the K20 level is highest in cultures 
infected with both Ad-CDX2 and Ad-HNF4α and the second highest level is in 
cultures infected with Ad-CDX2, Ad-HNF4α and Ad-HNF1α together. 
Immunostaining for VILLIN and HNF4α showed that CDX2, HNF4α and HNF1α 
ectopic expression did not provoke VILLIN protein expression in HET-1A cells (Fig. 
4.6) and K20 and SI protein were also not detected in any of the cultures (Fig.4.7, 
Fig. 4.8).        
 
We wished to understand whether ectopic expression of HNF1α and CDX2 could 
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enhance intestinal gene expression in the stable HNF4α-expressing HET-1A clones 
(HNF4α-c1 and HNF4α-c5). To address this possibility, HET-1A cultures were 
infected with Ad-CDX2or Ad-HNF1α alone and in combination. Results from 
RT-PCR analysis demonstrated that in both the HNF4α-c1 and HNF4α-c5 stable cell 
lines CDX2 in the absence and presence of HNF1α increased LGR5 and ISX 
transcription, and also induced K20 and SI transcription (Fig. 4.9). ISX was also 
weakly induced by HNF1α in HNF4α-c1, but not in HNF4α-c5. Results from qPCR 
analysis revealed that the level of the VILLIN gene was increased in HNF4α-c1 cells 
compared to the control HET-1A cells (Fig. 4.10). The K20 level was also increased 
in HNF4α-c1 cells infected with Ad-CDX2 in the absence and presence of 
Ad-HNF1α. VILLIN protein expression was also determined by immunostaining but 
was not induced (Fig. 4.11).    
 
4.2.5 FOXA2, CDX2, HNF1α and HNF4α induces intestinal gene expression 
To study the role of FOXA2 in BM development, HET-1A cells were infected with 
Lenti-FOXA2. Immunostaining result showed that FOXA2 protein was detected in 
Lenti-FOXA2 infected cultures, but not in control cultures (Fig. 4.12A). Because the 
Foxa2 transgene was of mouse origin, the mouse Foxa2 gene was expressed after 
Lenti-FOXA2 infection (Fig. 4.12B). Human type FOXA2 was very weakly 
expressed in both Lenti-GFP and Lenti-FOXA2 treated cells. RT-PCR results also 
showed that FOXA2 ectopic expression did not provoke intestinal gene expression. 
FOXA2 overexpression also did not change K14 and K18 expression in HET-1A 
cells.   
 
We wanted to know whether ectopic expression of CDX2, HNF1α and HNF4α could 
induce intestinal gene expression in FOXA2-expressing cells. Lenti-FOXA2 infected 
HET-1A cells were further incubated with Ad-CDX2, Ad-HNF1α, Ad-HNF4α alone 
and in combination. Results from RT-PCR analysis showed that VILLIN was weakly 
induced by the transcription factor combination which contained HNF4α (Fig. 4.13). 
Additionally, SI, MUC2 and K20 were induced by CDX2 or the transcription factor 
combination which included this transcription factor. The endogenous human CDX2 
expression was also examined. The results showed that the endogenous CDX2 
expression was weakly detected in all the cultures which were incubated with 
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Ad-CDX2, Ad-HNF1α or Ad-HNF4α alone and in combination in the 
FOXA2-expressing cells.   
 
4.2.6 Lenti-HCH infection did not induce intestinal gene expression  
As it is not possible to control the relative levels of transcription factors in HET-1A 
cells we used the Lenti-HNF4α-2A-CDX2-2A-HNF1α (Lenti-HCH) viral particles to 
infect the cells. Immunostaining for CDX2 and HNF4α showed that the 
co-expression of CDX2 and HNF4α were observed in Lenti-HCH treated HET-1A 
cells (Fig. 4.14A). However, VILLIN and HNF4α co-staining results demonstrated 
that VILLIN protein was not induced by Lenti-HCH infection (Fig. 4.14B). The 
expression of intestinal genes in HET-1A cells infected with Lenti-HCH was also 
assessed by RT-PCR (Fig. 4.15). CDX2, HNF1α and HNF4α mRNA were ectopically 
expressed. However, intestinal gene expression was not induced by Lenti-HCH 







   
Figure 4.1. Defining the optimal adenoviral multiplicity of infection in HET-1A 
cells  
HET-1A cells were seeded the day prior to adenoviral infection. Different volumes of 
adenoviral GFP particles (Ad-GFP), corresponding to the required Multiplicity of 
infection (MOI), were added to the cell culture. Twenty-four hours after viral 
infection, the culture medium was replaced with fresh medium (but containing no 
virus). Green fluorescence images were taken at day 3 following infection. One of 





Figure 4.2. Time course of CDX2 and HNF4α expression in HET-1A cells 
HET-1A cells were incubated with Ad-Null, Ad-GFP, Ad-CDX2, Ad-HNF4α, or 
Ad-CDX2 and Ad-HNF4α viruses for 24 hours and then the medium was replaced 
fresh medium. Cells were collected at day 2, 4 or 6 and RT-PCR was performed. 
Controls include HT-29 or mouse intestine (positive, +) and PCR reaction without 







Figure 4.3. Ectopic CDX2, HNF4α and PDX1 expression induce intestinal gene 
expression in HET-1A cells  
HET-1A cells were treated with Ad-Null, Ad-CDX2, Ad-HNF4α or Ad-PDX1 alone 
or in combination for 24 hours. The medium was then replaced with fresh medium.  
Cells were harvested at day 4 and RT-PCR was performed on the isolated RNA 






Figure 4.4. Induction of intestinal gene expression by CDX2, HNF4α and 
HNF1α in HET-1A cells               
(A) HET-1A cells were incubated with Ad-Null, Ad-CDX2, Ad-HNF4α, Ad-HNF1α 
or with the combinations shown for 24 hours. Medium was then replaced with fresh 
medium. At day 4, cells were collected, RNA extracted and RT-PCR was performed. 







Figure 4.5. Intestinal gene expression induction following overexpression of 
CDX2, HNF4α and HNF1α in HET-1A cells               
HET-1A cells were incubated with Ad-Null, Ad-CDX2, Ad-HNF4α, Ad- HNF1α or 
with the combinations shown for 24 hours and the medium was refreshed. At day 4, 
cells were collected and RNA was extracted. VILLIN and K20 mRNA levels were 
quantified by qPCR and were normalised to β-ACTIN mRNA level. Bar chart 
expressed the relative mRNA levels of VILLIN compared with Ad-HNF4α infected 
control or mRNA levels of K20 compared with Ad-CDX2 infected control. Error 
bars represent standard error (SE) of three replicates. Statistical analysis performed 



























Figure 4.6. Forced CDX2, HNF4α and HNF1α did not induce VILLIN protein 
expression in HET-1A cells 
HET-1A cells were treated with Ad-Null, Ad-CDX2, Ad-HNF4α, Ad- HNF1α or 
various adenovirus combinations for 24 hours and the medium was replaced with 
fresh medium. Cells were fixed at day 4 and immunostaining was performed for 
VILLIN (green) and HNF4α (red). DAPI (blue) was counterstained for nuclei. Caco2 






Figure 4.7. K20 protein was not induced by forced CDX2, HNF4α and HNF1α 
expression in HET-1A cells 
HET-1A cells were infected with Ad-Null, Ad-CDX2, Ad-HNF4α, Ad- HNF1α or 
different adenovirus combinations for 24 hours. Medium was then replaced with 
fresh medium. At day 4, cells were fixed and immunostaining for K20 (green) was 
performed. DAPI (blue) staining was for nuclei. Embryonic intestine isolated from 
E12.5 mouse embryos and cultured for 10 days was used as the positive control. One 





Figure 4.8. SI protein was not detected following forced expression of CDX2, 
HNF4α and HNF1α in HET-1A cells 
HET-1A cells were incubated with Ad-Null, Ad-CDX2, Ad-HNF4α, Ad- HNF1α or 
the combinations for 24 hours and then the medium was changed. Cells were fixed at 
day 4. Immunostaining was performed for SI (green). DAPI (blue) was 
counterstained for nuclei. Embryonic day 12.5 intestine cultured for 10 days was 





Figure 4.9. CDX2 and HNF1α induced intestinal gene expression in 
HNF4α-expressing HET1A clones 
(A) HNF4α-HET1A clone 1 and clone 5 (HNF4α-c1 and HNF4a-c5) were incubated 
with Ad-Null, Ad-CDX2, Ad-HNF1α alone or in combination for 24 hours. At day 4, 
cells were harvested, RNA extracted and RT-PCR performed. β-ACTIN was used as a 









Figure 4.10. Intestinal gene expression was induced by Cdx2 and Hnf1α in 
Hnf4α-expressing HET1A clones 
HNF4α-HET1A clone 1 (HNF4α-c1) was incubated for 24 hours with the Ad-Null, 
Ad-CDX2, Ad- HNF1α adenoviral vectors either alone or in combination and then 
medium was replaced with fresh medium. At day 4, cells were harvested and RNA 
was extracted.VILLIN and K20 mRNA levels were quantified by qPCR and were 
normalised to β-ACTIN mRNA levels. Bar chart showing the relative mRNA levels 
of VILLIN compared with Ad-Null infected HNF4α-c1 or mRNA levels of K20 
compared with Ad-CDX2 infected HNF4α-c1. Error bars represent standard error 
(SE) of three replicates. Statistical analysis was performed with student paired t test. 







Figure 4.11. Cdx2 and Hnf1α did not induce Villin protein in Hnf4α-expressing 
HET-1A clones                                                                                                         
HET-1A cells were treated with Ad-Null, Ad-CDX2, Ad-HNF1α alone or in 
combination for 24 hour and the medium was replaced with fresh medium. (A) At 
day 4, cells were fixed for VILLIN (green) and HNF4α (red) immunostaining. DAPI 







Figure 4.12 – Forced FOXA2 expression did not induce intestinal gene 
expression in Het-1A cells  
HET-1A cells were incubated with or without Lenti-FOXA2 virus for 24 hours and 
medium was replaced with fresh medium. (A) Cells were fixed at day 3 following 
infection for FOXA2 (green) immunostaining. DAPI (blue) was counterstained for 
nuclei. (B) Cells were harvested at day 7 following infection and RT-PCR was 
performed to examine gene expression. β-ACTIN was used as a loading control. One 





Figure 4.13. Intestinal gene expression was induced by CDX2, HNF4α and 
HNF1α in FOXA2-expressing HET-1A cells                         
HET-1A cells were infected with lenti-FOXA2 virus and medium was changed 24 
hours later. At day2, cells were sub-cultured. At day3, Ad-CDX2, Ad-HNF1α, 
Ad-HNF4α or the combinations were added into cell culture and at day 4, medium 
was replaced with fresh medium. Cells were harvested at day 7 and RT-PCR was 
performed to examine gene expression. β-ACTIN was used as a loading control. One 




Figure 4.14. Lenti-HCH (HNF4α-2A-CDX2-2A-HNF1α) infection did not 
induce Villin protein                                              
HET-1A cells were incubated with the Lenti-HCH virus for 24 hours and the medium 
was replaced with fresh medium. Three days after Lenti-HCH virus infection, 
HET-1A cells were fixed for immunostaining. Results showed that (A) CDX2 (green) 
and HNF4α (red) were co-localized in Lenti-HCH infected HET-1A cells (B) 
VILLIN (green) was not detected in HNF4α-positive cells (red) in Lenti-HCH 





Figure 4.15. Intestinal gene expression was not provoked following Lenti-HCH 
infection  
HET-1A cells were infected with lenti-HCH virus for 24 hours and then medium was 
changed. Cells were harvested at day3 following infection. RNA was extracted and 
RT-PCR was performed to analyse gene expression levels. β-ACTIN was used as a 





4.3.1 Ectopic expression of CDX2 and HNF4α in HET-1A cells 
The aim of the work described in the present chapter was to investigate the role of 
candidate transcription factors in the conversion of stratified squamous epithelium to 
intestinal type columnar epithelium. Initially we tested different MOIs using a 
control reporter virus Ad-GFP to optimise adenoviral-mediated gene overexpression 
in HET-1A cells (Fig. 4.1). Based on the cell viability and GFP expression an MOI 
10 was chosen for the adenoviral-mediated gene delivery experiment. In addition to 
MOI, the time course of transgene expression was also assessed (Fig. 4.2). The 
highest level of transgene CDX2 and HNF4α expression was between 2 and 4 days 
after initial adenoviral infection. Considering that downstream genes might only be 
provoked at the later stage, in the following adenoviral infection experiments, cells 
were harvested at day 4 post-infection for immunostaining or RT-PCR analysis.  
 
We wished to explore whether HNF4α and CDX2 ectopic expression induced 
intestinal gene expression in HET-1A cells. RT-PCR results showed that forced 
HNF4α expression induced VILLIN gene expression in HET-1A cells. This is 
consistent with the results shown in Chapter 3 in which ectopic HNF4α expression 
(mediated by lenti-HNF4α infection) induced VILLIN expression. Forced CDX2 
expression induced SI expression in the HET-1A cells (Fig. 4.2). SI is only expressed 
in differentiated enterocytes (Traber, 1990). In the intestinal epithelium, SI is a 
CDX2 target gene. CDX2 binds to the SI promoter region and activates SI 
transcription (Suzuki et al., 2008; Suh et al., 1994). Previous studies have shown that 
CDX2 is able to induce SI expression during intestinal epithelial differentiation (Suh 
& Traber, 1996). It has also shown that stable transfection of CDX2 in HET1A cells 
led to a 1.5-fold increase in SI mRNA expression according to qPCR analysis (Liu et 
al., 2007). These observations may explain why SI can be found in BM tissue (Wu et 
al., 1993).  
 
We wished to determine whether ectopic expression of CDX2 could provoke K20 
and MUC2 expression (Fig. 4.2). In the intestinal epithelium, K20 is mainly detected 
in the villus region (Zhou et al., 2003; Moll et al., 1990). The expression of K20 can 
also be found in BM tissue (van Baal et al., 2008). However, the role of CDX2 in 
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K20 expression remains unclear. MUC2 is a goblet cell marker (Gambus et al., 1993; 
Chang et al., 1994) and MUC2 expression is detected in BM tissue (Arul et al., 2000; 
Tamagawa et al., 2012). It was reported that CDX2 directly activates MUC2 
expression via binding to the MUC2 promoter region in the intestinal cells 
(Yamamoto et al., 2003; Mesquita et al., 2003). However, ectopic expression of 
CDX2 in HET-1A cells did not induce MUC2 expression (Fig. 4.2). The fact that 
CDX2 did not induce MUC2 expression might due to the DNA methylation and 
Notch inhibition. First, regulation of MUC2 promoter by methylation is important 
for regulating MUC2 gene expression (Gratchev et al., 2001; Vincent et al., 2007; 
Okudaira et al., 2010). It was shown that the higher level of MUC2 promoter 
methylation corresponds to a lower MUC2 expression level in colorectal cancer 
tissues (Okudaira et al., 2010). Therefore, the reason that MUC2 was not induced by 
CDX2 might be due to the highly methylated status of the MUC2 promoter. Second, 
apart from DNA methylation, the Notch signalling pathway might be involved in 
regulating MUC2 expression. It is known that MUC2 is a marker for secretory goblet 
cells (Gambus et al., 1993; Chang et al., 1994) and the inhibition of Notch signalling 
drives the intestinal stem cells differentiating towards the secretory cell fate (Stanger 
et al., 2005; van Es et al., 2005a). The activated Notch signalling might negatively 
regulate MUC2 expression. More importantly, it was shown that in the OE19 (human 
adenocarcinoma from gastric cardia and oesophageal junction) and OE33 (human 
oesophageal adenocarcinoma) cell lines, that inhibition of Notch signalling by 
treating cells with γ-secretase inhibitor 
N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) 
increased CDX2 as well as MUC2 gene and protein expression in a dose dependent 
manner (Tamagawa et al., 2012). Therefore, the induction of MUC2 by CDX2 might 
also require the inhibition of Notch signalling in the HET-1A cells. Taken together, it 
would be interesting to study whether the inhibition of DNA methylation with the 
DNA methyltransferase inhibitor 5’Aza and whether the inhibition of Notch 
signalling (with γ-secretase inhibitor DAPT), could induce MUC2 expression in the 






4.3.2 PDX1 ectopic expression in HET-1A cells 
It was reported that Pdx1 deletion in adult mice causes anterior transformation in the 
gastro-duodenum junction and also shows the presence of foci of stratified squamous 
epithelium. It was also suggested that PDX1 might be involved in the pathogenesis 
of BM (Holland et al., 2013). However, forced PDX1 expression in HET-1A cells 
did not induced intestinal gene transcription (Fig. 4.3). Co-expression of HNF4α 
with PDX1 showed a slightly higher VILLIN mRNA level than HNF4α expression 
alone, but the co-expression of PDX1, CDX2 and HNF4α only showed weak VILLIN 
expression. This implies that PDX1 may not play a crucial role in the early 
development of BM. However, the expression of the PDX1 target genes (such as 
AKP3) could be checked to understand whether the ectopic PDX1 protein in HET-1A 
cells is functional. Complementary work going on in the lab using this transgene to 
convert hepatocyte-like cells to pancreatic beta-cells suggests the protein is 
functional.  
 
4.3.3 Ectopic expression of CDX2, HNF4α and HNF1α in HET-1A cells 
HNF1α regulates terminal differentiation and cell growth in the intestinal epithelium 
(Lussier et al., 2010; D’Angelo et al., 2010) and HNF1α is expressed in BM tissue 
(Piessen et al., 2007), suggesting a link between HNF1α expression and BM 
development. From the RT-PCR results, the ectopic expression of HNF1α in HET-1A 
cells showed weak ISX induction, but HNF1α did not induce VILLIN, SI or K20 (Fig. 
4.4). The ectopic expression of both HNF1α and CDX2 increased ISX, K20 and SI 
transcription compared with CDX2 ectopic expression alone. The regulation of ISX 
expression by CDX2 has previously been reported. The deletion of Cdx2 in mouse 
gut (Cdx2
loxP/loxP
,Foxa3-Cre) reduced Isx mRNA level in both adult and embryonic 
intestine (Gao et al., 2009). The expression of ISX in BM has not been previously 
reported. From my results, the RT-PCR data suggest that in addition to CDX2, 
HNF1α and HNF4α also induce ISX expression. Further work is necessary to test 
whether ISX is expressed in BM tissue.LGR5 is a putative intestinal stem cell 
marker (Barker et al., 2007). LGR5 protein was found in BM tissue, but was not 
detected in normal oesophageal epithelium (von Rahden et al., 2011). The 
relationship between CDX2 and LGR5 is still not clear. From the RT-PCR results, 
ectopic expression of HNF1α, HNF4α and CDX2 transcription factor combinations 
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which included CDX2 increased LGR5 expression level in HET-1A cells (Fig. 4.4). 
It is possible that CDX2 may direct the differentiation of HET-1A cells into an 
intestinal stem cell lineage. However, the LGR5 protein expression and the 
expression of other intestinal stem markers such as BMI1 and MUSASHI-1 could be 
explored in the future (Barker, 2013). Whether the ectopic expression of CDX2 leads 
oesophageal epithelial cells to be in a progenitor/stem state before differentiating 
into SI and K20 expressing cells, remains to be investigated. It would also be useful 
if primary oesophageal epithelial cells or transgenic mice can be used as models to 
address this issue. RT-PCR results also showed that K14 and K18 level was not 
altered by the ectopic expression of HNF4, CDX2 or HNF1α (Fig. 4.4). This might 
due to the fact that HET-1A cells show the columnar cell characteristics with the 
expression of K8 protein, but not K14 protein (Chapter 3.2.1). HNF4, CDX2 and 
HNF1α which are expressed in the columnar intestinal cells would not change 
columnar phenotype in the HET-1A cells. Therefore, cells which show the squamous 
phenotype such as the primary cultured oesophageal epithelial cells, should be used 
to test the effects of HNF4, CDX2 or HNF1α on K18 and K14 expression.      
 
The VILLIN qPCR results demonstrated that the highest VILLIN induction was by 
CDX2 and HNF4α, and followed by HNF4α alone (Fig.4.5). Similarly, the highest 
K20 expression was induced by CDX2 and HNF4α, but the second highest K20 
induction was by CDX2, HNF1α and HNF4α ectopic expression. These results 
suggest that CDX2 and HNF4α together trigger intestinal differentiation in the 
oesophageal epithelial cells, and HNF1α might not play such a key role. However, 
according to the statistical analysis results, the addition of Ad-CDX2 in Ad-HNF4α 
infected cells did not significantly increase the VILLIN and K20 gene expression 
(p>0.05). In the qPCR analysis, due to the variation in adenoviral infection 
efficiency among the three independent experiments, the increase level of VILLIN 
and K20 expression varies widely. The variation in adenoviral infection efficiency 
might mainly be due to the cell dissociation and cell seeding step before infection. 
The presence of clumping cells in the culture may lead to the lower viral infection 
efficiency, because cells in clumps reduce the contact area between virus and cells. 
Therefore the improvement of cell dissociation and seeding techniques as well as 
more repeated experiments could provide more reliable results.  
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VILLIN, K20 or SI protein was not detected according to the immunostaining results 
(Fig.4.6, 4.7, 4.8). The absence of protein expression might be due to the short 
period of ectopic CDX2, HNF1α and HNF4α expression. In addition, the cell line 
used might also be an issue, as VILLIN protein was induced by HNF4α in primary 
oesophageal epithelial explants (more details will be showed in Fig 6.6A, B and 
Chapter 6.2.2). In primary oesophageal epithelial explant model, cells express p63 




 [60µM]), but HET-1A cells do not express p63 
and K14. This might implicate p63 and K14-expressing basal cells have greater 
plasticity to convert to BM cells. In addition, it is also possible that another 
transcription factor(s) required for VILLIN protein expression is missing in the 
HET-1A cells.  
 
The ectopic expression of CDX2 and HNF1α were also tested in HNF4α-c1 and 
HNF4α-c5 stable cell lines (Fig. 4.9). The addition of CDX2 expression induced ISX, 
K20, LGR5 and SI expression in both HNF4α-c1 and HNF4α-c5. HNF1α also 
increased LGR5 expression in HNF4α-c1 and HNF4α-c5 and increased ISX in 
HNF4α-c1. These results reveal that CDX2 and HNF1α may enhance the intestinal 
gene expression in HNF4α-expressing cells. VILLIN and K20 qPCR analysis further 
reveals that VILLIN and K20 level was highest in the culture with Ad-CDX2 
infection (Fig. 4.10). However, results of statistical analysis revealed that there is no 
significant difference (p>0.05) in VILLIN mRNA level between Ad-CDX2 infected 
HNF4α-c1 cells and HNF4α-c1 control. Because the experiments were only 
performed in triplicate, more replication may need to be performed to obtain more 
reliable results. Finally, VILLIN protein expression was not detected in the 
HNF4α-c1 and HNF4α-c5 (Fig. 4.11). Overall, these results are consistent with the 
results of Ad-CDX2, Ad-HNF1α or Ad-HNF4α infection (Fig. 4.4, 4.6).  
 
4.3.4 Ectopic expression of FOXA2, CDX2, HNF4α and HNF1α in HET-1A cells 
Previous studies reported that FOXA2 in the intestinal epithelium regulates Goblet 
cell and enteroendocrine cell differentiation (Ye & Kaestner, 2009). However, further 
details of the function of FOXA2 in intestinal epithelium and the role of FOXA2 in 
the development of BM have not been explored. RT-PCR results showed that control 
Lenti-GFP infection induces very weak human type FOXA2 expression (Fig. 4.12A), 
118 
 
but this might be due to the non-specific binding of GFP to the FOXA2 promoter. 
RT-PCR results also showed that FOXA2 expression in HET-1A cells did not induce 
intestinal gene expression (Fig. 4.12B). Interestingly, CDX2, HNF1α and HNF4α 
ectopic expression induces the endogenous CDX2 gene expressing in 
FOXA2-expressing cells. MUC2 expression was also induced by CDX2 in 
FOXA2-expressing cells. Previous studies identified MUC2 as the target of both 
CDX2 and FOXA2. CDX2 or FOXA2 directly binds to MUC2 promoter and 
activates MUC2 transcription (van der Sluis et al., 2008; Yamamoto et al., 2003). In 
my studies, CDX2 or FOXA2 alone was not able to induce MUC2 expression (Fig. 
4.4, 4.12B), but CDX2 and FOXA2 together provoke MUC2 expression in HET-1A 
cells (Fig. 4.13). This might reflect the fact that intestinal transcription factors work 
in synergy to regulate intestinal gene expression (Boudreau et al., 2002; van der 
Sluis et al., 2008).   
 
4.3.5 Forced expression of CDX2, HNF4α and HNF1α by using 
Lenti-HNF4α-2A-CDX2-2A-HNF1α virus in HET-1A cells 
In 4.2.4 section, ectopic CDX2, HNF1α and HNF4α expression was carried out by 
using the separate viral vectors and each vector only carries one transgene. However, 
there are several disadvantages to this approach. For example, firstly, the expression 
level might not be comparable between the different transgenes. Secondly, all the 
transgenes might not be co-expressed in the same cell. Thirdly, using multiple viral 
vectors might mean using higher total amounts of virus in order to reach the 
optimized expression level, but this may decrease cell viability. Therefore, a 
polycistronic Lenti-HNF4α-2A-CDX2-2A-HNF1α (Lenti-HCH) vector was created. 
In this vector, CDX2, HNFf1α and HNF4α were linked by self-cleaving 2A peptides. 
CDX2, HNF1α and HNF4α can be expressed from a single promoter at the 
comparable level by using only one lentiviral vector. Using 2A peptides in 
polycistronic vectors for expressing multiple transgenes has been successful applied 
in various cell reprogramming studies (Akinci et al., 2012; Szymczak & Vignali, 
2005; Carey et al., 2009)  
         
In the Lenti-HCH infection experiment, CDX2 and HNF4α were co-expressed in the 
same HET-1A cell according to the immunostaining results (Fig.4.14A), but the 
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co-expression of CDX2, HNF1α and HNF4α was unable to be confirmed due to the 
availability of a suitable HNF1α antibody. RT-PCR results demonstrated that CDX2, 
HNF1α and HNF4α transgene were all expressed in HET-1A cells. However, the 
expression of intestinal genes was not detected (Fig. 4.15). The failure of inducing 
intestinal genes might due to the poor infection efficiency (~25%). This could be 
improved by concentrating lentiviral supernatant to increase the viral titre. In 
addition, single cell clones could be selected and expanded for analyzing the changes 
of gene expression profile. Finally, it is also important to examine whether 
transgenes are properly translated into protein and this could be checked by Western 
blotting. The induction of the protein downstream targets could also be evaluated to 







Chapter 5                    
The role of exogenous factors and 
DNA methylation in the 





In Chapters 3 and 4, I examined the ability of key transcription factors to induce the 
reprogramming of stratified squamous epithelial cells to intestinal cells. While 
changes in gene expression may induce the cell type transformation seen in Barrett’s, 
the question also arises as to what are the extracellular stimuli for these alterations.  
Changes in DNA methylation, release of inflammatory mediators, bile acid exposure, 
and the role of the Wnt, Notch and BMP pathways have all been implicated in the 
development of BM. In this chapter, I therefore investigated the role of these 
exogenous factors in the development of BM. Before discussing the results I will 
briefly discuss the role of each factor in BM.  
 
5.1.1 DNA methylation in BM 
DNA methylation is the mechanism by which a methyl group is added to the C5 
position of cytosine to form 5’-methylcytidine. The process of DNA methylation is 
referred to as an epigenetic modification. The methylation process is catalyzed by a 
family of DNA methyltransferases (DNMTs) including DNMT1, DNMT3a, and 
DNMT3b. DNMT1 maintains DNA methylation status during DNA replication, 
whereas DNMT3a and DNMT3b methylate unmethylated DNA de novo. DNA 
methylation results in the inhibition of transcription factor binding to DNA. DNA 
methylation also inhibits the recruitment of accessory proteins required for gene 
transcription (Taby & Issa, 2010; Moore et al., 2013). It is well established that DNA 
methylation is involved in embryonic development, gene imprinting, X-chromosome 
inactivation as well as development of cancer (Taby & Issa, 2010). In studies of BM 
development, a number of reports showed the “DNA methylation signature” alters 
during the progression from normal oesophagus to BM (Eads et al., 2001; Kaz et al., 
2011; Agarwal et al., 2012; Alvi et al., 2013). For example, the promoter region of 
the tumour suppressor gene p16 and adenomatous polyposis coli (APC) in BM 
biopsy material has a higher prevalence of hypermethylation (p16=30%; APC=50%) 
compared with the human normal oesophageal epithelium (p16=0%; APC=0%) 
(Wang et al., 2009). It was also demonstrated that the CDX1 promoter is 
hypomethylated in BM compared with the normal human oesophageal epithelium in 
which the CDX1 promoter is predominately methylated (Wong et al., 2005). In 
addition, research in which a transgenic mouse model was used to study the role of 
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CDX2 in the development of BM also suggested that epigenetic regulation might be 
involved in the development of BM. Ectopic Cdx2 expression in mice oesophageal 
epithelium using the cytokeratin 14 promoter to drive transcription factor expression 
(K14-Cdx2) did not induce intestinal metaplasia. However, after treating the 
K14-Cdx2 mice with the DNA methylation inhibitor, 5’Aza, the expression of 
BM-associated proteins CDX1 and K18 was induced (Kong et al., 2011b). Therefore, 
the inhibition of DNA methylation may promote the pathogenesis of BM. 
 
5.1.2 Inflammation and BM 
BM follows a sequence in terms of oesophagitis-BM-dysplasia-oesophageal- 
adenocarcinoma. BM development is linked to chronic inflammation caused by 
GORD. It is known that intrinsic (genetic alterations) and extrinsic (inflammation or 
infection) stimuli can lead to the activation of inflammation-related pathways such as 
NF-κB and STAT3. The activation of the NF-κB pathway results in the production of 
inflammatory mediators such as IL-1β and TNFα which in turn can further stimulate 
the NF-κB pathway. Overall this can lead to even more inflammatory mediators 
being secreted and creates a cancer-related inflammatory microenvironment 
(Mantovani et al., 2008). Activation of the NF-κB pathway is associated with cell 
differentiation, cell survival and cancerogenesis (Ben-Neriah & Karin, 2011). In the 
context of BM, the expression level of NF-κB is increased in BM and oesophageal 
adenocarcinoma (O’Riordan et al., 2005). It is therefore possible that the cell type 
transformation observed in BM could potentially be linked to the activation of the 
NF-κB pathway. In addition, the CDX2 gene is a target of the NF-κB pathway and 
the CDX2 promoter has two putative binding sites for NF-κB further suggesting that 
NF-κB might contribute to the development of BM (Kim et al., 2002; Kazumori et 
al., 2006).  
 
IL-1β 
Interleukin-1β(IL-1β) is a cytokine produced by activated macrophages. It was 
reported that the level of IL-1β level is up-regulated in oesophagitis tissue 
(Fitzgerald et al., 2002a; Hamaguchi et al., 2003; O’Riordan et al., 2005; Rieder et 
al., 2007). One report showed that the level of IL-1β is significantly increased in BM 
(O’Riordan et al., 2005). In contrast, no difference in the total amount of IL-1β 
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expression has been observed in BM (Fitzgerald et al., 2002a). However, the 
Fitzgerald group further suggested that the IL-1β level is in fact higher at the 
squamous-columnar junction at the proximal end of BM and above the inflamed 
squamous epithelium compared with the distal end of BM (Fitzgerald et al., 2002b). 
More importantly, a recent experimental animal model supports the concept that 
aberrant IL-1β expression is able to induce a BM-like phenotype in the mouse 
oesophagus (Quante et al., 2012). In the study, L2-IL-1β transgenic mice were used 
in which the Epstein-Barr virus (ED-L2) promoter drives IL-1β expression in the 
tongue, oesophagus, and squamous forestomach (Nakagawa et al., 1997; Quante et 
al., 2012). The oesophageal overexpression of IL-1β in L2-IL-1β mice initiated and 
mimicked disease progression from oesophagitis, BM, dysplasia to oesophageal 
adenocarcinoma (Quante et al., 2012). Taken together, these data suggest that 
elevation of IL-1β is potentially linked to the development of BM.       
 
IL-6 
Interleukin 6 is a cytokine secreted by macrophages and T cells and functions in both 
a pro- and anti-inflammatory capacity. It has been reported that the levels of IL-6 are 
raised in oesophagitis and BM tissue compared with normal oesophageal epithelium 
(Rieder et al., 2007). IL-6 signalling primarily involves the initial binding of IL-6 to 
the IL-6R (IL-6 receptor)/gp130 (glycoprotein 130) receptor complex which leads to 
the phosphorylation of JAK (Janus kinase). The phosphorylated JAK then 
phosphorylates STAT (signal transducers and activators of transcription). The 
phosphorylated STAT moves to the nucleus and activates the downstream target 
genes including genes regulating cell survival, proliferation, differentiation and 
angiogenesis. In addition, the binding of IL-6 to the IL-6/gp130 receptor could also 
activate the MAPK (mitogen-activated protein kinase) cascade to activate target gene 
expression (Heinrich et al., 2003; Dvorak & Dvorak, 2013). The IL-6 pathway 
activation may play an important role in BM carcinogenesis. For example, results 
from the examination of BM biopsies by immunohistochemistry staining and the 
analysis of a transformed BM cell line (BAR-T) in which p53 expression is inhibited 
and H-Ras
G12V
 is overexpressed, all revealed that IL-6/STAT3 pathway is linked to 
apoptosis resistance (Dvorakova et al., 2004; Zhang et al., 2011; Dvorak & Dvorak, 
2013). Furthermore, in the L2-IL-1β transgenic mice, IL-1β-induced BM and 
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oesophageal adenocarcinoma phenotypes thought to be mediated through the IL-6 
signalling pathway. Firstly, IL-6 expression is elevated in L2-IL-1β mice. Secondly, 
knock out of IL-6 (L2-IL-1β/IL-6-/- mice) reduced BM phenotype and also abolished 
dysplasia and development of adenocarcinoma. Therefore, IL-6 may be involved in 
the development and the progression of BM (Quante et al., 2012).   
 
IL-17 
IL-17 is a proinflammatory cytokine and is a key mediator of both innate and 
adaptive immune responses (Korn et al., 2009). It has been reported that IL-17 
upregulates proinflammatory cytokine secretion such as TNFα, IL-1β and IL-6 by 
macrophages (Jovanovic et al., 1998). IL-17 expression is associated with chronic 
inflammatory and autoimmune diseases (Miossec et al., 2009; Korn et al., 2009). 
IL-17 is also implicated in the development of cancer (including skin cancer, breast 
cancer and non-small cell lung cancer (NSCLC)) (Zhu et al., 2008; Chen et al., 2010; 
Yusuf et al., 2012). Related to this observation is the fact that the proportion of 
IL17-producing cells is increased in oesophageal adenocarcinoma (Chen et al., 
2012c). The expression of IL-17 is also increased in BM, dysplasia and oesophageal 
adenocarcinoma of human samples in comparison with the oesophageal stratified 
squamous epithelium. The increase of IL-17 level is therefore potentially linked to 
disease progression in BM (Bannister et al., 2012).  
 
TNF-α 
Tumour necrosis factor α (TNF-α) is involved in both innate and adaptive immune 
response and there is extensive evidence in the literature suggested that TNF-α 
participates in chronic inflammation and inflammation-associated cancer progression 
(Balkwill, 2006). In BM research, it has been shown that TNF-α levels are raised in 
oesophagitis tissue , BE, dysplasia and oesophageal adenocarcinoma compared with 
normal oesophageal epithelium (Tselepis et al., 2002; Hamaguchi et al., 2003). 
Importantly, the increase in TNF-α is positively associated with the stage of 







Interferon γ (IFN-γ) is a proinflammatory cytokine and has important 
immunoregulatory functions. IFN-γ promotes the activity of neutrophils, 
macrophages and natural killer cells (Schroder et al., 2004; Zhong et al., 2011).  
IFN-γ expression is up-regulated in oesophagitis tissues compared to normal 
stratified squamous oesophageal epithelium (Fitzgerald et al., 2002a; Zhong et al., 
2011). In BM studies, two publications investigated the relationship of IFN-γ 
between BM and normal oesophageal epithelium. One report in which IFN-γ 
expression was examined by RT-PCR showed that there is no significant difference 
between BM and normal tissues (Fitzgerald et al., 2002a). However, in the second 
report using immunohistochemistry to assess IFN-γ expression, Zhong et al 
suggested that the level of IFN-γ was increased in BM samples (Zhong et al., 2011). 
The difference between these two observations might be due to the different 
sampling position and examination methods (RT-PCR versus immunohistochemistry) 
(Zhong et al., 2011).   
 
LPS 
Lipopolysaccharide (LPS) is the main component of outer membrane of Gram 
negative bacteria. LPS treatment stimulates the secretion of the inflammatory 
mediator IL-8 in BAR-T cells (Verbeek et al., 2013). The mechanism involves in the 
stimulation of Toll-like receptor 4 (TLR4) by LPS, which then activates the NF-κB 
pathway leading to the transcription of the downstream target IL-8 (Kunsch & Rosen, 
1993; Beyaert, 2011; Verbeek et al., 2013). In addition, a study investigated the 
microbiomes of the human distal oesophageal region showing that the microbiome 
population can be classified into two groups depending on the hierarchical clustering 
(genetic distance). The result implies that the major microbiomes found in normal 
oesophagus belong to type1 which are mainly Gram positive bacteria. Conversely , 
the dominant microbiomes in oesophagitis and BM are mainly type2 which are 
mainly Gram negative bacteria (Yang et al., 2009, 2012). Therefore, microbial LPS 






Bile salts and acid 
GORD is the main risk factor for BM pathogenesis and bile acids are the key 
components of gastro-oesophageal refluxate (Badreddine & Wang, 2010). Bile acids 
induce ROS and NO production and causes DNA damage in oesophageal epithelial 
cells (Table 5.1). Therefore, bile acid exposure is associated with genetic alternations 
which may lead to development of BM development.(Jenkins et al., 2007; Dvorak et 
al., 2007; Jolly et al., 2009; Goldman et al., 2010; McAdam et al., 2012) 
 
Bile salts or acid might initiate BM via activation of the NF-κB pathway. Previous 
studies showed that bile salts or acid activated NF-κB pathway in the oesophageal 
epithelial cells (Table 5.2) (Jenkins et al., 2004; Duggan et al., 2006; Wu et al., 2008; 
Cronin et al., 2010a). NF-κB in turn may regulate CDX2 expression by binding to 
the promoter and enhancing transcriptional activity. The increase in CDX2 promoter 
activity brought about by bile salt or acid exposure can be inhibited by mutating the 
CDX2 promoter’s putative NF-κB binding sites or by using an NF-κB inhibitor 
Bay11-7085 (blocking inhibitor κB (IκB) phosphorylation) or IKK (IκB kinase) 
inhibitor (Kazumori et al., 2006; Huo et al., 2010). Therefore, bile acid might act 
through the NF-κB pathway to induce CDX2 expression. Indeed, it was observed 
that bile acid induced or increased CDX2 expression level in oesophageal epithelial 
cells and BM cells respectively (Table 5.3) (Marchetti et al., 2003; Kazumori et al., 
2006; Huo et al., 2010). Apart from CDX2, a bile salt mixture (cholic acid, 
glycocholic acid and taurocholic acid) can induce Cdx1 and increase Klf4 expression 
in primary cultured rat oesophageal epithelial cells (Kazumori et al., 2009, 2011). In 
addition, DCA exposure at pH5 decreased p63 expression in primary cultured human 
oesophageal epithelial cells (Roman et al., 2007). These results implicate that bile 
acids might drive the BM phenotype by inducing intestinal transcription factors and 







Bile salt/acid treatment Results Cell type References 






Jenkins et al. 2007 
0.5 mM bile acid cocktail of 






Dvorak et al. 2007 
0.5mM bile acid of GCA, TCA, 





CP-A Goldman et al., 
2010 
DCA, pH5 DCA and/or acid  ↑iNOS, ↑NO 
DCA ↑NO 
 
OE33 McAdam et al. 
2012 
Sodium deoxycholate ↑NO  
DNA damage 
HET-1A Jolly et al. 2009 
 
Table 5.1. The induction of NO, ROS or DNA damage by bile salts and/or acid  
The Table summarises some examples wherethe induction of NO, ROS or DNA 
damage is induced by bile salts and/or acid in different oesophageal cell types. DCA,  
deoxycholic acid; GCA, glycocholic acid; TCA, taurocholic acid; GDCA, 
glycodeoxycholic acid; GCDCA, glycochenodeoxycholic acid; ROS, reactive 





Bile salt/acid treatment Cell type References 
100 ~300 uM  DCA OE33 Jenkins et al. 2004; 
Jenkins et al. 2008; 
McAdam et al. 2012 
pH6.5 SKGT-4 Esophageal 
adenocarcinoma 
Duggan et al. 2006 
DCA 300 µM, pH 5 ~7 OE33, KYSE, 
squamous, BM’s 
biopsies 
Cronin, Alhamdani, et 
al. 2010 
DCA 100 µM SEG-1 Wu et al. 2008 
400 µM bile salts cocktail of GCA, 
TCA, GCDCA,TCDCA, GDCA, 
TDCA (20:3:15:3:6:1 in molar 
concentration) and/or pH5.5 
 
NES cells originated 
from BM biopsy 
specimens 
Huo et al. 2010 
 
Table 5.2. Examples of the activation of NF-κB pathway by bile salts and/or 
acid  
Table showing examples of NF-κB pathway activation by bile salts and/or acid in the 
different types of oesophageal epithelial cells. DCA, deoxycholic acid; GCA, 
glycocholic acid; TCA, taurocholic acid; GCDCA, glycochenodeoxycholic acid; 
TCDCA, taurochenodeoxycholic acid; GDCA, glycodeoxycholic acid; TDCA, 




Table 5.3. The induction of CDX2 expression by bile salts and/or acid  
Table lists the details of CDX2 induction or up-regulation by bile salts and/or acid in 
various oesophageal epithelial cell types. CA, cholic acid; DHCA, dehydrocholic 
acid ; GCDCA, glycochenodeoxycholic acid; TCDCA, taurochenodeoxycholic acid; 
GDCA, glycodeoxycholic acid; TDCA, taurodeoxycholic acid ; DCA, deoxycholic 
acid ; HKESC-1 and HKESC-2 human squamous cell carcinoma cell lines. 
  
Bile salt/acid treatment Cell type Results References 
50 µM CA or  






Kazumori et al. 
2006 
400 µM bile salts cocktail of 
GCA, TCA, GCDCA,TCDCA, 
GDCA, TDCA (20:3:15:3:6:1 in 
molar concentration) and/or pH4, 
10 min, 3 times per day for 7 
days 
NES cells originated 




Huo et al. 2010 





Marchetti et al. 
2003 




Induce or increase 
CDX2 gene 
Hu et al. 2007 
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5.1.3 Notch, Wnt and BMP4 in BM 
Notch signalling  
The Notch signalling pathway is important for cell growth, differentiation and also 
cell death. Notch is a heterodimeric transmembrane receptor protein composed of an 
extracellular domain and a transmembrane domain. The Notch extracellular domain 
interacts with Notch ligand on adjacent cells. Once the ligand binds to the receptor, 
the intracellular part of the Notch receptor the transmembrane domain is cleaved to 
yield a free Notch intracellular domain (NICD) which then translocates into the 
nucleus and regulates gene expression (Andersson et al., 2011; Kopan, 2012). In 
intestinal epithelium, Notch signalling maintains the stem cells in a proliferative and 
undifferentiated state. Notch signalling also controls cell differentiation in the 
intestine. Indeed inhibition of Notch signalling leads to a commitment into secretary 
lineage in the intestinal epithelium (van Es et al., 2005a; Fre et al., 2005; van der 
Flier & Clevers, 2009; van Es et al., 2010).  
 
The link between Notch signalling and BM has been studied previously. It was 
reported that bile acids can inhibit Notch signalling in the oesophageal 
adenocarcinoma cells (OE19 and OE33) and inhibition of Notch signalling by the 
DAPT increased CDX2 and MUC2 expression. It has also been also confirmed that 
bile acid exposure up-regulated CDX2 and MUC2 expression in OE19, OE33 and 
HET-1A cells. Therefore, it was proposed that bile acids can act through inhibition of 
Notch signalling thereby inducing CDX2 expression (Morrow et al., 2009; 
Tamagawa et al., 2012). Furthermore, in the L2-IL-1β transgenic BM mouse model, 
inhibiting Notch signalling by treating the L2-IL-1β mice with the γ-secretase 
inhibitor dibenzazepine (DBZ), increased the population of Goblet-like cells (Quante 
et al., 2012). Therefore, inhibition of Notch signalling may be important for the 
development of BM.  
 
BMP4  
Bone morphogenetic protein 4 (BMP4) is a member of the transforming growth 
factor β (TGF-β) family which regulates cell differentiation, proliferation and 
migration (Badreddine & Wang, 2010). The link between activation of the BMP4 
pathway and development of BM has been studied. BMP4 expression was enhanced 
in the L2-IL-1β transgenic mice of BM animal model. Additional treatment of the 
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bile acid DCA can also enhance BMP4 expression level (Quante et al., 2012). 
 
In vitro studies showed that bile acids can induce BMP4 expression in human 
primary oesophageal epithelial cells (Zhou et al., 2009). BMP4 protein has been 
detected (and indeed the BMP4 pathway is activated) in oesophagitis and BM, but 
not in the normal stratified squamous epithelium. Additionally, BMP4 treatment in 
the human primary oesophageal squamous epithelial cells induced a columnar 
phenotype with the expression of CK7 and CK20 (Milano et al., 2007). Importantly, 
it has been suggested that stromal BMP4 plays an important role in development of 
BM. BMP4 expression is detected in the adjacent mesenchymal cells in the 
embryonic oesophagus and at this stage embryonic oesophageal epithelial columnar 
in phenotype (Yu et al., 2005; Que et al., 2006; Milano et al., 2007). BMP4 is not 
expressed in the adult oesophagus, but BMP4 is re-expressed in BM, particularly in 
the mesenchymal region (Milano et al., 2007; Wang et al., 2010). Additionally, 
BMP4 can induce SOX9 expression and ectopic expression of SOX9 may induce a 
columnar phenotype in HET-1A cells. Taken together, BMP4 secreted from 
mesenchymal cells may induce a squamous-to-columnar cell type conversion in the 
development of BM (Wang et al., 2010; Gibson et al., 2013).  
 
Wnt  
The Wingless (Wnt) pathway is activated by the binding of Wnt ligand to Frizzled 
and low-density lipoprotein receptor-related protein (LRP) receptors. Binding of the 
ligand to the receptor prevents β-catenin from being bound and phosphorylated by 
the complex of APC, glycogen synthase kinase 3 (GSK3), axin and casein kinase I 
(CKI). The non-phosphorylated β-catenin will not be sent to the proteasome for 
degradation, so β-catenin can accumulate and translocate into the nucleus wherein it 
binds to the TCF/β-catenin complex to activate the transcription of Wnt target genes 
(van der Flier & Clevers, 2009). In the intestine, Wnt signalling is important for 
embryonic intestinal development, Paneth cell terminal differentiation and crypt 
stem cell proliferation (Gregorieff & Clevers, 2005; van Es et al., 2005b; Barker et 
al., 2007; Garcia et al., 2009; Sato et al., 2011; Schuijers & Clevers, 2012). In 
addition, evidence shows that the aberrant Wnt activation is highly linked to 





It has been reported that activation of Wnt signalling, assessed by nuclear β-catenin 
accumulation, is positively associated with neoplastic progression of BM (Bian et al., 
2000; Osterheld et al., 2002). In addition, the increase of Wnt2 expression, and the 
promoter methylation in both the APC and the Wnt antagonist, secreted 
frizzled-related protein 1 (SFRP1) genes, is observed in BM tissue (Clément et al., 
2006). Moreover, studies also showed that the introduction of dominant-active Wnt 
effector CatCLef in which an amino-terminally truncated β-catenin is fused to a 
full-length LEF1, initiated BM marker Na1/H1 exchanger 2 (NHE2) expression in a 
3D organotypic model of oesophageal epithelium (Kong et al., 2011a). This suggests 
that the development of BM or the progression of BM to adenocarcinoma may be 
associated with the Wnt signalling activation. 
 




5.2.1 Inhibition of DNA methylation did not induce intestinal gene expression 
In Chapter 3.2.3, I showed that ectopic expression of HNF4α induces intestinal 
VILLIN gene expression in HET-1A cells. To test whether the inhibition of DNA 
methylation can further induce or enhance intestinal gene expression, 5’Aza 
treatment was performed in HET-1A cells which have been infected with Ad-CDX2 
and Ad-HNF4α. RT-PCR results demonstrated that 5’Aza did not induce or enhance 
intestinal gene expression in either control or CDX2 and HNF4α expressing cells 
(Fig. 5.1) and there was no change in K14 and K18 expression under all conditions.    
 
5.2.2 Inflammatory factors did not induce CDX2 or HNF4α expression in 
HET-1A cells 
In order to test whether HET-1A cells could respond to inflammatory factors we 
initially treated the cells with 10 or 100 ng/ml of IL-1β, TNF-α, LPS, IL-17 or IFNγ 
for 15 or 60 minutes after 24-hour serum starvation I then determined the expression 
of pp65 or ppERK to investigate whether these inflammation-related exogenous 
factors could stimulate NF-κB or ERK signalling respectively. The results showed 
that pp65 and ppERK levels are enhanced by IL-1β, TNF-α, LPS and IL-17. The 
level of ppERK is only moderately increased and pp65 level was not increased by 
IFNγ, while the level of pp65 was elevated by IL-1β, TNF-α and IFNγ mixture (Fig. 
5.2). STAT3 signalling activation by IL-6 was determined in HET-1A cells. After 
24-hour serum starvation HET-1A cells were treated with 10 or 100 ng/ml of IL-6 for 
15 or 60 minutes. Western blotting showed that pSTAT3 level is slightly enhanced 
following 15 minutes of treatment with IL-6 (Fig. 5.3).   
 
Next, to evaluate whether inflammation-related exogenous factors contribute to BM 
development, HET-1A cells were treated with IL-1β, IL-6, IL-17 or TNF-α at 10 - 
100 ng/ml or LPS at 10 - 100 µg/ml  for varying lengths of time (1, 4 or 7 days) 
(Fig. 5.4). RT-PCR analysis showed that CDX2 or HNF4α expression was not 
induced and K14 or K18 gene expression was not altered. The combination of IL-1β 
and TNF-α also did not induce CDX2 or HNF4α expression (Fig. 5.5). To test 
whether IFN-γ is potentially involved in the pathogenesis of BM, HET-1A cells were 
treated with 10 - 100 ng/ml of IFN-γ for 1, 4 or 7 days. Neither CDX2 nor HNF4α 
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expression was induced by IFN-γ treatment of HET-1A cells (Fig. 5.6A). The effect 
of combining IFN-γ, IL-1β and TNF-α was also tested. Cells were treated with 100 
ng/ml of IFN-γ, IL-1β and TNF-α but unfortunately the cells did not survive (data 
not shown). However, cells treated with 10 ng/ml of IFN-γ, IL-1β and TNF-α were 
viable, but even under these conditions, the expression of CDX2 and HNF4α was not 
induced (Fig 5.6B).  
 
We extended the experiments on inflammatory mediators to test whether the 
combination of cytokines and bile salts could induce intestinalisation of HET-1A 
cells. To address this possibility, HET-1A cells were treated for 4 days with 100 
ng/ml of either IL-6 or IL-1β alone, or in the presence of 50 µM DCA. CDX2, 
HNF4α and VILLIN expression were not induced. K14 and K18 expression levels 
were not altered (Fig.5.7).  
 
5.2.3 Bile acid and BM 
To test the effect of DCA on intestinal gene expression in different oesophageal cell 
types, four different models were used: 7-days cultures of adult mouse oesophageal 
epithelial explants, 24-hour ex vivo cultures of E11.5 mouse oesophagus, HET-1A 
and OE33 cell lines. All four models were treated with 100 - 400 µM of DCA for 24 
hours. We examined the expression of two intestinal transcription factors CDX2 and 
HNF4α. Neither were expressed by adult oesophageal epithelial explants following 
treatment with 400 µM DCA (Fig. 5.8A). Surprisingly, weak HNF4α expression was 
detected in the control ex vivo cultures of E11.5 mouse oesophagus. However, the 
expression of HNF4α and CDX2 were not detected following treatment with either 
100 or 400 µM DCA. Control HET-1A cells did not express CDX2 and HNF4α, but 
400 µM DCA treatment did appear to induce weak CDX2 expression (Fig. 5.8B). 
CDX2 and HNF4α were expressed in OE33 cells, but remarkably DCA treatment 
reduced CDX2 and HNF4α expression level.   
 
The effects of cholic acid (CA), glycocholic acid (GCA) and taurocholic acid (TCA) 
bile acids on gene expression were evaluated. HET-1A cells were cultured with 200 
or 400 µM CA, GCA, TCA or mixture of CA, GCA and TCA for 48 hours. Cells 
treated with 400 µM of CA, GCA and TCA mixture did not survive. RT-PCR showed 
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that CA, GCA, TCA or the combination did not induce CDX2 or HNF4α expression 
(Fig. 5.9). 
 
5.2.4 BMP4, Notch and Wnt signalling and BM 
In Chapter 3, I showed that stable Hnf4α-expressing HET-1A clones (HNF4α-c1 and 
HNF4α-c5) could be established. To further test the potential roles of BMP4, Notch 
and Wnt pathways in BM pathogenesis, HET-1A and HNF4α-c1 and HNF4α-c5 
stably-expressing HET-1A cells were treated with 10 or 100 ng/ml of BMP4, 5 or 25 
µM DAPT or 0.5 or 1 µM 1m for 7 days. DAPT is a γ-secretase inhibitor and is used 
to block Notch signalling activation (Dovey et al., 2001). 1m is a novel GSK3 
inhibitor and has been used to activate the Wnt/β-catenin pathway in cell 
differentiation studies (Bone et al., 2009, 2011). Treatment with BMP4, DAPT and 
1m did not provoke intestinal gene transcription in HET-1A, HNF4α-c1 and 
HNF4α-c5 HET-1A cells (Fig. 5. 10). There was also no change in the expression of 
K14 and K18.   
 
5.2.5 BMP4 and DCA did not induce CDX2 or HNF4α expression 
To assess the effect of BMP4 and DCA exposure in BM pathogenesis, HET1-A, 
HNF4α-c1 and HNF4α-c5 HET-1A cells were treated with 100 ng/ml of BMP4, 100 
or 400 µM of DCA or both BMP4 and DCA for 24 hours. RT-PCR results showed 






Figure 5.1. Treatment with the DNA methyltransferase inhibitor 5-Azacytidine 
did not increase intestinal gene expression in Ad-HNF4α and Ad-CDX2 infected 
HET-1A cells 
HET-1A cells were infected with Ad-Null or Ad-HNF4α plus Ad-CDX2. After 
24-hour hours following infection, cells were treated with 1 or 4 µM 5’-Azacytidine, 
or DMSO for 3 days. Cells were harvested at day 4 and RT-PCR was performed. 
β-ACTIN was used as a loading control. Controls include HT-29 cells or mouse 
intestine (positive, +) and reaction that did not contain sample (negative, -). 






Figure 5.2. Cytokine treatment activated ppERK or NF-κβ pathway in HET-1A 
cells                                                                                                                             
After 24-hours of serum starvation, HET-1A cells were treated with 10 or 100 ng/ml 
of IL-1β, TNFα, LPS, IL-17, IFN-γ, or the mixture of IL-1β, TNFα and IFN-γ for 15 
or 60 minutes. Western blotting was performed to determine the level of ppERK and 
pp65 expression. GAPDH was used as a loading control. Experiments were 







Figure 5.3. IL-6 activated pSTAT3 pathway in HET-1A cells                         
Twenty-four hours after serum starvation, HET-1A cells were incubated with 10 or 
100 ng/ml of IL-6 for 15 or 60 minutes. Cells were harvested and the pSTAT3 level 
was determined by western blotting. GAPDH was used as a loading control. 





Figure 5.4. IL1β, IL-6, TNFα, LPS or IL17 treatment did not induce CDX2 and 
HNF4α expression in HET-1A cells                                                                        
HET-1A cells were treated with 10 or 100 ng/ml IL-1β, IL-6, TNFα or IL-17, or 10 
or 100 µg/ml of LPS for 1, 4 or 7 days. RNA was extracted and RT-PCR was 
performed. β-ACTIN was as a loading control. These experiments were repeated 3 





Figure 5.5. IL1β and TNFα did not induce CDX2 and HNF4α expression in 
HET-1A cells 
HET-1A cells were treated with IL1β, TNFα either alone or in combination (at a 
concentration of 100 ng/ml) for 7 days and cells were harvested. RT-PCR was 
performed. β-ACTIN was used as a loading control. The experiments were repeated 3 





Figure 5.6. IFNγ, IL-1β and TNF did not induce CDX2 and HNF4α expression 
in HET-1A cells in HET-1A cells 
(A) HET-1A cells were treated with IFNγ at a concentration of either 10 or 100 
ng/ml. After IFNγ treatment for 1, 4 or 7 days, cells were harvested and RT-PCR was 
performed. (B) HET-1A cells were treated with 10 ng/ml of IFNγ, IL-1β and TNF for 
7 days and RT-PCR was then performed. β-ACTIN was used as a loading control. 
The experiments were repeated 3 times. Typical results are shown. Experiments were 











Figure 5.7. IL-1β, IL-6 and DCA treatment did not induce intestinal gene 
expression in HET-1A cells                                         
HET-1A cells were treated with 100 ng/ml of IL-1β or IL-6 along, or with 50 µM 
DCA for 4 days. Cells were harvested and RT-PCR was performed. β-ACTIN was 
used as a loading control. The experiments were repeated 3 times. Typical results are 







Figure 5.8. DCA treatment in different oesophageal epithelial cell types  
(A) Adult mouse oesophageal explants which has been cultured in BME medium for 
7 days were treated with 400 µM DCA for 24 hours. Mouse embryonic oesophagus 
isolated from E11.5 embryos was cultured for 24 hours and then was treated with 
100 or 400 µM DCA for 24 hours. (B) HET-1A or OE33 cells were incubated with 
100 or 400 µM DCA for 24 hours. Cultures were then harvested and RT-PCR was 
performed. β-ACTIN was used as a loading control. The experiments were repeated 3 






























































































Figure 5.9. Cholic acid, glycocholic acid, and taurocholic acidtreatment did not 
induce CDX2 and HNF4α expression in HET-1A cells   
HET-1A cells were treated with 200 or 400 µM bile salt cholic acid (CA), 
glycocholic acid (GCA) and taurocholic acid (TCA) or the 200 µM mixture of cholic 
acid, glycocholic acid and taurocholic acid for 48 hours. Cells were harvested and 
RT-PCR was performed. β-ACTIN was used as a loading control. The experiments 



















Figure 5.10. BMP4, DAPT or 1m treatment did not induce intestinal gene 
expression in HET-1A cells 
HET-1A cells were treated with 10 or 100 ng/ml of BMP4, 5 or 25 µM of DAPT, or 
0.5 or 1 µM of 1m for 7 days. Cells were harvested and RT-PCR was performed. 
β-ACTIN was used as a loading control. The experiments were repeated 3 times. 








Figure 5.11. BMP4 and DCA treatment did not induce CDX2 and HNF4α 
expression in HET-1A cells   
HET-1A cells were treated with 100 ng/ml of BMP4, 100 or 400 µM of DCA, or the 
mixture of BMP4 and DCA for 48 hours. Cells were harvested and RT-PCR was 
performed. β-ACTIN was used as a loading control. The experiments were repeated 3 







5.3.1 DNA methylation and BM 
Previous studies showed that epigenetic regulation could potentially be a key step in 
the development of BM. The inhibition of DNA methylation by 5’Aza treatment in 
retrovially-infected CDX2 oesophageal cells increased BM marker levels, including 
K20 and DRA/SLC26A3 in immortalized human esophageal keratinocytes 
(EPC-hTERT). Similar observations of BM marker induction, such as CDX1 and 
K18 was seen in K14-Cdx2 transgenic mice treated with 5-Aza (Kong et al., 2009, 
2011b). In HET-1A cells, 5’Aza treatment did not increase or induce the expression 
of the selected intestinal genes in Ad-HNF4α and Ad-CDX2 infected cells (Fig. 5.1). 
In fact, HET-1A cell line was immortalized by introducing SV-40 large T antigen 
(Stoner et al., 1991). It was found that SV-40 large T antigen works with Ras protein 
to activate DNA methyltranferase, DNMT3B. Therefore, SV-40 large T antigen 
could result in aberrant DNA methylation profile (Soejima et al., 2003; Li et al., 
2005). Therefore, it was suggested that if HET-1A cells were used as a study model, 
the effects of DNA methylation inhibition in development of BM might be different 
from the normal oesophageal cells (Kong et al., 2009). Primary oesophageal 
epithelial cells will be a more suitable model for the study of epigenetic effects on 
the initiation of BM and the related results is shown in Chpater 6.2.3.  
 
5.3.2 Inflammation-related exogenous factors and BM 
Bile acid can also induce ROS and NO production which in turn leads to DNA 
damage, and therefore activate the intrinsic pathway of inflammation (Dvorak et al., 
2007; Jenkins et al., 2007, 2008; Jolly et al., 2009; Goldman et al., 2010; McAdam et 
al., 2012). In this chapter, several key inflammatory factors were added to the 
HET-1A cell cultures to understand whether they play a role in BM development. 
Exogenous factors IL-1β, TNF-α, LPS, IL-17, IL-6 and IFN-γ were tested. Previous 
studies showed that the combination of cytokines (TNF-α and IFN-γ) resulted in the 
synergistic effect of prostaglandin E2 (PGE2) synthesis in lung epithelial A549 cells 
(Wright et al., 2004) and PGE2 has been known to be involved in inflammation and 
carcinogenesis (Kalinski, 2012; Nakanishi & Rosenberg, 2013). Therefore, the 
effects of treating HET-1A cell with the combinations of IL-1β and TNF-α, or IL-1β, 
TNF-α and IFN-γ were also investigated. Additionally, DCA has been shown to 
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accelerate IL-6 and IL-1β induced BM phenotype in L2-IL1β transgenic mice 
(Quante et al., 2012). Thus, the effects of IL-6, IL-1β and DCA in HET-1A were also 
tested. However, RT-PCR results showed that BM-related genes were not induced by 
the treatment of all the exogenous factors tested (Fig.5.4-5.7). The failure to induce 
BM-related genes such as CDX2 and HNF4α, might be due to the relatively short 
period of cytokine treatment. Indeed the development of BM is linked to chronic 
inflammation (Dvorak & Dvorak, 2013). In the L2-IL1β transgenic mice model, 
L2-IL1β mice displayed moderate inflammation 6 months after birth and 90% 
developed a BM-like phenotype at 12-15 month old, but only 20% of L2-IL1β mice 
had high grade dysplasia or oesophageal adenocarcinoma at 20-22 months old 
(Quante et al., 2012). Therefore, 7 days cytokine treatment may not be sufficient to 
induce BM phenotype. It might be possible to treat the cell line for longer time 
periods if the cells could be passaged while treating with the cytokines. Alternatively, 
a promoter luciferase vector for intestinal transcription factors such as CDX2 and 
HNF4α genes could be created. A screening test in which the oesophageal epithelial 
cells were transfected with promoter luciferase vector and then were treated with the 
different inflammation-related exogenous factors could be performed. Through 
observing the luminescence signal intensity which is related to the amount of 
luciferase produced, this screening test will demonstrate the induction of different 
exogenous factors on the promoter activity of the intestinal transcription factors.       
 
5.3.3 Bile acid in BM development 
The exposure of the oesophagus epithelium to bile salts and/or acid has been 
considered as a major factor for BM pathogenesis (Spechler, 2002; Souza, 2010). It 
has also been reported that oesophageal aspirates from the GORD patients contained 
higher concentration of bile acid than aspirates from the non-GORD patients (Kauer 
et al., 1997). The purpose of the studies on bile salt and acid treatment in this chapter 
were, firstly, to test whether bile salt and acid can induce intestinal transcription 
factors CDX2 and HNF4α expression and, secondly, to determine whether bile salt 
and acid can enhance HNF4α-induced intestinal gene expression. The examination 
of the effects of 24-hour DCA treatment showed different responses according to the 
origins of the oesophageal epithelial cells (Fig. 5.8). The results of the CDX2 
induction of by DCA in HET-1A cells is consistent with a previous report (Hu et al., 
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2007). However, in OE33 cells, CDX2 and HNF4α expression is reduced by DCA 
treatment. The result of CDX2 reduction by DCA is contradictory to previously 
published material. In previous reports, the CDX2 level in OE33 cells was slightly 
up-regulated by 8 or 12 hour DCA treatment (50-200 µM) (Tamagawa et al., 2012). 
It was demonstrated that bile salt mixture CA, TCA and GCA triggered Cdx1 and 
Klf4 expression in primary rat oesophageal epithelial cells (Kazumori et al., 2011, 
2009). However, in my studies, CA, TCA and GCA did not induce Cdx2 and HNF4α 
transcription in HET-1A cells (Fig.5.9). This might be due to the difference in cell 
types used. Additionally, the different time course, the different bile salt 
concentrations and the lower pH condition (< pH7) could be tested.  
 
Our original hypothesis was that HNF4α is a key driver of the switch from stratified 
squamous epithelium to intestinal epithelium. One possibility for HNF4α is that bile 
acids might induce the transcription factor as occurs in the liver and intestine (Jung 
et al., 2007; Hylemon et al., 2009; Lefebvre et al., 2009). Whether the ectopic 
HNF4α expression in BM is directly induced by bile acid has not been reported 
previously. My data showed that HNF4α expression was not induced by DCA in all 
cell types examined. A more extensive panel of conditions could be tested including 
different exposure periods, reducing the pH further from pH 6 and testing the 
addition of exogenous factors such as cytokines IL-1β and TNFα. In addition, other 
bile salts which have been shown to induce or increase CDX2, such as DHCA or bile 
salts cocktail of GCA, TCA, GCDCA,TCDCA, GDCA, TDCA (as listed in table 5.3) 
could be tested. It has been reported that different types of bile salt have different 
optimized pH condition to reach their maximum activity (Cronin et al., 2010b). In 
addition, it is also possible that ectopic expression of HNF4α is not directly 
up-regulated by bile acid, but by other intestinal transcription factors, particularly 
CDX2. It has been reported that HNF4α promoter contains CDX2 binding sites (Gao 
et al., 2009) and indeed CDX2 positively regulates HNF4α transcription through 
binding to HNF4α promoter and the 3’ enhance region during intestinal 
differentiation in Caco2 cells (Boyd et al., 2010). Therefore, the ectopic expression 





5.3.4 Notch, Wnt and BMP4 in BM 
Notch  
In both HET-1A and HNF4α-expressing cells, the inhibition of Notch pathway by 5 
or 25 µM DAPT treatment for 7 days did not induce or enhance intestinal gene 
expression (Fig.5.10). Previous studies using 20µM DAPT treatment of HET-1A 
cells for 48-hour increased CDX2 and MUC2 mRNA levels by 2- and 3-fold 
respectively (Tamagawa et al., 2012). In this report, the mRNA level was evaluated 
by real-time PCR method which would be more subjective than the traditional PCR 
used in this chapter. Therefore, real-time PCR could be utilized in experiments in the 




Several studies have indicated that aberrant activation of the Wnt/β-catenin 
signalling pathway is involved in the neoplastic progression of BM (Osterheld et al., 
2002; Clément et al., 2006). However, it remains to be investigated whether 
Wnt/β-catenin signalling activation also participates in the development of BM. In 
my study, treating HET-1A cells or HNF4α-expressing HET-1A cells with the GSK3 
inhibitor, 1m (which activates the Wnt/β-catenin pathway) did not provoke or 
enhance intestinal gene expression (Fig. 5.10). A previous study showed that the 
activation of Wnt signalling by introducing a dominant-active Wnt effector CatCLef 
caused intestinalized of immortalized primary human oesophageal cells (Kong et al., 
2011a). Nevertheless, the intestinalization was only observed when cells were 
cultured in the 3D organotypic model. This might implicate that cell-cell contact and 
polarization plays a role in Wnt-mediated BM development (Kong et al., 2011a). 
Therefore, a 3D organotypic culture system might be needed for the investigation of 
the role of Wnt/β-catenin signalling in the induction of intestinal transcription factor 
including HNF4α and CDX2. 
 
BMP4 
BMP4 either alone or in combination with DCA did not trigger or enhance intestinal 
gene transcription in either control HET-1A cells or in HET-1A cells expressing 
HNF4α (Fig.5.10. 5.11).  Previous reports showed that BMP4 induced a 
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columnar-type cytokeratin expression in human primary oesophageal epithelial 
cultures (Milano et al., 2007). BMP4 was also shown to induce Sox9 expression in 
HET-1A cells (Wang et al., 2010). However, there is no direct evidence showing that 
BMP4 alone is sufficient to drive intestinal metaplasia in the oesophageal epithelial 
cells. Therefore, BMP4 might promote columnar phenotype in the early development 
BM, but other exogenous factors or master transcription factors are probably 








Using mouse oesophageal explant 





6.1.1 Issues of using oesophageal cell lines as a model for BM 
In the Introduction (section 1.7), I described the use of oesophageal cell lines in BM 
research. These cell lines include those derived from normal oesophageal epithelium, 
BM or oesophageal adenocarcinoma. However, two main issues arise when using 
cell lines for BM research. Firstly, the phenotype of several cell lines has been 
questioned. For example, BIC-1, SEG-1, SK-GT-5 and TE-7 are in fact not 
oesophageal adenocarcinoma cell lines, but represent the colon adenocarcinoma 
(BIC-1), lung carcinoma (SEG-1), gastric fundus adenocarcinoma (SK-GT-5) or 
squamous carcinoma (TE-7) respectively (Boonstra et al., 2007; Alvarez et al., 2008; 
Boonstra et al., 2010).  
 
Secondly, during the cell line generation process, cells may undergo genetic 
transformation in order to become immortalized. Therefore, the genetic 
transformation may change the original characteristics of the cells (Kong et al., 
2010). For example, the HET-1A cell line was immortalized by the ectopic 
expression of the viral SV-40 gene (Stoner et al., 1991). SV-40 introduction results 
in the inactivation of p53 protein. Nevertheless, in BM and adenocarcinoma, p53 
mutation (inactivation) is not usually observed until the stage of high-grade dysplasia 
(Weaver et al., 2014). Furthermore, SV-40 ectopic expression has also been shown 
to alter epigenetic states through activating DNMT3a (Li et al., 2005). Indeed 
epigenetic mechanisms have been suggested to be involved in the development of 
BM (di Pietro et al., 2012). Lastly, BM is the condition in which the lining of 
stratified squamous type of oesophageal epithelium is replaced by an intestinal-type 
columnar epithelial monolayer. The ideal cell model for BM model should display 
the characteristics of squamous epithelial cells. Nevertheless, the cell lines current 
widely used for BM research, particularly HET-1A cells, displays columnar 
epithelial phenotype as shown in Figure 3.1 in Chapter 3. Therefore, there may be 
some bias when using HET-1A cells to recapitulate the BM in terms of the 






6.1.2 3D culture models for human oesophageal epithelial epithelium 
It has been suggested that the optimum in vitro model for BM studies should 
preserve the characteristics of the in vivo oesophageal cells, display the three 
dimensional (3D) organotypic architecture and can survive long-term (Colleypriest, 
2010). Because tissue and organs exist in 3D in the physiological environment, cells 
cultured in a 3D organotypic system offers some advantages over the 2D cell culture 
system. For example, cells cultured in the 3D system mimics a more physiologically 
relevant tissue environment than the 2D cell culture. The 3D culture system not only 
supports the interaction between cells and extracellular matrix (ECM) but also cells 
cultured in the 3D model may represent the different differentiated cell morphology 
and function. 
 
A number of reports have described the establishment of 3D human oesophageal 
epithelial culture models which mimic the features of the mature oesophageal 
epithelium (Underwood et al., 2010; Green et al., 2010; Maghsoudlou et al., 2014). It 
was shown that when cultured with the oesophageal fibroblasts, that primary human 
oesophageal epithelial cells are able to develop the stratified squamous structure. 
Additionally, a proliferative p63-expressing basal layer can be observed in this 3D 
organotypic culture (Underwood et al., 2010). Another report also has shown the 
success in developing a 3D culture system in which human oesophageal epithelial 
cells were cultured with fibroblasts on a porcine oesophagus-derided matrix (Green 
et al., 2010). In this system, a mature, stratified epithelium was produced and the 
epithelium resembled the similar expression pattern to the mature oesophageal 
epithelium including the K14 basal marker and differentiated markers K4 and 
Involucrin (Green et al., 2010).  
 
6.1.3 Primary mouse oesophageal epithelial explants as a model for studying 
BM 
As human oesophageal tissue is in limited supply we sought to develop from an 
alternative source. The use of mouse oesophageal epithelial cells as a model for 
studying BM has been described (Colleypriest, 2010). In the study, mouse 
oesophageal epithelium was stripped from the muscular layer and the epithelium was 
cut into small pieces (1-2 mm). The epithelial pieces were then placed on a scratched 
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plastic cover slide in a 35mm dish supplied with culture medium. Because some 
mesenchymal cells remains attached to the oesophageal epithelium, mesenchymal 
cells will grow as a feeder layer under the epithelial cells when cultured in BME 
medium. Results from the histological examination showed that this explant culture 
model not only recapitulates the in vivo oesophageal stratified structure but also 
preserves the expression of oesophageal epithelial markers. Oesophageal epithelial 
cells at different differentiation stages were observed including basal cells (p63 / 
K14-expressing) and suprabasal/differentiating cells (K4 / Involucrin-expressing). 
Furthermore, in this mouse oesophageal explant culture technique, the expansion of 
oesophageal epithelial cells can be manipulated by using different culture medium. 
When oesophageal explants were cultured in the low calcium Epilife medium (Ca
2+
 
[60µM]) instead of BME medium (Ca
2+
 [1.8mM]), the oesophageal explant grew 
into a monolayer cell sheet. Cells cultured in the Epilife medium contained a 
homogenous population of p63- and K14-expressing cells which represent the 
immature oesophageal cell population of the basal layer (Colleypriest, 2010).       
 
6.1.4 Aim 
The aim of this chapter was to utilise the primary mouse oesophageal epithelial 
cultures as a model to explore the mechanisms underlying the development of BM. 
In the first part of this chapter, adenoviral-mediated gene delivery was performed to 
induce HNF4α expression in the oesophageal epithelial cells. The effects of ectopic 
HNF4α expression on intestinal gene expression were then examined. In the second 
part of the chapter, mouse oesophageal explants were exposed with bile salt and/or 
acid to mimic the GORD condition. The expression of HNF4α, CDX2 and other 




6.2 Results  
6.2.1 Mouse oesophageal epithelial explants as model for BM studies 
Previous studies in the Tosh lab showed that mouse oesophageal epithelial explants 
can be maintained in either of two culture media: BME medium and Epilife medium. 
Mouse oesophageal epithelial explants cultured in the BME high calcium medium 
([Ca
2+
] 1.8mM) developed into a stratified structure resembling the in vivo 
oesophageal epithelial structure, whilst in the low calcium Epilife medium ([Ca
2+
] 
60µM), cells expanded into single-layer cell sheet (Colleypriest 2010). The 
morphology of explants which were cultured under either condition for 7 days is 
demonstrated in Fig. 6.1A. Immunostaining results showed that the explants cultured 
in the BME medium were positive for K14. Cells located near the original explant 
were positive for p63, but cells at the periphery of the cultures were negative for p63 
(Fig. 6.1B). By contrast, cells cultured in the Epilife medium were all positive for 
both K14 and p63 (Fig. 6.1B).     
 
6.2.2 Ectopic HNF4α expression in mouse oesophageal epithelial explants 
induces squamous-to-columnar cell type switch and VILLIN expression 
In order to understand whether forced HNF4α expression in the mouse oesophageal 
explants induces intestinal gene expression, an adenoviral vector which carries the 
HNF4α gene (Ad-HNF4α) or a control adenoviral vector (without any transgene and 
referred to as Ad-Null) was tested in mouse oesophageal epithelial explants. The 
explants were maintained in culture in Epilife medium (as these allow better access 
for the viral particles) for 7 days prior to infection. Following HNF4α expression 
(but not Ad-Null) there was a morphological change and the epithelial cells enlarged 
in culture 3 days after infection (Fig. 6.2).  
 
We next determined the expression of K8 and K14 in oesophageal explants 
following Ad-Null and Ad-HNF4α infection. Ad-Null infected cells did not express 
the columnar marker K8, but approximately 8% of cells in Ad-HNF4α infected 
cultures expressed K8 (Fig. 6.3A and Table 6.1A). All cells in Ad-Null infected 
cultures were positive for K14. However, in Ad-HNF4α treated cultures, around 25% 
lost K14 expression (Fig. 6.3B and Table 6.1B). Furthermore, we performed 
co-staining for both K8 and K14. Immunostaining for both K8 and K14 
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demonstrated that some K8-positive cells lost K14 expression, indicating that the 
squamous cells had undergone reprogramming to columnar-like cells (Fig. 6.4). It 
can also be observed that in some cells, the ectopic HNF4α expression inhibited p63 
expression (Fig. 6.5). Finally, the expression of intestinal VILLIN protein was 
checked. Forced HNF4α expression initiated VILLIN expression (Fig. 6.6A). 
Approximately 15.9% of cells in Ad-HNF4α infected cultures expressed VILLIN 
(Table 6.2). Finger-like protrusions expressing VILLIN can also be observed in 
higher magnification images (Fig. 6.6B). 
 
6.2.3 Inhibition of DNA methylation did not significantly induce intestinal gene 
expression 
In Chapter 5.2.1, I showed that 5’Aza did not induce or enhance intestinal gene 
expression in either control or CDX2 and HNF4α expressing cells. To further test the 
effect of the inhibition of DNA methylation on mouse oesophageal epithelial 
explants, explants were initially infected with Ad-HNF4α or Ad-Null virus for 24 
hours prior to treatment with 5’Aza. Explants treated with 2µM 5’Aza did not 
survive (data not shown). However, explants treated with 1µM 5’Aza did survive for 
up to 4 days. RT-PCR results showed that intestinal gene expression was not induced 
by this treatment in Ad-Null culture. In Ad-HNF4α culture, TFF3 was weakly 
induced by 5’Aza and TFF3 was not detected in cultures without 5’Aza treatment 
(Fig. 6.7). 
 
6.2.4 Bile acid and BM 
In the Chapter 5.2.3, I analysed the effects of DCA treatment on CDX2 and HNF4α 
expression in different oesophageal cell types. To further obtain informative studies, 
we decided to test the effects of bile acid treatment on intestinal gene expression in 
adult mouse oesophageal epithelial explants infected with Ad-HNF4α. We therefore 
cultured explants for 7 days prior to infection with either Ad-Null or Ad-HNF4α 
adenoviruses at 2.55 x 10
7
 IU/ml and at day 5, explants were treated with medium 
containing 300µM DCA at pH 6 for 24 hours. There was no induction of intestinal 
genes in the Ad-Null infected cells treated with or without DCA (Fig. 6.8). In the 
Ad-HNF4α infected cultures, VILLIN and TFF3 were detected, but surprisingly, 
VILLIN and TFF3 levels were reduced with DCA treatment. The expression of other 
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selected intestinal genes was not detected.   
 
We considered that the DCA might require a longer duration of exposure to induce a 
change in gene expression. We therefore extended the period of DCA treatment for 
up to 3 days. Mouse adult oesophageal epithelial explants were infected with 
Ad-HNF4α. At day 3, explants were incubated with 50 or 100 µM DCA for a further 
3 days. To mimic GORD, some cultures which were incubated with DCA containing 
medium were further treated with DCA containing medium at pH 6 for 10 minutes, 3 
times a day for 3 days. The results suggest there was no increase in VILLIN or TFF3 











Figure 6.1. Characterization of mouse oesophageal epithelial culture  
Mouse oesophageal epithelium was isolated and cut into small pieces and then 
cultured on scratched plastic slides before being placed in 35mm dishes supplied 
with different culture medium. (A) Phase contrast images displayed the oesophageal 
epithelial cells maintained in either BME or Epilife medium after 7 days of culture. 
(B) Immunostaining result displayed that in BME medium, cells near the central 
original explant expressed p63 and most of the cells expressed K14. By contrast, 
cells cultured in Epilife medium all co-expressed p63 and K14. One of two 






Figure 6.2. Ectopic Hnf4α expression in primary mouse oesophageal epithelial 
explants 
After 7 days of culture in Epilife medium, mouse oesophageal epithelial explants 
were treated with either Ad-HNF4α or Ad-Null virus (5.1 x 105 IU) for 24 hours and 
then medium was changed. Phase contrast images showed the morphology of 
oesophageal epithelial explants with Ad-Null or Ad-HNF4α infection at day3. 






Figure 6.3. The induction of K8 and the loss of K14 following Hnf4α expression 
in mouse oesophageal epithelial explants 
Mouse oesophageal epithelial explants were cultured in Epilife medium for 7 days 
and then Ad-HNF4α or Ad-Null virus was added. Twenty-four hours later, the 
medium was replaced with fresh medium. Following 2 days of further culture, cells 
were fixed for immunostaining. (A) K8 is not detected in the Ad-Null infected 
cultures, but K8 is found in the Ad-HNF4α cultures. (B) All cells in the Ad-Null 
treated culture expressed squamous cell marker K14, but a proportion of the cells in 
Ad-HNF4α treated culture no longer expressed K14 (arrow). The experiments were 





Table 6.1. The number of HNF4α/K8 and HNF4α/K14 expressing cells in mouse 
oesophageal epithelial explants following HNF4α expression  
Mouse oesophageal epithelial explants were cultured in Epilife medium for 7 days. 
Explants were infected with Ad-HNF4α or Ad-Null virus for 24 hours before the 
medium was changed. Following 2 days the explants were fixed for immunostaining. 
Table shows the number of (A) HNF4α and K8 and (B) HNF4α and K14 expressing 
cells based on the immunostaining results Figure 6.3A and 6.3B. The experiments 







Figure 6.4. Ectopic expression of HNF4α in adult mouse oesophageal epithelium 
induces a squamous-to-columnar switch in phenotype  
Seven days after culture in Epilife medium, mouse oesophageal epithelial explants 
were infected with Ad-HNF4α or Ad-Null virus for 24 hours and then the medium 
was replaced with fresh medium. The explants were fixed after 2 days of further 
culture. Immunostaining was performed to examine the expression of K8 and K14. 
Merged images of K8 and K14 demonstrate that explants infected with Ad-Null 
continue to express K14. However, some cells (arrow) in the Ad-HNF4α culture 
were negative for K14 and positive for K8, indicating that the cells may have 
undergone a squamous-to-columnar cell type switch. The experiments were 






Figure 6.5. The down-regulation of p63 by HNF4α ectopic expression in 
oesophageal epithelium 
After 7 days of maintenance in Epilife medium, Ad-Null or Ad-HNF4α virus was 
added into mouse oesophageal epithelial cultures and medium was replaced 24 hours 
later. After 2 days of further culture, the explants were fixed. (A) Immunostaining 
results showed that some HNF4α-expressing cells down-regulated the expression of 
p63 (arrow), while in Ad-Null infected cells were all positive for p63. The 





Figure 6.6. The induction of VILLIN expression by ectopic HNF4α expression 
in adult mouse oesophageal epthelium 
Mouse oesophageal epithelial explants were cultured in Epilife medium for 7 days 
and then were treated with either Ad-HNF4α or Ad-Null virus (5.1 x 105 IU) for 24 
hours. The explants were fixed after 2 days of further culture. VILLIN and HNF4α 
immunostaining results displayed that (A) intestinal protein VILLIN is not expressed 
in the Ad-Null-infected cells, but ectopic HNF4α expression induces VILLIN 
expression. (B) Microvilli protrusions can be observed in the high magnification 












Table 6.2. The number of HNF4α/VILLIN expressing cells in mouse 
oesophageal epithelial explants following HNF4α expression  
Mouse oesophageal epithelial explants were cultured in Epilife medium for 7 days. 
Explants were infected with Ad-HNF4α or Ad-Null virus for 24 hours before the 
medium was changed. Following 2 days the explants were fixed for immunostaining. 
Table shows the number of HNF4α and VILLIN expressing cells based on the 











Figure 6.7. Treatment with the DNA methyltransferase inhibitor 5’-Azacytidine 
enhanced intestinal gene expression in Ad-HNF4-infected oesophageal epithelial 
explants 
Mouse oesophageal epithelial explants were initially cultured in BME medium for 7 
days and then treated with either Ad-Null or Ad-HNF4α. After 24-hours of viral 
infection, the cells were treated with 1µM 5’-Azacytidine or DMSO for a further 4 
days. Cells were harvested at day 5 and RT-PCR was performed. Controls include 
mouse intestine (positive, +) and reaction without sample (negative, -). β–ACTIN 






Figure 6.8. DCA treatment did not enhance intestinal gene expression in 
HNF4α-expressing mouse oesophageal epithelial explants 
Mouse oesophageal epithelial explants were cultured in BME medium for 7 days and 
then infected with Ad-HNF4α or Ad-Null for 24 hours. The medium was then 
changed. At day 5, cells were treated with medium containing 300 µM DCA, at pH 6 
for 24 hours. Cells were then harvested and RT-PCR performed. β-ACTIN was used 





Figure 6.9. DCA and low pH treatment did not enhance intestinal gene 
expression in HNF4α-expressing mouse oesophageal epithelial explants 
Mouse oesophageal epithelial explants which have been cultured in BME medium 
for 7 days were incubated with Ad-HNF4α virus for 24 hours, and medium was 
changed. At day 3, cultures were treated with medium containing 50 or 100 µM 
DCA.  DCA treated cultures were further treated with DCA containing medium at 
pH 6 for 10 minutes, 3 times per day for 3 days. Cultures were harvested at day 6 
and RT-PCR was performed. β-ACTIN was used as a loading control. The 




6.3.1 Ectopic HNF4α expression in primary mouse oesophageal explants 
Primary mouse oesophageal explants can be cultured in the serum-containing BME 
medium or under serum-free conditions in Epilife medium. Oesophageal epithelial 
explants in BME medium formed a stratified structure resembling in vivo 
oesophageal epithelium structure. Additionally, p63-expressing cells were observed 
near the original epithelial explant, but not at the edge of the outgrowth of cells. By 
contrast, oesophageal epithelial explants in Epilife medium formed a single layer and 
homogenously expressed p63 and K14 of basal cell phenotype. Because explants in 
Epilife medium formed a single layer, this greatly improves the virus infection 
efficiency compared with the virus infection efficiency in explants cultured in BME 
medium. The difference between the media is mainly due to the difference in 
calcium concentration. BME medium contains 1.8mM Ca
2+





is an import regulator for human epidermal keratinocyte 
differentiation. Epidermal keratinocyte stratified and showed terminal differentiation 
when cultured in the high Ca
2+
 concentration (1.0mM), but epidermal keratinocyte 
remained in undifferentiated state and grew in single layer when maintained in lower  
Ca
2+ 
concentrations (0.3mM) (Boyce & Ham, 1983). 
 
We tested the ability of HNF4α to induce a phenotypic switch in the 
K14/p63-positive cells maintained in Epilife medium. Following ectopic expression 
of HNF4α, the columnar marker K8 expression was induced and squamous marker 
K14 expression was decreased in the primary mouse oesophageal epithelial cells. 
Furthermore, K8 and K14 dual staining showed the presence of K14 negative and K8 
positive cells. Additionally, HNF4α ectopic expression resulted in the loss of p63 and 
induction of VILLIN protein expression. Taken together, this evidence suggests that 
HNF4α ectopic expression may induce a squamous-to-columnar cell type conversion 
and may also induce intestinal differentiation. It will be interesting to investigate 
whether HNF4α induces morphological features of intestinal epithelial cells such as 
microvilli as has been observed in NIH-3T3 cells (Babeu et al., 2009). It will also be 
important to investigate the expression of other intestinal genes, and understand the 
mechanisms and signalling pathway underlying the development of BM. For 
example, the p63 gene expression could be checked by RT-PCR and p63 protein 
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level could be examined by Western blotting in a time and dose (Ad-HNF4α amount) 
dependent manner. It is also important to understand how HNF4α inhibits p63 
expression. According to the search results from web-based tool (HNF4 Motif Finder, 
http://nrmotif.ucr.edu) (Bolotin et al., 2010), there is no potential HNF4α binding site 
found in the −2 kb to +1 bp region of the p63 promoter. Therefore, HNF4α might 
indirectly inhibit p63 expression. It is also possible that the loss of p63 is the indirect 
effect of the intestinal differentiation. 
 
Finally , it has been suggested that HNF4α might regulate intestinal function and 
differentiation through regulating the Wnt/β-catenin signalling pathway (Cattin et al., 
2009). In the study, conditional knockout of Hnf4α in adult mice (Villin-Cre-ERT2; 
Hnf4αloxP/loxP) increased the β-catenin level in the nucleus revealing the activation of 
Wnt/β-catenin pathway. In vitro studies also showed that HNF4α inhibited 
β-catenin/TCF-dependent luciferase activity in human colorectal cancer cells 
HCT116, and HNF4α interacts with TCF-4 protein in HCT116 and Caco-2/TC7 cells. 
These results suggest that HNF4α inhibits Wnt/β-catenin pathway in the intestinal 
epithelium. Wnt/β-catenin pathway has been known to play a critical role in the 
regulation of cell proliferation and differentiation balance, and the maintenance of 
stem cells and progenitor cells in the intestinal epithelium (Pinto & Clevers, 2005). 
Therefore, it is important to investigate whether Wnt/β-catenin signalling pathway 
contributes to the HNF4α-induced intestinal differentiation in normal oesophageal 
epithelial cells. 
 
6.3.2 DNA methylation mechanism and BM  
Epigenetic regulation could be an important factor in the development. Studies in 
both EPC-hTERT cell line and K14-Cdx2 transgenic mice showed that the inhibition 
of DNA methylation by 5’Aza treatment induce BM marker expression, but BM 
marker expression was not observed in non-treatment control groups (Kong et al., 
2009, 2011b). In Chapter 5.2.1, I investigated the effects of 5’Aza treatment in 
HNF4α-expressing HET-1A cells. Results showed that the expression of BM 
markers was not induced by 5’Aza treatment. In this chapter, I further used mouse 
oesophageal epithelial explant culture as a model to understand whether 5’Aza 
treatment could induce the expression of BM markers. My study results showed that 
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5’Aza treatment weakly enhanced TFF3 expression level in mouse oesophageal 
epithelial explants infected with Ad-HNF4α compared to Ad-HNF4α infected 
explants alone (Fig. 6.7). The inhibition of methylation by 5’Aza might open the 
inactivated promoter regions and enhance transcriptional activity (Kong et al., 
2011b). Indeed, the DNA methylation mechanism is involved in the development of 
BM. It was observed that there are differences in the promoter methylation profile 
between normal oesophageal epithelium and BM (Eads et al., 2001; Wang et al., 
2009; Kaz et al., 2011; Agarwal et al., 2012; Alvi et al., 2013). In the future it will be 
interesting to investigate the effects of DNA methylation inhibition by treating 5’Aza 
on CDX2, and both CDX2 and HNF4α-expressing oesophageal epithelial explants. 
 
6.3.3 Bile acid/salt and BM 
It has been known that patients with GORD have increased risk of BM and bile salt 
and acid are the potential toxic component of gastric contents (Dvorak et al., 2007; 
Souza, 2010). Therefore, it has been considered that the exposure of bile salt and 
acid at the lower end of the oesophageal epithelium are the key factors for BM 
development. The aim of exposure of bile salt and acid on oesophageal epithelial 
explants was to understand whether bile salt and acid could (i) induce intestinal gene 
expression and (ii) enhance HNF4α-induced intestinal genes. My results showed that 
bile salt and acid stimulation did not enhance intestinal gene expression in mice adult 
oesophageal epithelial explants which has been infected with Ad-HNF4α (Fig. 6.8, 
6.9). The failure of intestinal gene induction could be due to exposure time, pH, and 
concentration and types of bile salts. The effects of bile salt and acid on CDX2 
expression in normal primary oesophageal epithelial cells have been described 
(Marchetti et al., 2003; Kazumori et al., 2006; Huo et al., 2010). Study in primary 
mouse oesophageal epithelial cells showed that exposure to pH3.5 for 18 days 
induced CDX2 protein expression (Marchetti et al., 2003). Another report in which 
rat oesophageal epithelial cells were used as the study model demonstrated that 
50 µM CA or 100µM DHCA treatment for 24 hours induced CDX2 protein 
expression (Kazumori et al., 2006). However, acid (pH4) and/or bile salts cocktail 10 
minutes, 3 times a day for 7 days treatment did not induce CDX2 expression in 
oesophageal epithelial cells derived from GORD patients without BM (Huo et al., 
2010). Therefore, a more extensive panel of conditions including different exposure 
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periods, different pH, and different types and different concentration of bile salts 








Chapter 7                    




7.1 Limitations of the study  
In this thesis, three cell models were used for studying the development of BM: 
HET-1A cells, mouse oesophageal epithelial explants cultured in BME medium and 
explants cultured in Epilife medium. HET-1A cells were the most widely used cell 
model in my thesis. Culturing HET-1A cells was relatively less labour intensive and 
expanding HET-1A cells was relatively robust when compared with culturing the 
primary mouse oesophageal epithelial explants. However, HET-1A cells might not 
be a suitable model for studying BM, because HET-1A cells do not represent the 
normal oesophageal squamous characteristics. HET-1A cells do not show the typical 
squamous markers such as K14 and p63, but express instead the columnar marker 
K8 and mesenchymal marker Vimentin (Figure 3.1 in Chapter 3). Therefore, as an 
alternative model I utilised mouse oesophageal epithelial explants. 
 
Mouse oesophageal epithelial explants cultured in BME medium displayed the 3D 
multilayer structure resembling the in vivo oesophageal stratified squamous 
epithelium (Colleypriest, 2010). However, the major problem of using this culture 
system as a model is the poor infection efficiency with the adenoviral-mediated gene 
delivery. Because of the thickness of the 3D epithelial multilayer, only cells at the 
explant periphery were able to be infected with the adenovirus. Therefore, to 
improve the adenoviral infection efficiency, mouse oesophageal epithelial explants 
cultured in low calcium (Ca
2+
 [60µM]) Epilife medium were used.  
 
Mouse oesophageal epithelial cells cultured in Epilife medium grew as a monolayer 
and showed the characteristics of the basal oesophageal epithelial cells with the 
expression of K14 and p63. The efficiency of the adenoviral infection was 
significantly improved under these culture conditions. However, the reproducibility 
of the establishment of the explants cultured in the low calcium medium is not ideal. 
There are difficulties in expanding cells and cells were also only able to survive for 
up to two weeks in the low calcium media. In addition to Eplife medium (Invirtogen), 
different types of low calcium keratinocyte media and medium from difference 
sources including MCDB153 (Sigma) and MCDB153 kit (Biochrom) were tested. 
Furthermore, to create low calcium medium, a method for removing calcium from 
the BME medium was also evaluated. A low calcium environment was created by 
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supplementing the BME medium with either of the calcium chelators EDTA or 
BAPTA (1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid). However, the 
poor consistency and reproducibility of culturing oesophageal explant cultures in the 
low calcium medium did not improve. Therefore, the model of oesophageal explant 
cultured in under low calcium conditions was not used extensively in this thesis. In 
the future, other culture methods could be tested. For example, oesophageal 
epithelium could be dissociated into single cells before culture in the low calcium 
medium. If the culture conditions could be optimised, the experiments performed in 
HET-1A cells in this thesis could be re-evaluated including the ectopic expression of 
intestinal transcription factors and the screening of exogenous factors.       
 
7.2 The role of master intestinal transcription factors in BM 
As shown in Chapter 4, in addition to the intestinal markers K20, SI, ISX, ectopic 
CDX2 expression in HET-1A cells up-regulated LGR5, a marker for stem cells in 
several types of organs including the intestine and the stomach. Although LGR5 
protein expression should be determined, the up-regulation of LGR5 gene expression 
raised the possibility that, if CDX2 is involved in the early stage of BM, the 
oesophageal squamous cell may turn into a stem cell state and then differentiate into 
intestinal-like cells. This can be investigated by overexpressing CDX2, and for 
example, real-time tracking of LGR5-GFP and VILLIN-mCherry expression at the 
single cell level.         
                                                                
Overexpression of CDX2 and HNF4α (either alone or in combination) in HET-1A 
cells induced expression (at least at the mRNA level) of VILLIN and K20. Indeed the 
levels of VILLIN and K20 were the highest when both transcription factors were 
overexpressed. The improvement of the consistency of the viral infection efficiency 
and more repeated experiments will provide the more reliable results of whether 
there is a synergistic effect of CDX2 and HDX4α on inducing intestinal gene 
expression. Although K14-CDX2 transgenic did not display a BM phenotype (Kong 
et al., 2011b), it will be interesting to investigate whether BM phenotype can be 
induced by double ectopic CDX2 and HNF4α expression in the K14-CDX2; 
K14-HNF4α transgenic mice model. Another possible synergistic effect was also 
observed in the ectopic expression of FOXA2 with the addition of CDX2. FOXA2 
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and CDX2 together induced MUC2 expression which was not induced by either 
FOXA2 or CDX2 alone. Given that the possible synergistic effect of intestinal gene 
expression by CDX2 and HNF4α or by CDX2 and FOXA2, a polycistronic construct 
of FOXA2, CDX2 and HNF4α could be created and tested in oesophageal epithelial 
squamous cells to understand whether the coexpression of FOXA2, CDX2 and 
HNF4α induces a more robust BM phenotype.        
 
In this thesis, the induction of the intestinal phenotype was assessed by intestinal 
gene and protein expression. In fact, the intestinal phenotype can also be evaluated 
through electron microscopy method. The presence of intestinal epithelial 
ultrastructural features including microvilli and mucin granules are important 
characteristics of the intestinal epithelium (Fre et al., 2005; Quante et al., 2012).  
 
7.3 Regulatory network of CDX2, HNF1α and HNF4α in BM development 
Gene expression is complex and finely regulated. The gene expression is controlled 
by the combination of transcription factors rather than the individual transcription 
factor. Indeed, in the intestinal epithelium, the transcription factor network regulates 
intestinal cell growth and cell fate decisions (Phillips & Hoopes, 2008; Olsen et al., 
2012). The potential regulatory network in the intestinal epithelium includes CDX2, 
HNF1α and HNF4α and has been described in Chapter 1.5.4. It possible that the 
development of BM is also controlled by the regulatory network of intestinal 
transcription factors. My results on CDX2, HNF1α and HNF4α ectopic expression in 
the HET-1A cells (Fig 4.5, 4.10) showed that VILLIN and K20 mRNA levels were 
highest in Ad-HNF4α and Ad-CDX2 co-infected cells. Additionally, the mRNA 
levels of VILLIN and K20 in Ad-HNF4α, Ad-CDX2 and Ad-HNF1α infected cells 
were lower than the levels in cells infected with Ad-HNF4α and Ad-CDX2. It 
remains to be investigated that whether HNFα and CDX2 work cooperatively to 
transcribe K20 and VILLIN in HET-1A cells and whether HNF1α may have 
inhibitory effects on K20 and VILLIN expression when HNF4α and CDX2 are also 
present. It is known that transcription factors could influence each other’s binding to 
the DNA (Phillips, 2008). Therefore, the negative regulation of gene expression by 
one transcription factor may occur through impeding the binding of other 
transcription factors to the DNA. 
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Hierarchical role of intestinal transcription factors in BM development 
The combinational control of transcription factors could exhibit a hierarchical and 
dynamic pattern. For example, it was found that the dynamic pattern of C/EBPα, 
C/EBPβ and C/EBPδ expression is different between C/EBPs and cell types 
(adipocyte and granulocyte) during the differentiation process (Calkhoven & Ab, 
1996; Cao et al., 1991; Scott et al., 1992). Similarly, it is likely that intestinal gene 
expression may be controlled by the hierarchical and dynamic transcription 
factors network. In this context, CDX2 interacts with intestinal DNA with GATA-6 
in cell proliferation, while CDX2 partners with HNF4α during cell differentiation 
(Verzi et al., 2010). In addition, CDX2 enables the binding of HNF4α to the 
chromatin in the mouse adult intestinal epithelium (Verzi et al., 2013). Finally, the 
“two-hit hypothesis” has been purposed to explain the development of BM. In the 
hypothesis, the ectopic expression of HNF4α first leads to oesophageal squamous 
cell converting into columnar cell type and in the next step, CDX2 differentiates 
columnar cell into intestinal-like cell (Colleypriest, 2010). This hypothesis might 
also be supported by the fact that HNF4α is also expressed in the stomach which is 
lined by the columnar-type cells, but CDX2 expression is only limited to the 
intestine (Gao et al., 2009; Takano et al., 2009). Additionally, CDX2 ectopic 
expression in transgenic mice (Fox3-Cdx2) developed intestinal metaplasia in the 
gastric mucosa (Silberg et al., 2002).  
 
By contrast, it is also possible that CDX2 firstly induced by NF-κB activation due to 
the bile acid exposure or inflammatory response caused by GORD (Kim et al., 2002; 
Jenkins et al., 2004; Kazumori et al., 2006). CDX2 ectopic expression may then 
induce HNF4α expression and the combination of CDX2 and HNF4α expression 
leads to BM. Especially it was observed that in the developing mice, HNF4α 
expression is largely increased during the intestinalisation process between 
E14.5-E16.5 (Li et al., 2009). During this period, the intestinal epithelium is 
reorganised and villus structure is formed. Therefore, it was speculated that HNF4α 
plays an important role in the final stabilisation of intestinal epithelium in the 




Therefore, the specific order and the dynamic expression of the master intestinal 
transcription factors may be important when investigating the effects of the ectopic 
expression of intestinal transcription factors in BM development. For example, the 
sequential expression could be exanimated by comparing the presence of intestinal 
transcription factors in the BM tissue and the adjacent normal or oesophagitis 
squamous tissue. The relative levels of the different intestinal transcription factors 
expressed in the BM tissue could also be investigated. Additionally, in the in vitro 
experiment, CDX2 could first be introduced for a period of time and then followed 
by the HNF4α introduction in the oesophageal cells or vice versa. The effects of 
intestinal gene induction could then be investigated.   
 
Threshold level of transcription factor in cell fate determination 
The expression level of transcription factor might be a major mechanism that 
regulates cellular differentiation. For example, studies in hematopoietic stem cell 
differentiation revealed that the concentration of transcription factor PU.1 is a critical 
factor that alters the threshold level of cell fate. The high expression level of PU.1 
shows normal hematopoietic development. However, when the expression level of 
PU.1 is low and meets a threshold, with other mutation such as c-MYC, 
hematopoietic stem cells could undergo malignant transformation and this leads to 
leukemia (Rosenbauer et al., 2005). In BM, whether the initiation of intestinal 
differentiation requires the expression of intestinal transcription factor to reach a 
threshold level remains to be investigated. In particular, because multiple intestinal 
transcription factors may be involved, it will be interesting to understand whether the 
development of BM requires the expression of the particular intestinal transcription 
factors which are all required to meet their individual threshold level.    
 
Post-translational modification and epigenetic mechanism in BM 
Besides the threshold level and dynamic pattern of transcription factors, the 
modulation of transcription factor activity itself may also be important for the 
temporal and spatial specificity of the gene expression. Transcription factor function 
and activity could be affected by the post-translational modifications such as 
phosphorylation, glycosylation, sumoylation, acetylation and ubiquitination (Tootle 
& Rebay, 2005). For example, studies showed that HNF4α activity could be 
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modulated by phosphorylation. Phosphorylation at HNF4α Ser158 facilitates the 
recruitment of transcriptional co-activator, PC4, and enhances the target gene 
transcription (Guo et al., 2007). However, phosphorylation at HNF4α Ser78 results 
in the failure of HNF4α binding to the DNA and therefore inhibits the HNF4α 
transcription activity (Sun et al., 2007). In addition to post-translational modification, 
DNA methylation, imprinting and conceding DNA of epigenetic mechanisms also 
exert a finer level of control over gene expression (Phillips, 2008).  
 
An epigenetic mechanism has been suggested to be involved in the BM development 
(Kong et al., 2011b). In addition to DNA methylation, histone modification might 
also play a role in the BM pathogenesis. It was demonstrated that the ectopic 
expression of HOXB5, 6 and 7 were associated with BM development. Analysis in 
human specimens of BM-related oesophageal adenocarcinoma revealed that Histone 
3 lysine 27 trimethylation (H3K27me3) level was reduced, and histone 3 acetylation 
(AcH3) level was increased near the transcription start region of HoxB5, 6 and 7, 
compared with the normal oesophageal epithelium. The degree of chromatin 
decomposition in HOXB locus was positively associated with the progression of BE 
and oesophageal adenocarcinoma (di Pietro et al., 2012). Therefore, it will be 
interesting to investigate the importance of histone modification in the development 
of BM. 
 
In summary, the mechanisms underlying BM development may not only involve the 
ectopic expression of intestinal transcription factors, but mechanisms such as the 
threshold and dynamic regulation of intestinal transcription factors, epigenetic 
mechanism and post-translational modification could also be critical. More 
importantly, in addition to intestinal transcription factors, the transcriptional control 
from squamous oesophageal transcription factors such as p63 should also be taken 
into consideration. It will be important to know when and how the expression of p63 
is inhibited and what the effects of p63 inhibition are in terms of the loss of 






7.4 Model for BM research 
In this thesis, the forced expression of HNF4α in the mouse oesophageal epithelial 
explants induces VILLIN protein expression. However, HNF4α only induces VILLIN 
mRNA but not VILLIN protein expression in HET-1A cells. Given that epithelial 
explants (in low Ca
2+




 basal cell type, but HET-1A cells 
lack p63 and K14 expression, this implied that BM cells may be arise from the 
oesophageal epithelial cells at stem or progenitor lineage. In addition, it has also 
been observed the oesophageal epithelial cells cultured in 2D or 3D culture system 
showed a different response to Wnt signalling activation (Kong et al., 2011a). The 
activation of Wnt pathway only provoked BM gene expression in cells which are 
cultured under the 3D culture environment. This suggests that the mechanism 
involved in the cell-cell contact may be important for BM development. Therefore, 
the chosen cell models and culture conditions are important for BM research. 
 
7.5 Cell origin of BM 
LGR5, Musashi-1 and doublecortin-like kinase-1 (DCLK-1) are intestinal stem cell 
markers and have also been suggested as cancer stem cell markers. Recent studies 
show that that Musashi-1, LGR5 and DCLK-1 expression were increased in BM and 
oesophageal adenocarcinoma (Bobryshev et al., 2010; Becker et al., 2010; Todaro et 
al., 2010; Vega et al., 2012; Wu et al., 2012). These findings may support that BM 
cells are originated from stem cell population. It is therefore the different research 
strategy and study models may be required to understand the mechanism of BM 
development. For example, it would be important to identify the location of 
Musashi-1, LGR5 or DCLK-1 stem cell population in the oesophagus. Lineage 
tracing of stem cells in animals and observing the phenotype changes of stem cells 
following exposure to exogenous factors, such as bile acid, will help to the 
understanding of the molecular mechanism underlying BM pathogenesis.  
 
7.6 Conclusion 
The aims of my PhD project were (i) to understand the role of candidate intestinal 
transcription factors on BM development and (ii) to investigate whether the exposure 
of candidate exogenous factors initiate BM. The results from the HET-1A cell model 
showed that intestinal transcription factors including HNF4α, CDX2 and HNF1α 
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induced the transcription of intestinal genes including K20, VILLIN and SI. 
Additionally, intestinal transcription factor FOXA2 may also play a role in 
intestinalisation, but further investigation is required. Results from the model of the 
oesophageal epithelial explants revealed that HNF4α ectopic expression induces 
squamous-to-columnar cell type conversion and VILLIN protein expression. The 
work presented in this thesis would suggest that the ectopic expression of intestinal 
transcription factors including HNF4α, CDX2 and HNF1α and FOXA2 may have a 
potential link to the development BM.  
 
Results from the treatment of various candidate exogenous factors did not show the 
effects on intestinal differentiation in the HET-1A cell or HNF4α-expressing 
HET-1A cells. However, this may due to the experimental design and the cell model 
used. In the future, longer exposure period and the use of suitable cell models such 
as primary oesophageal epithelial culture could be tested to understand the role of 
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Shuttle vectors for production of recombinant adenoviral virus  
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Lentiviral vector  
Lenti-FOXA2, plasmid/vector pL-S- FOXA2-I-puro 
Lenti-HNF4α, plasmid/vector pL-S-HNF4α-I-EGFP 
Lenti- mutant HNF4α, plasmid/vector pL-S-HNF4α mutant-I-puro 
Lenti-HCH, plasmid/vector pL-S-HCH-I-puro 












SIN: Self-Inactivating 3’ Long Terminal Repeat (LTR) 
PRE: post-transcriptional regulatory element 
IRES: EMCV internal ribosome entry site 
SFFV: strong internal promoter of SFFV (Spleen focus forming virus) 
PPT: central polypurine tract 
RRE: Rev responsive element 
dGag: portion of the HIV-1 gag gene with a closed reading fram  
PBS: primer binding site 
RU5: 5’-HIV-1 repeat and U5-region of the LTR 
RSV: rous sarcoma virus promoter 
Source (Iacob et al., 2011) 
FOXA2, HNF4α,  
HNF4α mutant, 



































Sequence: Lenti-mutant HNF4α 





































Sequence: Lenti-HCH (HNF4α-2A-CDX2-2A-HNF1α) 
-2A-CDX2-2A-HNF1α HNF4α
TTGGTACCGGATCCatgcgactctccaaaaccctcgtTgacatggacatggccgactacagtgctgcactggacccag
cctacaccaccctggaatttgagaatgtgcaggtgttgacgatgggcaatgacacgtccccatcagaaggcaccaacctcaacgcg
cccaacagcctgggtgtcagcgccctgtgtgccatctgcggggaccgggccacgggcaaacactacggtgcctcgagctgtgacg
gctgcaagggcttcttccggaggagcgtgcggaagaaccacatgtactcctgcagatttagccggcagtgcgtggtggacaaagac
aagaggaaccagtgccgctactgcaggctcaagaaatgcttccgggctggcatgaagaaggaagccgtccagaatgagcgggac
cggatcagcactcgaaggtcaagctatgaggacagcagcctgccctccatcaatgcgctcctgcaggcggaggtcctgtcccgaca
gatcacctcccccgtctccgggatcaacggcgacattcgggcgaagaagattgccagcatcgcagatgtgtgtgagtccatgaagg
agcagctgctggttctcgttgagtgggccaagtacatcccagctttctgcgagctccccctggacgaccaggtggccctgctcagag
cccatgctggcgagcacctgctgctcggagccaccaagagatccatggtgttcaaggacgtgctgctcctaggcaatgactacattgt
ccctcggcactgcccggagctggcggagatgagccgggtgtccatacgcatccttgacgagctggtgctgcccttccaggagctgc
agatcgatgacaatgagtatgcctacctcaaagccatcatcttctttgacccagatgccaaggggctgagcgatccagggaagatcaa
gcggctgcgttcccaggtgcaggtgagcttggaggactacatcaacgaccgccagtatgactcgcgtggccgctttggagagctgc
tgctgctgctgcccaccttgcagagcatcacctggcagatgatcgagcagatccagttcatcaagctcttcggcatggccaagattga
caacctgttgcaggagatgctgctgggagggtcccccagcgatgcaccccatgcccaccaccccctgcaccctcacctgatgcagg
aacatatgggaaccaacgtcatcgttgccaacacaatgcccactcacctcagcaacggacagatgtccacccctgagaccccacag
ccctcaccgccaggtggctcagggtctgagccctataagctcctgccgggagccgtcgccacaatcgtcaagcccctctctgccatc
ccccagccgaccatcaccaagcaggaagttatcGAATTCAAAATTGTCGCTCCTGTCAAACAAACTC
TTAACTTTGATTTACTCAAACTGGCTGGGGATGTAGAAAGCAATCCAGGTCCAGAT
ATCatgtacgtgagctacctcctggacaaggacgtgagcatgtaccctagctccgtgcgccactctggcggcctcaacctggcgc
cgcagaacttcgtcagccccccgcagtacccggactacggcggttaccacgtggcggccgcagctgcagcggcagcgaacttgg
acagcgcgcagtccccggggccatcctggccggcagcgtatggcgccccactccgggaggactggaatggctacgcgcccgga
ggcgccgcggccgccgccaacgccgtggctcacggcctcaacggtggctccccggccgcagccatgggctacagcagccccgc
agactaccatccgcaccaccacccgcatcaccacccgcaccacccggccgccgcgccttcctgcgcttctgggctgctgcaaacg
ctcaaccccggccctcctgggcccgccgccaccgctgccgccgagcagctgtctcccggcggccagcggcggaacctgtgcga
gtggatgcggaagccggcgcagcagtccctcggcagccaagtgaaaaccaggacgaaagacaaatatcgagtggtgtacacgga
ccaccagcggctggagctggagaaggagtttcactacagtcgctacatcaccatccggaggaaagccgagctagccgccacgctg
gggctctctgagaggcaggttaaaatctggtttcagaaccgcagagcaaaggagaggaaaatcaacaagaagaagttgcagcagc
aacagcagcagcagccaccacagccgcctccgccgccaccacagcctccccagcctcagccaggtcctctgagaagtgtcccag
agcccttgagtccggtgtcttccctgcaagcctcagtgtctggctctgtccctggggttctggggccaactgggggggtgctaaaccc
caccgtcacccagTCTAGAAAAATTGTCGCTCCTGTCAAACAAACTCTTAACTTTGATTTA
CTCAAACTGGCTGGGGATGTAGAAAGCAATCCAGGTCCAGATATCatggtttctaaactgag
ccagctgcagacggagctcctggcggccctgctcgagtcagggctgagcaaagaggcactgatccaggcactgggtgagccggg
gccctacctcctggctggagaaggccccctggacaagggggagtcctgcggcggcggtcgaggggagctggctgagctgccca
atgggctgggggagactcggggctccgaggacgagacggacgacgatggggaagacttcacgccacccatcctcaaagagctg
221 
 
gagaacctcagccctgaggaggcggcccaccagaaagccgtggtggagacccttctgcaggaggacccgtggcgtgtggcgaa
gatggtcaagtcctacctgcagcagcacaacatcccacagcgggaggtggtcgataccactggcctcaaccagtcccacctgtccc
aacacctcaacaagggcactcccatgaagacgcagaagcgggccgccctgtacacctggtacgtccgcaagcagcgagaggtgg
cgcagcagttcacccatgcagggcagggagggctgattgaagagcccacaggtgatgagctaccaaccaagaaggggcggagg
aaccgtttcaagtggggcccagcatcccagcagatcctgttccaggcctatgagaggcagaagaaccctagcaaggaggagcgag
agacgctagtggaggagtgcaatagggcggaatgcatccagagaggggtgtccccatcacaggcacaggggctgggctccaacc
tcgtcacggaggtgcgtgtctacaactggtttgccaaccggcgcaaagaagaagccttccggcacaagctggccatggacacgtac
agcgggccccccccagggccaggcccgggacctgcgctgcccgctcacagctcccctggcctgcctccacctgccctctccccca
gtaaggtccacggtgtgcgctatggacagcctgcgaccagtgagactgcagaagtaccctcaagcagcggcggtcccttagtgaca
gtgtctacacccctccaccaagtgtcccccacgggcctggagcccagccacagcctgctgagtacagaagccaagctggtctcagc
agctgggggccccctcccccctgtcagcaccctgacagcactgcacagcttggagcagacatccccaggcctcaaccagcagccc
cagaacctcatcatggcctcacttcctggggtcatgaccatcgggcctggtgagcctgcctccctgggtcctacgttcaccaacacag
gtgcctccaccctggtcatcggcctggcctccacgcaggcacagagtgtgccggtcatcaacagcatgggcagcagcctgaccac
cttgcagcccgtccagttctcccagccgctgcacccctcctaccagcagccgctcatgccacctgtgcagagccatgtgacccagaa
ccccttcatggccaccatggctcagctgcagagcccccacgccctctacagccacaagcccgaggtggcccagtacacccacacg
ggcctgctcccgcagactatgctcatcaccgacaccaccaacctgagcgccctggccagcctcacgcccaccaagcaggtcttcac
ctcagacactgaggcctccagtgagtccgggcttcacacgccggcatctcaggccaccaccctccacgtccccagccaggaccct
gccggcatccagcacctgcagccggcccaccggctcagcgccagccccacagtgtcctccagcagcctggtgctgtaccagagct
cagactccagcaatggccagagccacctgctgccatccaaccacagcgtcatcgagaccttcatctccacccagatggcctcttcctc
ccagtaaGGATCCTCTAGAtt 
 
 
